Yaya tsawon lokacin da waɗannan alamun suka ci gaba?
Ya kamata a bi da dukan ciwon kirji ta wannan hanyar, musamman ma a shekarunka.
Kuma da zazzabi.
Kuma za a bincika hawan jikinka da kuma yawan sinadarin da ke cikin jikinka.
Kuma yanzu kana da zazzabi?
Kuma kana jin wannan ciwon a cikin kirji yanzu?
Kuma ba ka da wahalar numfashi?
Kuma za ka iya gaya mini wasu alamun da kake da su ban da wannan?
Kuma yaya zafin da ya same ka?
Ina da ciwon tari kuma.
Kuma ina da ɗan sanyi da tari.
Kuma ina da ciwon kirji mai tsanani a yau.
Kuma wannan lokaci ne da ya dace da zazzabin hayar da ke damun ka?
Kuma yana da zafi a kirji.
Kuma ina da zazzabi.
Kuma ina so ka bayyana inda kake jin ciwon kirji.
Suna kuma da zazzabi.
Kuma da tarihin ciwon sukari naka,
Kuma kamar yadda kuka sani, ina jin kamar ƙirjina za su karye.
Kuma kamar yadda ka sani, mutane suna ta yin tari a kaina a koyaushe.
Kuma kana jin zafi a kirji.
Kuma na ce wannan matsi ne a kirjinka.
Kowa a cikin iyalinka yana da matsalar zuciya, ko ciwon zuciya, ko ciwon zuciya, ko kuma hawan cholesterol, ko kuma hawan jini.
Akwai wasu alamun ko kuma wasu matsaloli da ka lura da su ban da ciwon tsoka?
Akwai wasu a gidan da suke da irin wannan ciwon?
Kana da wasu alamun cutar kuwa?
Kuna jin wahalar numfashi?
Har yanzu kana jin ciwon kirji?
Domin wannan shine lokacin mura.
Amma bai kamata mu manta da ciwon kirji da ke faruwa a zuciya ba.
Amma matsalar da ta fi muni yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa da suke tari a kaina.
Amma muna bukatar mu ɗauki kowane ciwon kirji da muhimmanci.
Amma yanzu kana numfashi yadda ya kamata, ko ba haka ba?
Na manta da shi saboda ciwon kirji.
Kana jin kamar wani yana matsa maka a kirji?
Har yanzu kana jin kamar ba ka da numfashi?
Suna da irin wannan ciwo?
Kana da wani ciwo mai tsanani kamar hawan jini ko wani abu makamancin haka?
Kana da wasu cututtuka ko kuma ciwon sukari?
Kuna jin wani numfashi tare da wannan ciwon kirji?
Shin kana da hawan jini?
Shin kana jin wani numfashi shiru tare da shi?
Ka san alamun da take da su?
Ka ga hoton?
Ya sha ruwa mai yawa yau.
Duk da haka, ana gwada shi don ciwon sukari.
Duk da haka, tana da irin wannan cututtuka kamar yadda nake da shi.
Yaya zafin zafin jikinka yake?
Kuma matsin jininka fa?
Idan zazzabin ya ci gaba da tashi,
Idan zazzabi ya kai ɗari biyu ko sama da haka.
Idan ka ga cewa kana da wata cuta ko kuma wata cuta da take bukatar ƙarin bincike
Na yi zazzabi jiya.
Ni ma na yi zazzabi.
Ina da zazzabi a jiya.
Ina da ciwo mai tsanani a nan cikin kirji.
Ina kuma da wahalar numfashi.
Zan aika maka da hoto.
Ina da ciwon kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina ganin mura ce.
A ganina, mura ce mai sauƙi.
Shin yana kama da wani mai nauyi yana zaune a kirjinka?
Ya fara da ciwon kai da zazzabi a lokaci guda.
Akwai ciwo a tsakar kirji na.
Matsi ne kamar ciwon kirji.
Yana cikin kirjina.
Yana tsakiyar kirjina.
Yana tsakiyar kirji.
Na ji ciwo a kirji.
Ina matukar damuwa da wannan ciwon kirji.
Ina so ka kwatanta mini wannan ciwon kirji.
Kamar hawan jini ko ciwon sukari.
Kamar dai a tsakiyar kirji.
Yanzu za ka iya cin tachipirin.
Yanzu, Mary, kwana nawa ne kake da irin wannan ciwo?
Yanzu na ce kana da ciwon kirji.
Ina jin ciwon kirji a wasu lokatai.
To, akwai wasu alamun da ba su da zafi?
Ko kuwa kana jin wani yana zaune a kan kirjinka?
Yana kama da zazzabi da ciwon kai da kuma ciwon tsoka.
A tsakiya na kirji.
Ka nuna mini inda nake jin zafi a wannan hoton.
Tun da ka samu zazzabi.
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da ciki?
To, yaranku suna da irin wannan ciwo?
Ka gaya mini game da ciwon kirjinka.
Jinin yana tashi da dare.
Jinin da na sha a cikin kwanaki biyu da suka gabata.
Jinin da ya gabata ya fara tashi.
Wannan shi ne Dr. Porter a cikin ER a cikin cibiyar da aka yi wa jinya.
To, za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a gaban jikina, a nan a kirjina.
Ina da ciwon kirji mai tsanani.
To, lokacin da na ji wannan ciwo a kirjina,
Wace irin ciwon kirji kake da shi?
Yaushe ne wannan ciwon kirji ya fara?
Ina ciwon kirjinka yake?
Ina kake jin wannan ciwon a cikin kirji?
Kana da wani irin tsananin jin zafi a cikin kirjinka.
Ka sani ina da ciwon sukari da sauran abubuwa.
Ka ce kana da wannan ciwon kirji.
Yawan masu kamuwa da cutar korona (COVID-19) a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020
Adadin masu kamuwa da cutar coronavirus (COVID-19) na nuna irin wannan yanayin a ƙasashen EU/EEA da kuma Burtaniya, wanda ke tabbatar da cewa duk da cewa matakin ya bambanta daga ƙasa zuwa ƙasa, cutar ta COVID-19 tana ƙaruwa cikin sauri a kowace ƙasa.
Bisa ga kwarewar Italiya, ya kamata ƙasashe, asibitoci da kuma rukunin kula da gaggawa su ƙara kasancewa a shirye don ƙara yawan marasa lafiya na COVID-19 da za su bukaci kulawar lafiya, musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an bayar da rahoton wani rukuni na cututtukan huhu na sanadin rashin lafiya a birnin Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta ruwaito cewa, sabon kwayar cutar korona da ake kira yanzu SARS-CoV-2 ne ke haifar da cutar.
Tun daga lokacin, cutar da ke haifar da cutar SARS-CoV-2 ana kiranta cutar kwayar cutar korona (COVID-19).
Shaida ta zuwa yanzu ita ce kusan kashi 80 cikin 100 na mutanen da ke da COVID-19 suna da rashin lafiya mai sauƙi, wato, suna da kamuwa da cuta ta numfashi tare da ko ba tare da alamu ba, kuma yawancinsu suna murmurewa.
A kusan kashi 14 cikin ɗari, cutar ta COVID-19 ta ƙaru zuwa mummunar cuta da ke bukatar asibiti, yayin da sauran kashi 6 cikin ɗari ke fama da mummunar cuta da ke bukatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da suka yi jinya saboda COVID-19 ya kai kusan kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin yawan COVID-19 a kowace ƙasa a Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma Ƙasar Ingila (UK) kuma mun gwada su da lardin Hubei, China.
Mun kuma gwada adadin masu cutar COVID-19 a yanzu a ƙasashen EU/EEA da kuma Burtaniya da na Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Al'amuran COVID-19 a ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ƙasar Ingila
Bayan abin da ya faru a China, COVID-19 ya ƙara yaduwa ta hanyar ƙasa kuma yana bin sahun duniya na COVID-19 a halin yanzu a wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar EuroSurvivals na 5 ga Maris, 2020, Spiteri da sauransu sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai kamar yadda WHO ta bayyana.
A Tarayyar Turai/Yankin Tattalin Arziki na Turai, an bayar da rahoton mutane uku na farko da aka tabbatar da su daga Faransa a ranar 24 ga Janairu, 2020 daga mutanen da suka dawo daga Wuhan, lardin Hubei, China.
Ya zuwa ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashe 30 na EU/EEA da United Kingdom (UK), inda tsakanin 31 ga Disamba, 2019 zuwa wannan kwanan wata, an ba da rahoton kamuwa da cutar 39,768 da mutuwar 1,727, tare da kamuwa da cutar 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin mutane da suka kamu da cutar COVID-19
A Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Turai (ECDC), ana sabunta adadin mutanen da suka kamu da COVID-19 a kowace ƙasa a dukan duniya, wanda aka samo daga tushe na hukuma kawai kamar ma'aikatar kiwon lafiya na ƙasashe, da hukumomin kiwon lafiya na ƙasa da na yanki, da kuma WHO, kowace rana da ƙarfe 8:00 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya da kuma kwatanta shi da na Italiya.
A matsayin ma'auni na yaduwar masu cutar COVID-19, mun lissafa adadin masu cutar COVID-19 a tsakanin kwanaki 14, sannan kuma mun yi la'akari da yanayin COVID-19 a duk ƙasashen EU/EEA da kuma Burtaniya tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma ba da adadin adadin waɗanda aka ba da rahoto a kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe, tare da kwatanta shi da adadin da aka samu a Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da kuma Birtaniya
An bi yanayin yawan adadin masu kamuwa da cutar COVID-19 a cikin kwanaki 14 a cikin EU/EEA da United Kingdom a lardin Hubei na kasar Sin (Hoto na 1).
A cikin EU/EEA da kuma Birtaniya gaba ɗaya, adadin COVID-19 ya fara ƙaruwa a kusan ranar 21 ga Fabrairu, sannan ya ƙaru sosai a kusan ranar 28 ga Fabrairu, 2020 (Supplementary material).
Wannan ya kasance ne saboda saurin karuwar adadin waɗanda aka ruwaito daga Italiya, amma duk ƙasashen EU/EEA da Burtaniya sun nuna irin wannan yanayin karuwa a yawan COVID-19 (mataki na gaba).
Shafi na 2 ya nuna adadin masu kamuwa da cutar COVID-19 a ƙasashen EU/EEA da kuma Birtaniya idan aka kwatanta da Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
An nuna cewa tun daga 15 ga Maris da karfe 8:00 na safe, wasu kasashe 15 na EU/EEA da kuma Burtaniya sun bayar da rahoton adadin masu kamuwa da cutar da ya yi daidai da wanda aka samu a Italiya makonni uku da suka gabata ko kuma kasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka ba da rahoton COVID-19 na ƙaruwa cikin sauri a Ƙungiyar Tarayyar Turai/Ƙungiyar Tattalin Arzikin Turai da kuma Ƙasar Ingila.
Yanayin da ake gani a yawan COVID-19 ya nuna cewa annobar tana ƙaruwa a cikin irin wannan saurin a dukan ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, kuma duk da cewa amsoshin lafiyar jama'a na ƙasa sun bambanta, ƙayyadaddun yanayi na ƙasashe da ladabi na zaɓar marasa lafiya waɗanda za a gwada su don tabbatar da COVID-19, gami da gwajin biyewa, na iya bambanta.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kusan kashi 10 cikin 100 na marasa lafiya na COVID-19 ke bukatar kulawa mai zurfi kuma majiyoyin labarai sun ruwaito cewa asibitoci da raka'o'in kulawa mai zurfi a wadannan yankuna sun riga sun kai iyakar karfin su.
A halin yanzu akwai bayanai game da asibitoci da/ko cibiyoyin kulawa mai zurfi na COVID-19 a duk fadin EU/EEA na kashi 6% da 1% na masu cutar (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara su a hanya mai tsari domin a ƙara yawan bayanan da ake da su na lura da yawan mutane da suka kamu da cutar da kuma yawan mutuwar da suka faru.
Wani bincike da aka yi a shekara ta 2010 ya nuna bambancin da ke tsakanin samun gado na kulawa mai zurfi da na matsakaici a Turai, daga 29.2 a Jamus zuwa 4.2 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu fiye ko ƙasa da na Italiya (kwana 12.5 na kulawa mai tsanani da matsakaicin kulawa ga mutane 100,000 a 2010).
Yanayin samfurin da ya danganci wadatar kulawar lafiya, tare da kimantawa ga kowace ƙasa ta EU/EEA da Burtaniya don yaduwar COVID-19 da ke haɗarin shiga asibiti sama da &gt; 90% na ƙarfin gado na kulawa mai mahimmanci, ana samun su a cikin sabuntawa ta shida na Cibiyar Kula da Cututtuka da Rigakafin Turai ta COVID-19 Rapid Risk Assessment.
Tun da yake an tattara cututtuka a wasu yankuna a cikin EU/EEA da kuma a Ƙasar Ingila, kuma asibitoci da kuma cibiyoyin kula da marasa lafiya suna kula da takamaiman yankuna, an fi son a ba da bayani game da cututtuka da kuma gado na kula da marasa lafiya a matakin cibiyar kula da marasa lafiya na yanki na 2 (NUTS-2).
Kwarewar Italiya da kuma yanayin da ake ciki a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ƙaruwa cikin sauri a Ƙungiyar Tarayyar Turai/Ƙungiyar Tattalin Arzikin Turai da kuma Ƙasar Ingila.
Saboda haka, dole ne jihohi, asibitoci da kuma cibiyoyin kula da gaggawa su shirya kansu don yanayin watsa SARS-CoV-2 na al'umma mai dorewa da kuma karuwar adadin marasa lafiyar COVID-19 da ke bukatar kulawa ta lafiya, musamman kulawa mai zurfi, kamar yadda yake faruwa a yankunan da cutar ta shafa a Italiya.
Kamar yadda aka nuna a cikin Cibiyar Kula da Cututtuka da Rigakafin Turai ta Binciken Hadarin gaggawa, hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin hanzarin.
Binciken hadarin nan da nan ya kuma lissafa matakan kiwon lafiya na jama'a don rage tasirin annobar.
Akwai iyakantaccen dama da kasashe za su iya ƙarawa wajen sa ido don rage yaduwar SARS-CoV-2 da rage matsin lamba a kan kulawar lafiya.
Idan wannan bai yi nasara ba, tsarin kiwon lafiya na sauran ƙasashen EU/EEA zai fuskanci karuwar adadin marasa lafiya da suke bukatar kulawa mai zurfi a cikin kwanaki ko makonni masu zuwa.
Barkewar cutar korona 2019 (COVID-19), wadda ke haifar da cutar SARS-CoV-2, ta kashe mutane fiye da 3,000, kuma ta raunata mutane fiye da 80,000 a China da sauran wurare a duniya, ta haifar da bala'i na jin kai.
SARS-CoV-2, kamar irin wannan kwayar cutar, SARS-CoV, wanda ya haifar da dubban mutane da cutar SARS a 2003, kuma za a iya yada shi daga batsa kuma ya haifar da irin wannan bayyanar ta hanyar irin wannan tsari.
Ko da yake, COVID-19 yana da ƙananan haɗari da mutuwar SARS amma yana da yaduwa da tasiri a tsakanin tsofaffi fiye da matasa da kuma tsakanin maza fiye da mata.
Domin a amsa yawan littattafan da ake wallafawa game da wannan cuta da ke tasowa, wannan talifin yana so ya ba da cikakken bayani game da wannan bincike da ke ci gaba da sauri.
Za mu tattauna abubuwa na asali game da annobar cutar, da abubuwan da ke haddasa ta, da ilmin ƙwayoyin cuta, da gane ta, da magani, da kuma yadda za a iya tsinkayar ciwon, da kuma yadda za a iya hana cutar.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fatan wannan bita zai taimaka wajen fahimtar cutar da take barazana da kuma kawar da ita.
Bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa yin irinsa ba ga duk Sinawa waɗanda aka bukaci su zauna a gidajensu a lokacin hutu da makonni da yawa bayan haka saboda sabon barkewar cutar kwayar cuta.
Kwayar cutar ta yi kama da kwayar cutar korona (COVID-19), wadda ta haifar da barkewar cutar SARS a shekara ta 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma ta sanya wa cutar da ke da nasaba da ita suna COVID-19.
Annobar ta fara ne a birnin Wuhan na kasar Sin, kuma nan da nan ta bazu zuwa ko'ina a kasar, da kuma kusan wasu ƙasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, cutar ta haifar da tabbatar da cutar COVID-19 80,000, tare da fitar da fiye da marasa lafiya 40,000 daga asibiti da mutuwar fiye da marasa lafiya 3,000.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 shine babban makiyin jama'a kuma yana iya zama mai ƙarfi fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga fiye da bincike 200 game da COVID-19 wanda ya haɗa da ilimin ƙwayoyin cuta na musamman, annobar cutar, abubuwan da ke haifar da shi, ganewar asali, da magani, tun lokacin da aka ba da rahoton farko a ranar 7 ga Janairu 2020 wanda ya gano jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa.
Wannan bita na da manufar taƙaita ci gaban bincike a sabon batun da ke ci gaba da sauri.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da SARS da kuma wani cuta da ke haifar da cutar, wato cutar MERS, wanda ya barke a shekara ta 2012.
Za mu kuma tattauna abin da muka sani game da rigakafin cuta da kuma yadda za a iya yin hasashen cutar da kuma wasu tambayoyi masu muhimmanci da har yanzu ake yi.
An yi la'akari da cewa kwayar cutar korona ba ta kashe mutane ba, kuma tana da alhakin kusan kashi 15 cikin 100 na zazzabin sanyi na kowa.
Duk da haka, a wannan karni mun fuskanci kwayar cutar korona biyu da ta yi sanadiyar mummunar cuta ga mutane, SARS-CoV da MERS-CoV, wadanda suka fara bullowa a China a 2003 da Saudi Arabiya a 2012, bi da bi, kuma nan da nan suka bazu zuwa wasu ƙasashe da yawa da gagarumar yaduwar cuta da kuma mutuwar mutane.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta kwayar cutar corona a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, an fara bayar da rahoton rukunin cutar huhu da ba a san asalinsa ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta Sin.
Bayan kwana bakwai, an sake gano kwayar cutar korona.
A ranar 15 ga Janairu, 2020, Wuhan ta ba da rahoton mutuwar mutum na farko.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an samu rahoton kamuwa da cutar a tsakanin ma'aikatan kiwon lafiya, wanda ke nuna yiwuwar kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan tare da dakatar da dukkan hanyoyin sufuri na jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti kan cutar ya ruwaito cewa daga cikin mutane 41 da aka tabbatar da cutar, marasa lafiya 21 ne kawai suka sami hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, wanda aka ɗauka a matsayin wurin da kamuwa da cuta ta samo asali daga asalin dabba da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta ayyana annobar a matsayin gaggawa ta duniya.
A lokacin da aka wallafa wannan rahoto, cutar ta riga ta bazu a duk fadin kasar Sin da kuma wasu kasashe 50 a duniya (Figure 2.2).
Yayin da lamarin ke ci gaba da hanzari, har yanzu ba a tantance ainihin girman cutar da kuma yadda take da hatsari ba.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da yawa da aka gudanar kan marasa lafiya 8,866 ciki har da marasa lafiya 4,021 da aka tabbatar da cutar COVID-19 ya ba da ƙarin bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya shafi mutane na dukan shekaru, amma ya fi shafar waɗanda suke tsakanin shekaru 30 zuwa 65.
Kusan rabin waɗanda suka kamu da cutar (47.7%) sun haura shekaru 50, kaɗan ne kawai ke ƙasa da shekaru 20, kuma 14 ne kawai ke ƙarƙashin shekaru 10.
SARS-CoV-2 ya yi wa maza da yawa illa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya yaɗu tsakanin ƙungiyoyi a cikin da kewaye da Hubei.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farkon kamuwa da cutar zuwa ganewar asali.
Matsakaicin lokacin da aka yi a cikin gida shi ne kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin kamuwa da cutar daga farkonta zuwa mutuwa ya kai kwanaki 9.5 (4.8-13).
Ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar.
Yawan masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da yawan tafiye-tafiye kafin bikin bazara a China.
Yawan mutuwar tsakanin marasa lafiya da aka tabbatar da su ya kai 1.44% (yanayin tabbaci 95%: 1.10-1.86%), kuma yawan mutuwar da aka gyara ga kowane mai haƙuri ya kai 3.06% (yanayin tabbaci 95%: 2.02-4.59%).
Abubuwa uku na haɗarin COVID-19 sune jinsi (maza), shekaru (≥60), da kuma ciwon huhu mai tsanani.
Coronaviruses wani nau'i ne na manyan ƙwayoyin cuta masu ɗauke da takaddun DNA mai ɗauke da jerin abubuwa masu kyau.
Ana iya raba su zuwa nau'i huɗu, wato alpha, beta, gamma, da delta, kuma an san cewa coronaviruses na jinsi biyu, alpha da beta suna cutar mutane.
S-coated fork na sinadarin sukari yana haɗuwa da masu karɓar sa na salula wanda shine enzyme mai canza angiotensin 2 (ACE2) da kuma dipetayl peptidase 4 (DBP4) na SARS-CoV da MERS-CoV, bi da bi, sannan kuma haɗin membrane yana faruwa.
Ana fitar da kwayar cutar ribosome DNA zuwa cytoplasm; bayan an sake kwayar kwayar cutar, ribosome DNA tare da sunadarai na glucose da sunadarai na nucleic acid sun hada da kwayar cuta mai dauke da feronates, wanda ya hada da membrane na plasma don fitar da kwayar cutar.
An bayar da rahoton jerin sunayen SARS-CoV-2 na farko a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 wani sabon nau'in beta-CoV mai mutuntaka sama da kashi 99.98% a cikin samfurori 10 da aka tantance daga wurin da cutar ta bulla, kasuwar abincin teku ta Hunan a Wuhan.
Kwayar SARS-CoV-2 ta fi kama da kwayar SARS-CoV fiye da ta MERS-CoV.
An gano SARS-CoV-2 a cikin ƙananan ɓangarorin jikin mutum.
An gano cewa enzyme na mutum wanda aka canza zuwa angiotensin 2 shine mai ɗaukar SARS-CoV-2 da SARS-CoV.
Duk da haka, S-protein na SARS-CoV-2 yana da alaƙa da enzyme na mutum wanda ya canza zuwa angiotensin 2 da rauni fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da wani ɗan ƙaramin furotin mai ƙyalli wanda aka rubuta ta hanyar orf3b da kuma wani furotin mai ƙyalli wanda aka rubuta ta hanyar orf8.
Orf3b a cikin SARS-CoV-2 na iya taka rawa a cikin cutar ta kwayar cuta da kuma iyakance bayyanar IFNβ; duk da haka, orf8 ba shi da wani yanki ko tsari wanda aka san aikinsa.
A ranar 18 ga Fabrairu, 2020, Chu da sauransu sun ba da rahoton cikakken tsayin enzyme na mutum wanda aka canza zuwa angiotensin 2 a ƙarƙashin microscope mai zurfin gaske tare da ƙayyadaddun 2.9 Å a cikin mahaɗin tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa mahaɗin, wanda yake da buɗe da rufe, ya haɗu don samar da dimer kuma ACE2-B0AT1 zai iya ɗaure S, yana ba da tabbaci don gano kwayar cutar corona da kamuwa da cuta.
Maganin amino acid mai zaman kansa wanda ya dogara da sodium zai iya zama makasudin magani don gwajin magunguna don hana kamuwa da SARS-CoV-2.
Mai watsa shiri na asali da mai watsa shiri na tsakiya
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga batsa kuma an kai su ga mutane ta hanyar cats da kuma camels, bi da bi.
Ta hanyar kwatanta ci gaban SARS-CoV-2 da sauran kwayar cutar korona, an yi la'akari da cewa bat-SL-CoVZX45 da bat-SL-CoVZX21 sune asalin SARS-CoV-2, inda sabon kwayar cutar ta yi daidai da kashi 96 cikin dari.
Duk da haka, ba a san wanda ya taimaka wa kwayar cutar ta ƙetare iyakar jinsin da ta kai ga mutane ba, kuma ba a bayyana hanyar da za ta iya yaduwa ba.
Ji da wasu sun nuna cewa macizai suna ɗauke da kwayar cutar daga bat zuwa ɗan adam wanda ya ƙunshi sake haɗuwa a cikin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa masu cin naman alade - dabbobi masu shayarwa masu dogon baki da ake amfani da su a maganin gargajiya na kasar Sin - su ne mai iya daukar nauyin SARS-CoV-2 bisa ga kamannin kwayoyin halittar kashi 99% na kwayar cutar korona da aka gano a cikin masu cin naman alade da kuma SARS-CoV-2.
Duk da haka, bambancin kashi ɗaya cikin ɗari da ke cikin kwayoyin halittar mutum biyu, har yanzu bambanci ne mai girma, kuma muna jiran sakamako mai ƙarfi daga hujjoji na zahiri (siffa 33).
Ba a san ainihin yanayin SARS-CoV-2 ba.
SARS-CoV da MERS-CoV suna iya rayuwa a cikin dakin gwaje-gwaje na tsawon sa'o'i 48 a cikin yanayi mai bushe har zuwa kwana biyar a zafin jiki da ke ƙasa da digiri 20 da kuma danshi tsakanin kashi 40 zuwa 50%.
SARS-CoV-2 na iya samun irin wannan halayen.
An ba da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da UV da zafi a 56 °C na tsawon minti 30; ether, 75% ethanol, chlorine, peroxyacetic acid, chloroform, da sauran mai narkewa, amma ba chloroxide ba, na iya hana cutar sosai.
Dukan 'yan Adam ba su da kariya ga SARS-CoV-2 saboda haka suna iya kamuwa da sabon cutar.
A yanzu, babu wani bincike mai zurfi game da yadda jikin mutum yake amsa SARS-CoV-2.
Saboda haka, za mu iya komawa ga binciken da aka yi a baya game da wasu ƙwayoyin cuta na corona, musamman SARS-CoV, da MERS-CoV (siffa 4) 4.
A gaba ɗaya, bayan kamuwa da kwayar cutar mai masaukin baki, tsarin garkuwar jiki na gane ta ta hanyar masu karɓar tsarin (PRRS) ciki har da masu karɓar nau'in C masu kama da na alkinta, masu karɓar mai kama da na tul (TLR), masu karɓar mai kama da na nucleotide-linked compartment (NLR), da masu karɓar mai kama da na RIG-I (RLR).
Ta hanyoyi dabam dabam, kwayar cutar tana sa abubuwa masu kumburi su bayyana, ƙwayoyin rami su yi girma, da kuma haɗawar nau'in interferon I (IFN) da ke hana yaduwar kwayar cutar kuma yana sa manyan ƙwayoyin jini su yi aiki da rigakafin kwayar cutar.
Duk da haka, furotin N a SARS-CoV zai iya taimaka wa kwayar cutar ta guje wa amsawar garkuwar jiki.
Ba da daɗewa ba, tsarin rigakafin zai shiga yaƙi da cutar.
Kwayoyin T-Lymphoid, ciki har da CD4+ da CD8+ suna taka muhimmiyar rawa a cikin rigakafi.
CD4+ T cells suna motsa kwayoyin B don samar da kwayoyin cutar da suka dace da cutar, kuma CD8+ T cells suna kashe kwayoyin cutar kai tsaye.
Kwayoyin T masu taimako suna samar da sinadarin cytokines da ke sa kumburi ya yi tsanani don taimaka wa ƙwayoyin da ke kāre kansu.
Koyaya, kwayar cutar korona tana iya rage aikin T-cell ta hanyar sa a kashe T-cell.
Ƙwararrun rigakafi, da suka haɗa da sunadarai masu kama da C3a da C5a da kuma ƙwayoyin cuta, suna da muhimmanci wajen yaƙi da kamuwa da ƙwayoyin cuta.
Alal misali, na kawar da rigakafin da aka ware daga wani mai ciwon Mears-Cough da ya warke.
A wani ɓangare kuma, ƙwayar cuta da ke hana jiki yin aiki sosai tana haifar da yawan ƙwayoyin cuta a gida da ke iya sa ciwon huhu da sauran gabobin jiki ya lalace sosai, kuma a mafi muni, zai iya sa gabobin jiki da yawa su kasa aiki kuma su mutu.
Ana iya kamuwa da cutar SARS-CoV-2, wadda ta fara a cikin rukunin tsofaffi da ke da cututtuka da yawa da mata masu juna biyu.
Mutane da yawa suna da zarafin kamuwa da ƙwayoyin cuta fiye da wasu.
An kiyasta matsakaicin lokacin da za a yi wa SARS-CoV-2 kulawa kwanaki 1 zuwa 14, ko kuma kwanaki 3 zuwa 7, bisa ga nazarin farko na mutane 425 a birnin Wuhan.
Duk da haka, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa lokacin da ake yi wa jariri ciki ya kai kwanaki uku, kuma ya kai kwanaki 0 zuwa 24.
Wani bincike na baya-bayan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin da ake kula da yara a cikin gida shi ne kwanaki 4.8 (3.0-7.2) bisa alƙaluma na mutane 8,866.
Yana da muhimmanci sosai cewa hukumomin kiwon lafiya su daidaita lokacin keɓewar kai bisa ga lokacin kulawa mafi kyau, don hana mutane da suka kamu amma ba su da alamun cutar daga yada cutar ga wasu.
A matsayin al'ada, ana bukatar mutane da ke da cutar ko kuma waɗanda ke da cutar su keɓe kansu na tsawon kwanaki 14.
Shin ya kamata a ƙara wa mutum keɓewa zuwa kwanaki 24?
Sau da yawa zazzabi shi ne farkon bayyanar cutar COVID-19, kuma yana iya zama ba tare da wata alama ba ko kuma tare da wasu alamu, kamar su tari mai bushe, rashin numfashi, ciwon tsoka, juyayi, ciwon kai, ciwon makogwaro, hanci, ciwon kirji, rashin jin daɗi, da kuma amai.
Wasu marasa lafiya sun sha wahala daga numfashi da kuma/ko rashin iskar oxygen a cikin jini bayan mako guda da fara cutar.
A cikin mawuyacin yanayi, marasa lafiya suna ci gaba da samun ciwon numfashi mai tsanani, ciwon shanyewar jiki, ciwon shanyewar jiki, da kuma rashin ƙarfi.
Dole ne a gwada marasa lafiya da ke da zazzabi ko kuma da alamun numfashi da zazzabi mai tsanani, ko da ba tare da yin gwajin hoto da ke nuna rashin lafiyar huhu ba, don gano cutar da wuri.
Wani binciken alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa kashi 98% na alamun cutar zazzabi ne, kashi 76% na tari ne, kashi 55% na rashin numfashi ne, kashi 3% na zawo ne; kuma kashi 8% na marasa lafiya suna bukatar tallafin numfashi.
An samu irin wannan sakamako a wasu bincike biyu da aka yi a baya bayan nan a kan wani iyali da kuma wani da ya kamu da cutar daga wani da ba shi da alamun cutar.
A kwatankwacin haka, wani bincike na alƙaluma a shekara ta 2012 ya nuna cewa marasa lafiyar Mears-Cough suna da zazzabi (98%), tari mai bushe (47%), da kuma rashin numfashi (55%) a matsayin manyan alamun.
Duk da haka, kashi 80 cikin ɗari suna bukatar taimakon numfashi fiye da waɗanda ke da COVID-19 kuma sun yi daidai da yawan mutuwar MERS da ke da cutar.
An kuma lura da zawo (26%) da kuma ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiya da cutar SARS, zazzabi (99-100%), tari (29%-75%), rashin numfashi (40%-42%), zawo (20-25%), da kumburi (13-25%) sun kasance alamun da suka fi muhimmanci, kuma an bukaci a ba da tallafin numfashi ga kusan kashi 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin dari yayin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
A kwatankwacin haka, adadin mutuwar SARS a watan Nuwamba na shekara ta 2002 ya kai kashi 10 cikin 100 na waɗanda aka tabbatar da cutar, 8,096.
Ga Meers, mutuwar mutane 37% na 2,494 ne, bisa ga binciken alƙaluma da aka gudanar a watan Yunin 2012.
Wani binciken da ya gabata ya ba da rahoton cewa lambar haɓaka ta SARS-CoV-2 ta kasance mai girma har zuwa 6.47 a cikin 95% CI na 5.71 zuwa 7.23, yayin da lambar haɓaka ta SARS-CoV ta kasance tsakanin 2 da 4 kawai.
Kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamomin su, yawan mutuwar su, da kuma yawan haifuwar su an nuna su a cikin tebur Table1.1.
Lambar da ke sama ta nuna cewa SARS-CoV-2 na da ikon yaɗuwa fiye da na MERS-CoV da SARS-CoV, amma ba su da kisa fiye da na ƙarshe.
Saboda haka, ya fi wahalar shawo kan cutar SARS-CoV-2 fiye da yadda za a shawo kan cutar MERS-CoV da SARS-CoV.
Sau da yawa, ana soma kamuwa da cutar a cikin iyali ɗaya ko kuma a cikin jirgin ruwa ɗaya, kamar jirgin ruwa mai tafiya.
Marasa lafiya sukan yi tafiya ko zama a Wuhan ko wasu yankunan da cutar ta shafa, ko kuma su yi hulɗa da mutane ko marasa lafiya a cikin makonni biyu da suka gabata kafin cutar ta bulla.
Duk da haka, an ce mutane na iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba har tsawon makonni biyu, kuma marasa lafiya da suka warke da suka bar asibitoci na iya ɗaukar kwayar cutar kuma, wanda ke ba da gargaɗi don ƙara lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini (musamman ƙwayoyin lymphocytes) a farkon lokaci.
Alal misali, an gano ƙarancin lymphocytes tare da ƙididdigar ƙwayoyin jini 4x109/litre ciki har da ƙididdigar ƙwayoyin lymphocytes 1x109/litre, da kuma ƙaruwa na mai ɗaukar amine aspartate da kuma kwayar cutar jini a cikin marasa lafiya 1,099 da ke dauke da COVID-19.
An samu ƙaruwar ƙwayoyin cuta na hanta, tsoka, da kuma na myoglobin a cikin jinin wasu marasa lafiya, kuma an samu ƙaruwa a cikin furotin mai aiki da jini C da kuma ƙaruwar ƙwayoyin jini a cikin jini na yawancin marasa lafiya.
A cikin marasa lafiya masu ciwo mai tsanani, matakin D-dimer, wanda ya samo asali daga fashewar fibrin a cikin jini, ya ƙaru, kuma adadin ƙwayoyin lymphocytes ya ragu a hankali.
Rashin daidaito a hoton rediyo yana bayyana a yawancin marasa lafiya da COVID-19 kuma yana nuna inuwa mai ƙyalli biyu ko kuma gilashin gilashi a cikin huhu.
Wasu lokatai marasa lafiya suna fama da ciwon huhu, ciwon huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
Sa'ad da aka yi rashin numfashi mai tsanani, kumburi da ke fita daga jiki, da kuma ruwa da ke tarawa suna shafan canjin iskar gas.
Rashin aiki na ƙwayoyin huhu na nau'i na 1 da na 2 yana rage matakin magungunan farfajiya kuma yana ƙara matsin lamba, kuma hakan yana rage ikon ƙwayoyin huhu na faɗaɗa kuma yana ƙara haɗarin yin kumburi.
Saboda haka, ana gwada sakamakon da ya fi muni da kuma yadda cutar take da tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna cewa kwayar cutar huhu ta ɓace, kuma an samu ƙwayoyin halittar hyaluronic membrane, sellular lymphocyte, da kuma ƙwayoyin ƙwayoyin cuta masu yawa a cikin huhu na wani mai haƙuri wanda ya mutu saboda cutar, wanda ya yi daidai da cutar kamuwa da cuta ta kwayar cuta da kuma cututtukan cututtukan numfashi na gaggawa kuma ya yi kama da waɗanda ke faruwa a cikin marasa lafiya da ke da cutar SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar hawan polymerase chain reaction (PTPCR) a matsayin babban abin da zai iya gano cutar COVID-19.
Duk da haka, saboda yawan sakamako na rashin gaskiya, wanda zai iya hanzarta annobar, an fara amfani da bayyanar asibiti don ganewar asali (wanda ba ya dogara da RT-PCR a cikin mutum) a China a ranar 13 ga Fabrairu, 2020.
Haka ma yake da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar asibiti, gwaje-gwajen asibiti, da kuma binciken radiyo, yana da muhimmanci kuma yana da muhimmanci wajen yin ganewar asali.
A ranar 14 ga Fabrairu, 2020, kungiyar Feng Chang ta bayyana yarjejeniya don amfani da fasahar Sherlock mai tushen CRISPR don gano SARS-CoV-2, tana gano ɓangarorin RNA da aka kirkira don SARS-CoV-2 a cikin 20 × 10-18 mo/litre zuwa 200 × 10-18 mo/litre (10-100 kwafi a kowace microlitre na shigarwa) ta amfani da inhalation a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu mahimmanci ba.
Muna fatan cewa sabuwar fasahar za ta iya inganta ƙwarewa da dacewa sosai idan aka tabbatar da ita a cikin samfuran asibiti.
Saboda rashin kwarewa game da sabon kwayar cutar ta corona, likitoci suna iya ba da tallafi ga marasa lafiya da ke fama da cutar ta COVID-19 yayin da suke gwada magunguna da dama da aka yi amfani da su ko kuma aka ba da shawarar a baya don magance wasu kwayar cutar ta corona, kamar su SARS-CoV, MERS-CoV, da sauran cututtukan kwayar cuta (Table (Table 2).2).
Waɗannan sun haɗa da maganin da ake da shi yanzu da kuma wanda ake so, wato maganin rigakafin ƙwayoyin cuta, maganin hana kamuwa da cuta, maganin da ke sa mutum ya yi sanyi, ruwan jini daga marasa lafiya da suka warke, magani na kasar Sin, da kuma taimakon ɗan adam.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke don yin magani.
Kamfanonin ƙwayoyi suna gasa don samar da ƙwayoyin cuta da kuma allurar rigakafin cutar.
SARS-CoV-2 na kaiwa huhu hari da farko, kuma yana iya kaiwa wasu gabobin da ke fitar da enzyme mai canza angiotensin 2 hari, kamar su tsarin narkewa, hanji, da kuma koda.
Duk da haka, rashin lafiya da kuma rashin aiki na numfashi ne mafi tsanani ga marasa lafiya kuma sanadin mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage cututtuka da kuma ceton rayuka, ya haɗa da maganin oxygen na gaba ɗaya, iskar oxygen mai yawa, na'urar numfashi da ba ta da ƙarfi, da na'urar numfashi na wucin gadi da ke da ƙarfi bisa ga tsananin cutar.
Dole ne a tallafa wa marasa lafiya da ke fama da cututtukan numfashi mai tsanani ta hanyar yin amfani da maganin ECMOH, wanda ake amfani da shi wajen magance rashin ƙarfi na zuciya ko kuma rashin numfashi mai sa rai.
Bugu da ƙari, kiyaye ma'aunin ruwa, hanawa da kuma magance cututtuka na biyu da kuma ciwon kai, da kuma kāre aiki na gabobin jiki, su ma suna da muhimmanci ga waɗanda suke da cutar SARS-CoV-2.
An san cewa wannan guguwar cytokine tana haifar da halayen jiki na SARS da MERS.
Cytokine Storm wani nau'i ne na tsarin halayen kumburi wanda ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan sunadarai suna sa ƙwayoyin jikinmu su saki ƙwayoyin cuta masu yawa, kuma suna sa mu kamu da cututtukan numfashi da kuma rashin aiki da gabobin jiki.
Rashin hana rigakafi yana da muhimmanci wajen magance ƙanƙarar cytokine, musamman ma a yanayin marasa lafiya masu tsanani.
An yi amfani da maganin motsa jiki, tosilezomab, da kuma maganin anti-interleukin-6 na jini guda don magance matsalar cytokine.
Sauran magungunan hana rigakafin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
An yi amfani da maganin rigakafi da kuma maganin rigakafi a kan cutar SARS don rage lalacewar kumburi.
Duk da haka, ƙarin magungunan sun kasa taimaka wa masu cutar SARS da COVID-19 da suka kamu da cutar.
Maimakon haka, yana iya haifar da munanan cututtuka, musamman ma na rashin ciwon kasusuwa, wanda hakan ke shafar yadda ake sanin ciwon.
Duk da haka, an ba da shawarar yin amfani da gajerun hanyoyin motsa jiki a ƙananan da matsakaitan allurai don marasa lafiya masu tsanani na COVID-19.
A lokacin rubuta wannan rahoto, babu wani magani da aka tabbatar da ingancinsa.
Duk da haka, an gano cewa bada Remdesivir, wanda yake da kamanni da nucleotide, a cikin jini yana da tasiri a kan wani mara lafiya na COVID-19 na Amurka.
Remdesivir wani sabon maganin rigakafi ne da Gilead ta fara kirkirarsa don magance cututtukan da ƙwayoyin cutar Ebola da Marburg ke haifarwa.
Daga baya, Remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta masu ɗauke da DNA mai ɗauke da sarkar RNA, ciki har da MERS da SARS.
Bisa ga waɗannan ƙwayoyin cuta, Gilead ta kawo wannan abu zuwa China don yin gwaji a kan mutane da ke da SARS-CoV-2, kuma ana jiran sakamakon sosai.
Bugu da ƙari, an ba da shawarar yin amfani da Parisetinib, Interferon-alpha, Lupinavir/Ritonavir, da Ribavirin a matsayin magunguna masu yiwuwa ga marasa lafiya da ke fama da cututtukan numfashi.
Ciwon ciki, rashin jin daɗi, amai, lalacewar hanta, da sauran halayen rashin lafiya na iya faruwa bayan shan maganin hadewar Blupenavir/Ritonavir.
Ya kamata a lura da yadda waɗannan magunguna suke shafan wasu magunguna da ake amfani da su a kan marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da ƙwayoyin cuta
Ana samun jini daga marasa lafiya da suka warke daga wata cuta da ake son a yi wa wasu marasa lafiya da suke da wannan cuta ko kuma a hana mutane masu lafiya kamuwa da cutar.
Hakika, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa a cikin jinsu da suke yaƙi da wannan cuta.
Kwayoyin rigakafi sune jini masu rigakafi (A.G.) da ƙwayoyin lymphocytes suke samarwa don yaƙi da masu cutar da kuma wasu ƙwayoyin cuta. Suna ganewa da kuma ƙuntata ƙwayoyin cuta na musamman a cikin masu cutar.
Bisa ga wannan, an tattara jini daga jinin mutanen da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke da mummunar cuta allurar.
A cikin sa'o'i 24 suka sami sauƙi, tare da rage kumburi da ƙwayar cuta da kuma ingantaccen iskar oxygen a cikin jini.
Duk da haka, ana bukatar a tabbatar da kuma bayyana yadda ake amfani da wannan hanyar kafin a iya samun magani.
Bugu da ƙari, saboda tasirin maganin, wasu lahani da ke tattare da ruwan jini dole ne a kula da su sosai.
Alal misali, ƙwayoyin cuta suna iya sa jikin mutum ya yi tsananin damuwa kuma su sa a soma cutar cytokine, wadda za ta iya kashe mutum.
Yawan kwayoyin cutar a cikin jini ba shi da yawa, kuma ana bukatar jini sosai don magance marasa lafiya masu ciwo mai tsanani.
Yana da wuya a samar da takamaiman rigakafi da kuma samar da su da sauri don yaƙi da annobar duniya.
Saboda haka, ware kwayoyin halittu daga marasa lafiya da suka warke da kuma gano ƙwayoyin halittar da ke rubuta kwayar cutar, ko kuma bincika kwayar cutar da ke da tasiri a kan sunadarai masu muhimmanci na cutar, ya fi dacewa.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin cuta.
An yi amfani da maganin gargajiya na kasar Sin wajen warkar da cututtuka dabam dabam a ƙasar Sin na dubban shekaru.
Duk da haka, tasirinsa ya dogara ne da yawancin abubuwan da ke cikin tsari wanda ya bambanta bisa ga ganewar asali bisa ga ka'idodin maganin gargajiya na kasar Sin.
Yawancin sinadarai masu aiki ba a san su ba ko kuma ba a san su ba domin yana da wuya a samu kuma a bincika su ko kuma a gwada su da kyau.
A halin yanzu, saboda rashin ingantaccen magani na COVID-19, maganin gargajiya na kasar Sin ya zama daya daga cikin mahimman hanyoyin magani na madadin ga marasa lafiya masu saurin ciwo ko kuma waɗanda suka warke daga mawuyacin yanayi.
Alal misali, an gano cewa capsules na Shu Feng Ji Do da Lian Hua King Wen suna da tasiri wajen maganin COVID-19.
An lura da mafi girman adadin warkewa a cikin maganin COVID-19 a larduna da dama a China da suka yi amfani da maganin gargajiya na kasar Sin a kashi 87% na marasa lafiyarsu, ciki har da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da maganin gargajiya na kasar Sin kawai tare da kusan kashi 30% na marasa lafiyar COVID-19, ya sami mafi ƙarancin adadin warkewa (13%).
Duk da haka, wannan kwatancen ne na kusanci, domin akwai wasu abubuwa da yawa da za a yi la'akari da su, kamar yawan marasa lafiya da kuma tsananin cutar da suke fama da ita.
A ranar 18 ga Fabrairu, 2020, Poly Chang da abokan aikinsa sun buga wani bincike don kwatanta maganin magani na yamma (WM) shi kaɗai da maganin haɗin gwiwar magani na yamma da maganin gargajiya na kasar Sin.
Sun gano cewa lokacin da ake bukata don warkewa daga zazzabi, bayyanar cututtuka, da kuma asibiti sun yi kasa da yawa a cikin rukunin maganin gargajiya na yammacin kasar Sin fiye da na yammacin kasar kawai.
Mafi ban sha'awa, yawan cutar ta ƙara muni (daga m zuwa mai tsanani) ya yi ƙasa sosai a cikin rukunin maganin maganin gargajiya na Yammacin Turai + na gargajiya na kasar Sin (7.4% vs. 46.2%), kuma yawan mutuwar ya yi ƙasa a cikin rukunin maganin gargajiya na Yammacin Turai + na gargajiya na kasar Sin (8.8% vs. 39%).
Duk da haka, inganci da amincin maganin gargajiya na kasar Sin har yanzu suna jiran ƙarin gwaji da aka yi nazari sosai a kan manyan sikelin da kuma cibiyoyi da yawa.
Zai kuma kasance da ban sha'awa a bayyana yadda ake yin maganin kuma a bayyana abubuwan da suke da amfani a maganin gargajiya na kasar Sin ko kuma yadda ake hada su.
Marasa lafiya da ake zargi ko tabbatacce suna jin tsoron kamuwa da cutar, kuma waɗanda suke keɓe kansu suna jin baƙinciki, kaɗaici, da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin iskar oxygen, da tari, da kuma sakamako na magani, kamar rashin barci da ake samu daga shan kwayoyin halittar, na iya ƙara damuwa da kuma rashin kwanciyar hankali.
A farkon barkewar cutar SARS, an ba da rahoton wasu cututtuka na rashin lafiyar jiki ciki har da ciwon baƙin ciki na kullum, damuwa, tashin hankali, tashin hankali, bayyanar cututtuka na rashin hankali, hauka, har ma da son kashe kansa.
Kulawa da keɓewa da ake bukata, a matsayin wani ɓangare na amsoshin lafiyar jama'a ga ɓarkewar COVID-19, na iya sa mutane su ƙara damuwa da jin laifi game da tasirin kamuwa da cuta, keɓewa, da kuma ƙazantar da iyalansu da abokai.
Saboda haka, ya kamata a ba da kulawar lafiyar hankali ga waɗanda ke da cutar COVID-19, waɗanda ake zargi da cutar, waɗanda suka kamu da ita, da kuma sauran mutanen da suke bukatar kulawar.
Tallafin tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiya na hankali da yawa, sadarwa mai kyau tare da sabuntawa na yau da kullun da cikakke game da barkewar SARS-CoV-2 da tsare-tsaren magani, da amfani da na'urori na lantarki na musamman da aikace-aikace don kauce wa hulɗa kai tsaye da juna.
Alurar riga kafi mai inganci don yanke jerin watsa kwayar cutar daga wuraren ajiyar dabbobi da mutane masu kamuwa da cutar zuwa ga masu masaukin da ke da saukin kamuwa da cutar suna da mahimmanci kuma galibi suna dacewa da maganin antiviral wajen magance annobar da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari wajen samar da allurar rigakafin da ke bisa sunadarin S don samar da ƙwayoyin cuta masu tsaka tsaki, masu tasiri, na dogon lokaci da kuma/ko rigakafin rigakafin SARS-CoV.
An gwada rigakafin da aka yi amfani da shi a cikin dabbobi don maganin SARS.
Koyaya, ba a tabbatar da ingancin waɗannan alluran rigakafin a cikin jiki na tsofaffi da kuma a cikin ƙirar ƙirar ƙirar ƙira ba a cikin rigakafin kamuwa da kwayar cutar ta kwayar cutar dabba kafin fara nazarin asibiti.
Wataƙila saboda SARS ya ɓace shekaru 17 da suka shige kuma babu wani sabon hali da aka ba da rahoto tun daga lokacin.
Akasin haka, mutane da kuma kungiyoyi da ke fama da cutar MERS suna ci gaba da bayyana a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna saboda ci gaba da samun albarkatun dabbobi a yankunan da cutar ta addabe.
An tsara dabarun kariya daga MERS ta amfani da kwayar cutar da ba ta aiki, da kuma sinadarin DNA mai ƙarancin oxygen, da masu ɗaukar kwayar cutar, da nanoparticles, da kwayar cutar da ke kama da kwayar cutar, da kuma ƙananan ƙwayoyin sunadarai, wasu kuma an kimanta su a cikin ƙirar dabbobi.
Samar da maganin rigakafin SARS-CoV-2 mai lafiya da tasiri ga mutanen da ba su da rigakafi gaggawa ce kuma muhimmiyar aiki ne na shawo kan annobar da ke ci gaba a yanzu.
Duk da haka, shawo kan wannan matsala na da ƙalubale saboda tsawon lokacin da ake bukata (a matsakaici watanni 18) don samar da allurar rigakafi da kuma sauye-sauyen da ke faruwa a cikin kwayar cutar korona.
COVID-19, a matsayin sabon cuta, ya fara nuna cikakkiyar hanyar asibiti a cikin dubban marasa lafiya.
A yawancin yanayi, marasa lafiya suna iya warkewa a hankali ba tare da horo ba.
Duk da haka, COVID-19, kamar SARS da MERS, ana danganta shi da yawan yaduwar cutar da kuma yawan mutuwar marasa lafiya masu tsanani.
Saboda haka, gina samfurin hasashen ciwo yana da muhimmanci ga hukumomin kiwon lafiya su sa kan gaba wajen ba da sabis, musamman a yankunan da ke da iyakantaccen albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan na iya shafar ko kuma suna da alaƙa da yanayin cutar a cikin marasa lafiya na COVID-19 (Tashar 33):
Shekaru: Shekaru shi ne abu mafi muhimmanci da ke sa a yi tsammanin ciwon SARS, kuma haka yake a COVID-19.
COVID-19 ya fi rinjayar mutanen da shekarunsu suka kai 30 zuwa 65, kuma kashi 47.7% na waɗanda suka kai shekaru 50 a cikin binciken da aka yi kan mutane 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai zurfi sun fi fuskantar kamuwa da cututtukan da ke tattare da cutar da kuma rikitarwa kuma sun fi waɗanda ba su buƙatar kulawa (a matsakaicin shekaru 66 zuwa 51) tsufa, wanda ke nuna shekaru a matsayin mai hasashen sakamakon COVID-19.
Jima'i: Maza sun fi mata kamuwa da SARS-CoV-2 (0.31/100,000 vs. 0.27/100,000), kamar yadda aka nuna a sama.
Cutar zuciya da kuma cututtuka: Marasa lafiya da ke da cutar COVID-19 da suke bukatar kulawa mai tsanani suna da haɗarin kamuwa da ciwon zuciya mai tsanani da kuma rashin daidaitaccen bugun zuciya.
Har ila yau, haɗarin zuciya shi ne sanadin mutuwa mafi girma a cikin marasa lafiya da ke fama da cutar SARS.
An ba da rahoton cewa SARS-CoV-2 na iya haɗuwa da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta.
Ya kamata a lura cewa tsufa da rashin lafiya suna da nasaba sosai kuma suna iya shafar juna.
Sakamakon gwaji: Matsakaicin sinadarin C mai amsawa (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama, kuma an ba da shawarar cewa yana iya nuna cutar, amsawa ga magani, da kuma warkewa.
An kuma ba da shawarar cewa akwai dangantaka tsakanin matakin C-reactive protein da kuma tsananin cutar COVID-19 da kuma yanayin rayuwarta.
Bugu da ƙari, ƙaruwar enzyme na lactate (LDH), mai ɗaukar amino aspartate (AST), mai ɗaukar amino alanine (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Waɗannan sunadarai suna da ƙarfi a cikin gaɓoɓin jiki da yawa, musamman a zuciya da hanta, kuma ana fitar da su yayin da ake lalata nama.
Saboda haka, alamun rashin aiki ne na zuciya ko hanta.
Alamu na asibiti: Ana bukatar a yi la'akari da gwajin kirji da ci gaban alamun asibiti tare da wasu matsaloli don a iya hango sakamakon COVID-19 da kuma rikitarwa.
Amfani da maganin kashe kumburi: Kamar yadda aka bayyana a sama, maganin kashe kumburi shi ne maganin kashe kumburi da ake amfani da shi a matsayin magani na taimako ga cututtuka masu yaduwa don rage lalacewar kumburi.
Tun da aka yi amfani da maganin da ke motsa jiki sosai a cikin marasa lafiya da ke da cutar SARS, mutane da yawa da suka tsira sun sha wahala daga ciwon ƙashin ƙashi da kuma rashin ƙoshin lafiya na tsawon rai da kuma rashin ingancin rayuwa.
Saboda haka, ya kamata a yi amfani da maganin a ƙarancin allurai kuma na ɗan lokaci a cikin marasa lafiya da ke da COVID-19, idan ya cancanta.
Damuwa: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19, marasa lafiya da yawa sun sha wahala sosai; sau da yawa suna shan wahala tsawon lokaci a keɓewa, rashin tabbas, kuma sun ga mutuwar dangi da abokan aikin su.
Yana da muhimmanci a ba da shawara ta ruhaniya da kuma taimako na dogon lokaci don a taimaki waɗannan marasa lafiya su warke daga matsi kuma su koma rayuwa ta al'ada.
Bisa ga binciken alƙaluma da aka yi, COVID-19 ya nuna cewa yana da wasu halaye na annoba dabam da SARS.
Baya ga sake haifuwa a cikin ƙananan numfashi, SARS-CoV-2 na iya sake haifuwa a cikin ƙananan numfashi kuma yana haifar da ƙananan alamomi ko babu alamomi a farkon kamuwa da cuta, kamar sauran coronaviruses waɗanda ke haifar da sanyi.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko kuma lokacin da suke cikin gida suna iya samar da kwayar cutar sosai a lokacin da suke yin ayyukan yau da kullum, kuma hakan yana sa ya yi wuya a shawo kan annobar.
Duk da haka, ana ganin cewa kamuwa da cutar SARS-CoV-2 tana faruwa ne lokacin da marasa lafiya ke cikin matsanancin rashin lafiya, yayin da yawancin kamuwa da cutar ba ta faruwa a farkon lokaci ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma ta fi wahalar sarrafawa.
A yanzu haka ana kokarin yin hakan a kasar Sin, ciki har da rufe birnin Wuhan da biranen da ke kewaye da shi, da kuma sanya kusan dukkan mutane a cikin gidajensu, da fatan hana yaduwar cutar SARS-CoV-2.
Duk da cewa wadannan matakan sun yi wa tattalin arziki da sauran sassan kasar illa, adadin sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
Kimanin masu fata shi ne cewa annobar za ta kare a watan Maris kuma za a ci gaba da raguwa na tsawon watanni uku zuwa huɗu.
Duk da haka, wasu masana ba su da bege.
Paul Hunter da wasu sun kimanta cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekara ta 2020.
Ira Longini da wasu sun kirkiro wani samfurin da zai iya hango sakamakon annobar kuma sun ce SARS-CoV-2 zai iya shafar kashi biyu bisa uku na yawan mutanen duniya.
Wani rukunin 'yan Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin gwajin kwayar cutar da kuma na bakin jini na marasa lafiya da suka warke kuma suka bar asibiti makonni biyu da suka gabata, wanda ke nuna cewa sabon cutar da aka gano na iya zama irin wannan cutar ta mura.
Duk da haka, akwai alamun da ke nuna cewa kasar Sin za ta iya samun ci gaba bisa ga raguwar adadin sabbin masu kamuwa da cutar, wanda ke nuna cewa dabarun da ake amfani da su a yanzu na iya yin tasiri.
A dā, an yi hasashen cewa cutar Ebola za ta iya kashe mutane miliyan ɗaya, kuma za ta iya kashe mutane miliyan ɗari.
Duk da haka, an sami nasarar sarrafa cutar ta hanyar tsauraran matakan keɓewa da keɓewa.
Zai yiwu, kamar SARS-CoV, SARS-CoV-2 zai zama mai rauni wajen haifar da kamuwa da cuta kuma daga ƙarshe ya ɓace ko kuma ya zama ƙarancin kwayar cutar da ke rayuwa tare da mutane.
A ƙasa akwai kwatancen SARS da MERS na COVID-19 (hoto 55).
SARS-CoV-2 yana yaduwa sosai ta hanyar tari ko tari, kuma ana iya yaduwa ta hanyar hulɗa kai tsaye da abubuwa da ke dauke da kwayar cutar.
An kuma gano cutar a cikin fitsari, wanda ya nuna cewa za a iya kai ta daga fitsari zuwa baki.
Wani bincike na kwanan nan da aka yi a kan mutane 138 ya nuna cewa kashi 41 cikin 100 na waɗanda suka kamu da cutar sun kamu ne a asibitoci, har da marasa lafiya 17 da suka kamu da wasu cututtuka da suka riga sun kamu da su da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, dole ne a ɗauki matakan kariya don kare mutane, musamman masu kula da lafiya, ma'aikatan zamantakewa, 'yan uwa, abokan aiki, har ma da masu wucewa waɗanda suka yi hulɗa da marasa lafiya ko mutane masu cutar.
Saka abin rufe fuska shine layin farko na kariya da za a iya amfani da shi wajen rage haɗarin kamuwa da cuta; yin amfani da abin rufe fuska na tiyata da kuma abin rufe fuska na numfashi na N95 (seri na 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Takunkumin fuska na tiyata yana hana ɗigon ruwa daga mai cutar daga yaɗuwa ta iska ko kuma ya manne da kayan, inda za a iya watsa shi ga wasu.
Duk da haka, N95 (series 1860s) kawai zai iya kare daga numfashin ƙananan fure-fure na tsakanin 10 zuwa 80 nanometers, tare da kawai 5% na fure-fure na iya shiga cikin cikakkiyar hanyar; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma suna da girman kusan 85 nanometers.
Tun da yake ƙwayoyin za su iya shiga cikin abin rufe fuska guda biyar da aka saka tare, masu kula da lafiyar da ke hulɗa kai tsaye da marasa lafiya dole ne su sa abin rufe fuska na N95 (seri na 1860s) amma ba abin rufe fuska ba.
Bugu da ƙari ga abin rufe fuska, masu kula da lafiyar jama'a dole ne su sa rigunan kariya na jiki da suka dace domin rage hulɗa da cutar.
Ƙari ga haka, ƙwayoyin cuta suna iya kai mutum ta idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; mai yiwuwa cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu kula da lafiyar jama'a su sa takunkumin fuska ko kuma tabarau sa'ad da suke aiki da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma za ta iya shafawa, an shawarci kowa da kowa ya wanke hannuwansa da sabulu mai tsabta fiye da yadda ya saba, ya yi kokarin zama a gida don keɓe kai, kuma ya rage hulɗa da mutanen da ke da cutar.
Ana ganin nesa na ƙafa uku ya dace domin mutane su kasance nesa da mai ciwo.
Waɗannan hanyoyi ne masu kyau na rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo ne a matsayin sabon kwayar cutar zuwa duniyar ɗan adam, kamannin sa da SARS-CoV da aka ruwaito a ranar 7 ga Janairu, 2020 zai haifar da babban tashin hankali a China bisa ga ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwal.
Koyaya, har zuwa 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan bai tabbatar wa 'yan ƙasa cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakancewar mutum zuwa mutum ba kuma babu matsala wajen hana cutar da kuma hana ta.
Wannan sakon ya rage yawan fargabar jama'a, musamman a lokacin da kasar ke shirin bikin bazara, kuma lokaci ne mai matukar muhimmanci na rage cutar a Wuhan.
Hukumar rigakafin cuta a China na iya amfana daga wannan darasi mai tsanani kuma su yi gagarumin gyara a nan gaba.
Misali, waɗannan hukumomin dole ne su kasance (1) masu taka tsantsan yayin fitar da bayanai na jama'a saboda kowace kalma tana da mahimmanci ga 'yan ƙasa kuma tana iya canza halayensu da yanke shawara; (2) mafi ƙwarewa da aiki tare da bayanan da ba na yau da kullun ba daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci ko jami'ai; (3) mafi ƙuntatawa don ɗaukar wata cuta mai yuwuwa a farkon matakanta maimakon ƙoƙarin kwantar da hankalin jama'a; (4) mafi ƙwarewa don fitar da motsa jiki mai ma'ana da tasiri don haɓaka wayar da kan jama'a game da cututtukan cututtuka da kuma inganta tsarin mayar da martani na al'umma a kai a kai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya yaɗu a duk ƙasar Sin da kuma ƙasashe kusan 50 a duniya a lokacin da nake rubuta wannan.
Tun da yake cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, barkewar cutar ta COVID-19 ta haifar da jin cewa SARS na faruwa sau da yawa.
Duk da haka, akwai wasu bambance-bambance masu muhimmanci tsakanin COVID-19 da SARS, waɗanda suke da muhimmanci wajen shawo kan annobar da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yawan cutar da mutuwa ya fi girma a cikin tsofaffi fiye da matasa.
SARS tana da yawan mutuwa fiye da COVID-19 (10.91% vs. 1.44%).
Masu cutar COVID-19 suna yada cutar ko da ba su da alamun cutar, yayin da masu cutar SARS sukan yi hakan idan suna da ciwo mai tsanani, wanda hakan ke sa ya fi wuya a hana yaduwar cutar COVID-19 daga SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ke yaɗuwa da sauri kuma a wurare da yawa fiye da SARS-CoV.
Gwajin SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya da ke da COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya kamuwa da cutar.
Waɗannan sakamakon sun ƙara haɗarin yaduwar cutar sosai.
Duk da irin wannan saurin ci gaba a binciken COVID-19, har yanzu akwai wasu muhimman tambayoyi da za a warware, kamar haka:
Daga ina SARS-CoV-2 ya fito?
Ko da yake mun gano cewa SARS-CoV-2 da SARS-CoV-2 sun yi kama da juna da kashi 96 cikin dari, ba za mu iya kammala cewa SARS-CoV-2 ya fito ne daga batsa ba.
Wane irin dabba ne ya kai cutar daga mahaifar, kamar su batsa, zuwa ga mutane?
Idan ba mu san amsoshin lambobi na 1 da 2 ba, ba za mu iya hana yaduwar cutar ba, kuma za ta iya sake barkewa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da kuma nazarin kwayoyin sun nuna cewa SARS-CoV-2 yana da alaƙa da enzyme mai canzawa zuwa angiotensin 2, ta yaya ainihin cutar take shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje na rashin lafiya?
Ƙwayoyin da ke fitar da enzyme mai canja jini na angiotensin 2 a wasu gabobin jiki suna da wannan ƙwayoyin?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya ba da ganewar asali da kuma magani mai kyau ba.
Har yaushe za a ci gaba da wannan annobar?
Ta yaya ne kwayar cutar take samun ci gaba yayin da take yaduwa tsakanin mutane?
Zai zama annoba ta duniya, ko zai shuɗe kamar SARS, ko kuma zai sake dawowa a kai a kai kamar mura?
Yana da muhimmanci amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Duk da haka, ko da menene farashin, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu mayar da rayuwarmu yadda ta kasance.
Tushen dabbobi na kwayar cutar korona ta mutum
Juyin halitta da kuma daidaitawa sun jagoranci juyin halitta tsakanin coronaviruses da kuma masu masaukin su, ciki har da mutane, dubban shekaru.
Kafin 2003, an san cewa nau'i biyu na kwayar cutar korona ta ɗan adam tana haifar da rashin lafiya mai sauƙi, kamar mura.
Cutar SARS da cutar MERS sun nuna yadda cutar korona ta iya zama mai hadari da barazana ga rai.
Bayyanar SARS-CoV-2 a tsakiyar kasar Sin a karshen shekarar 2019 ya sake haskakawa a kan coronaviruses, kuma mun yi mamakin yadda yake yaduwa da sauri amma tare da iyawar cutarwa idan aka kwatanta da dan uwansa SARS-CoV.
Kwayar cutar korona ta mutum wata cuta ce ta dabbobi, saboda haka fahimtar asalin kwayar cutar korona ta mutum daga dabbobi zai taimaka mana sosai.
Yawancin kwayar cutar korona ta mutum ta fito ne daga batsa inda ba ta haifar da cuta ba.
An kuma gano wasu ƙwayoyin cuta na coronaviruses na ɗan adam.
Gano dabbobi masu gida yana da tasiri kai tsaye wajen hana cututtuka a cikin mutane.
Binciken yadda kwayar cutar korona ke hulɗa da mai masaukin ta dabbobi ya kuma ba da muhimmiyar fahimta game da yadda kwayar cutar korona ta fara a cikin mutane.
A cikin wannan bita, mun ba da taƙaitaccen bayani game da kwayar cutar korona guda bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin dabbobi da kuma canjin halittarsu.
Abu mafi muhimmanci shi ne, muna gwadawa da kuma yin hasashen bambancin kwayar cutar korona ta mutum daga ra'ayin juyin halitta da kuma sake tsara kwayoyin halitta.
A wannan mahallin, an tattauna game da cutar da annobar cutar korona ta 2019 (COVID-19) ta haifar.
Bugu da ƙari, ya kuma nuna abin da ake bukata don samun nasara a canja wurin mai masaukin baki da kuma yadda abubuwa masu rikitarwa na ci gaban cutar ke shafar tsananin cutar.
Coronaviruses (kwaronaviruses) na cikin iyalin coronaviruses, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu rufi da ke da wani nau'in RNA mai kyau.
Waɗannan ƙwayoyin cuta suna da babban jini a cikin ƙwayoyin cuta masu DNA mai ribosome, yana da tushe daga kilogiram 26 zuwa 32 kuma an kira su "ƙirar corona" domin tsarin su yana kama da kambi a ƙarƙashin siginar lantarki.
A bangaren tsarin halitta, kwayar cutar korona tana da kwayoyin halittar da ba a rarraba su ba, kuma suna da tsari iri ɗaya.
Kusan kashi biyu cikin uku na kwayoyin halitta suna da manyan tsarin karatu biyu (ORF1a da ORF1b), waɗanda suke juyawa zuwa nau'in polypeptide pp1a da pp1ab.
Ana ƙara sarrafa wasu sunadarai da yawa don samar da wasu sunadarai 16 da ba su da tsari, wanda ake kira nsp1~16.
Sauran bangaren kwayoyin suna dauke da tsarin karanta furotin, kamar su spike S, E shell, membrane M, da kuma DNA.
Har ila yau, nau'o'in coronaviruses daban-daban suna ɓoye wasu ƙarin sunadarai daga nau'o'in musamman.
Dangane da bambancin jerin sunayen sunadarai, an rarraba kwayar cutar corona zuwa nau'i huɗu (alpha coronavirus, beta coronavirus, gamma coronavirus, da delta coronavirus), daga cikinsu akwai nau'in beta coronavirus wanda ya hada da yawancin kwayar cutar coronaviruses na mutum kuma an raba shi zuwa nau'i huɗu (A, B, C, D).
Bayanan juyin halitta sun nuna cewa batsa da masu yin fashin suna aiki a matsayin tushen asalin yawancin kwayar cutar corona alpha da beta, yayin da tsuntsaye su ne babban wurin ajiyar kwayar cutar corona gamma da Delta.
A cikin shekaru dubbai, coronaviruses sun ci gaba da ƙetare iyakokin jinsuna kuma wasu sun bayyana a matsayin masu haifar da cututtuka masu tsanani ga mutane.
An san nau'o'in kwayar cutar korona guda bakwai.
Daga cikinsu akwai kwayar cutar korona ta mutum-229E da kwayar cutar corona ta mutum-NL63, wadanda suke cikin kwayar cutar corona ta alpha.
Sauran beta-coronavirus guda biyar sun hada da HCoV-OC43, HKU1, SARS-CoV, MERS-CoV, da SARS-CoV-2.
Kwayar cutar korona ta mutum-229E, kwayar cutar korona ta mutum-OC43, kwayar cutar korona ta mutum-HKU1, da kwayar cutar korona ta mutum-NL63 yawanci suna haifar da wasu alamu masu sauƙi, kamar sanyi ko zawo ko duka biyun.
Akasin haka, SARS-CoV, MERS-CoV, da sabon SARS-CoV-2 duk suna haifar da cuta sosai, suna haifar da kamuwa da cuta mai tsanani na ƙananan numfashi ga yawancin marasa lafiya tare da yiwuwar samun cutar rashin ƙarfi na numfashi (Acute Respiratory Syndrome) da kuma alamun rashin huhu.
An ware kwayar cutar korona ta mutum 229E, nau'in farko B814, daga hanci na marasa lafiya masu mura a tsakiyar shekarun 1960.
Tun daga lokacin an sami bayanai da yawa ta hanyar nazarin kwayar cutar ta HCoV-229E da kuma HCoV-OC43, waɗanda ke warkar da alamun kansu.
A gaskiya ma, an yarda da cewa cutar kwayar cutar korona ba ta da lahani har sai da barkewar cutar SARS.
Cutar SARS ta 2003 tana cikin cututtuka mafi muni a tarihin zamani, inda mutane 8,000 suka kamu da ita, kuma kusan kashi 10 cikin 100 sun mutu.
Bayan shekara goma, cutar MERS ta Gabas ta Tsakiya ta zama annoba a yankin Larabawa, kuma ta bazu zuwa sauran ƙasashe.
Kwayar cutar Coronavirus na mutum na 2019 (HCoV-2019), wanda aka sake masa suna SARS-CoV-2, shine sanadin cutar ta yanzu ta cutar Coronavirus na 2019 (COVID-19), wanda ya kashe mutane sama da 3,120 kuma ya kamu da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi gargadi kuma duniya ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin kwayar cutar korona bakwai na mutum sun samo asali ne daga dabbobi kamar su bat, ko mice, ko kuma dabbobi masu gida.
Shaida da dama na goyon bayan asalin juyin halitta na dukkanin kwayar cutar korona ta mutum daga batsa, inda ƙwayoyin cuta suke da sauƙin daidaitawa kuma ba sa haifar da cuta amma suna nuna bambancin kwayoyin halitta mai yawa.
Cutar ta COVID-19 ta haifar da ƙalubale na likita, kimiyya, zamantakewa, da ɗabi'a ga Sin da duniya.
Binciken asalin dabbobi na kwayar cutar korona ta nuna wani tsari na fahimtar tarihin halitta, da kuma abubuwan da ke motsawa da kuma abubuwan da ke hana motsi tsakanin jinsuna.
Wannan kuma zai iya jagorantar ko sauƙaƙa neman mai ajiya, mai watsa shiri na tsakiya da kuma mai watsa shiri mai girma (mai watsa shiri mai girma) na SARS-CoV-2, tare da muhimman tasiri don hana lalacewa a nan gaba.
A cikin wannan bita, mun ba da cikakken bayani game da asalin dabbobi, da yadda ake yaduwa tsakanin jinsuna, da kuma yadda kwayar cutar korona ta ɗan adam take sa mutane su kamu da cuta.
Musamman, za mu haskaka kuma mu tattauna da sanannen ra'ayi cewa kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cuta.
Muna kuma duba yadda ake tantance kwayar cutar ta Corona a cikin mutum, inda yawanci yawan kamuwa da cuta yakan sa a rage cutar.
A wannan mahallin, muna tattauna sakamakon annobar SARS-CoV-2 da ke faruwa yanzu.
An san da cutar korona a dabbobi tun daga ƙarshen shekarun 1930.
Kafin a fara ware kwayar cutar B814 na kwayar cutar ta mutum-229E daga ɓoyayyen hanci na marasa lafiya masu mura, an gano nau'ikan kwayar cutar ta Corona daga dabbobi da dama da suka kamu da cutar, ciki har da kaza, beraye, shanu, aladu, kuliyoyi, da karnuka.
A cikin shekaru goma da suka gabata, an gano nau'o'in kwayar cutar korona guda bakwai.
Ga taƙaitaccen tarihin gano kwayar cutar korona ta mutum (Tebur 1) domin ilimi da kuma jagora.
An ware kwayar cutar korona ta farko ta mutum-229E daga cikin numfashi na marasa lafiya da ke dauke da cutar numfashi a shekarar 1966, sannan aka daidaita ta ta rayu a cikin sahun kwayoyin WI-38 na huhu.
Marasa lafiya da ke dauke da kwayar cutar HCoV-229E suna fama da alamun sanyi na yau da kullun, gami da ciwon kai, tari, rashin jin daɗi, ciwon makogwaro, tare da zazzabi, da tari a kusan kashi 10 zuwa 20%.
Daga baya a shekara ta 1967, an ware kwayar cutar korona ta mutum-OC43 daga gonar gaɓa kuma an yi ta a cikin kwakwalwar jariri.
Bayanan asibiti na kamuwa da kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cuta.
HCoV-229E da HCoV-OC43 sun yadu a duniya, kuma sun fi yaduwa a lokacin hunturu a yanayin yanayi mai laushi.
A kullum, lokacin da ake samun waɗannan ƙwayoyin cuta bai kai mako ɗaya ba, sai kuma kusan makonni biyu kafin a ji ciwo.
A cewar wani binciken da aka yi da masu son kai, kamuwa da kwayar cutar HCoV-229E a cikin mutane masu lafiya ya haifar da sanyi.
Wasu marasa lafiya da ke da rashin lafiyar jiki ne kawai suka nuna cewa suna da mummunar rauni a cikin ƙananan na'urar numfashi.
SARS, wanda kuma ake kira da "Rhumotonia Luminosa", shi ne annoba ta farko da aka rubuta a tarihin ɗan adam da ke haifar da kwayar cutar SARS-CoV, kuma ita ce kwayar cutar ta uku da aka gano.
An fara samun cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na ƙasar Sin.
Annobar SARS ta haifar da mutane 8,096 da suka kamu da cutar, kuma 774 sun mutu, kuma ta bazu zuwa kasashe da nahiyoyi da dama.
Ko da kuwa wanda ya kamu da cutar, an kiyasta cewa kamuwa da cuta guda ɗaya na iya haifar da kusan biyu na biyu, tare da tsawon lokacin kulawa daga kwanaki 4 zuwa 7 kuma ana nuna ƙaruwar ƙwayar cuta a rana ta 10 na cutar.
Alamar SARS-CoV tana farawa da ciwon tsoka, ciwon kai, zazzabi, rashin jin daɗi, da kuma ɓacin rai, sai kuma ciwon numfashi, tari, da kuma numfashi.
Rashin ƙwayoyin lymph, rashin aiki na hanta, da kuma ƙaruwa na creatine kinase suna cikin cututtukan SARS da aka gano a cikin dakin gwaje-gwaje.
A cikin marasa lafiya da ke fama da cutar SARS, ana samun lalacewar jijiyoyin jini, ƙaruwa na ƙwayoyin jini, da kuma ƙaruwar ƙwayoyin jini.
Kusan kashi 20 zuwa 30 na marasa lafiya suna bukatar kulawa mai tsanani da kuma numfashi.
Ƙari ga ƙananan hanyoyin numfashi, a cikin mawuyacin yanayi, wasu gabobin jiki kamar su hanji, hanta, da kuma koda suna iya shan wahala. Wannan yakan faru ne sa'ad da ake samun ciwon cytokine, wanda zai iya kashe mutum musamman ma a marasa lafiya da ke da ƙarancin garkuwar jiki.
An fara gano kwayar cutar ne daga kwayar cutar huhu da aka bude wa wani dangin wanda ya fara kamuwa da cutar wanda ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi gagarumin kokarin bincike kan kwayar cutar korona ta mutum.
An ware kwayar cutar ta NC-63 daga wani yaro mai wata bakwai a Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara ƙanana, tsofaffi, da kuma marasa lafiya masu ƙarancin rigakafi da ke fama da cututtukan numfashi.
Colds, conjunctivitis, zazzabi, da kuma sinusitis, su ne alamun cutar da ke haifar da kwayar cutar ta NC63.
Wani bincike mai zaman kansa ya bayyana cewa an ware wannan kwayar daga hanci na wani yaro mai wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a Netherlands, ya yaɗu a dukan duniya.
An kiyasta cewa kwayar cutar ta NC-63 tana da alhakin kusan kashi 4.7% na cututtukan numfashi na yau da kullum, kuma yawan su ya fi yawa a farkon bazara, bazara da kuma hunturu.
Kwayar cutar ta NCV-NL63 tana da nasaba da cutar kumburi, wanda kuma ake kira da sunin shanyewar hanci.
A wannan shekarar, an gano kwayar cutar HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti saboda ciwon huhu da kuma ciwon hanta a Hong Kong.
Baya ga ciwon huhu da kuma ciwon hanta, an ba da rahoton cewa kwayar cutar HKU1 tana da nasaba da mummunar cutar asma.
An gano cewa kwayar cutar HKU1 tana yaduwa a duniya, tana haifar da rashin lafiya na numfashi, kamar kwayar cutar HKU-63, HKU-229E, da kuma HKU-OC43.
Dukkanin wadannan kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cuta a kasar Sin.
Gabaɗaya, idan coronaviruses suka sami wannan ikon na yaduwa da kyau kuma su ci gaba da kasancewa a cikin mutane, su ma ba sa yin kisa ko kuma su kamu da cuta.
An fara ware Merce-Kuf a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da ke fama da ciwon huhu da kuma rashin ciwon koda a Saudi Arabiya.
Duk da yake yawancin waɗanda aka tabbatar da su a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ba da rahoton cewa a ƙasashen Turai da Tunisia da yawa an kawo su daga ƙasashen waje kuma ba a yawan samun kamuwa da cuta ta hanyar hulɗa ta sirri.
Wani kuma barkewar cutar a Koriya ta Kudu a shekarar 2015 ya haifar da tabbatar da mutane 186 da suka kamu da cutar.
Alamun cutar MERS suna kama da na SARS, kuma suna kama da ciwon huhu mai tsanani.
Ba kamar SARS ba, mutane da yawa da ke da cutar MERS suna fama da rashin ciwon koda, wanda ke bambanta MERS da sauran cututtukan da ke haifar da kwayar cutar korona.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna da cututtukan da ke shafar hanji, kamar zawo da kuma zubar da ciki.
A ranar 14 ga Fabrairu, 2020, an bayar da rahoton fiye da lambobi 2,500 da aka tabbatar a dakin gwaje-gwaje tare da yawan mutuwar da ya kai kashi 34.4%, wanda ya sanya MERS-CoV ya zama daya daga cikin cututtukan da aka fi sani da su ga mutane.
A tsakiyar watan Disamba zuwa ƙarshen 2019, an gano rukunin marasa lafiya da cutar huhu da aka gano daga baya cewa ta samo asali ne daga cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar SARS-CoV-2 ta hanyar cutar numfashi ta ƙasa a matsayin gaggawa ta lafiyar jama'a mai muhimmanci a duniya, kamar yadda ta kira COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar 90,053 a duniya, kuma yawan mutuwar farko ya kai kashi 3.4%.
Ya kamata a lura cewa yawan mutuwar a lardin Hubei na kasar Sin ya kai kashi 4.2 cikin dari, yayin da na kasashen waje ya kai kashi 1.2 cikin dari.
SARS-CoV-2 na haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, kuma suna bayyana a cikin zazzabi, tari da kuma numfashi mai wuya.
Wasu ma suna da zawo.
Ciwon huhu yana cikin alamun da suka fi tsanani kuma yana iya saurin zama ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan kamanceceniya a jerin nucleotides na kashi 82%, duk da haka suna cikin rassa daban-daban na bishiyar juyin halitta.
SARS-CoV-2 ba shi da tsanani sosai amma yana da saurin kamuwa da cutar fiye da SARS-CoV da MERS-CoV.
An samu rahotanni cewa mutane da ke da cutar SARS-CoV-2 ba su da alamun cutar, kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran kwayar cutar korona guda shida sun nuna kamance da bambance-bambance masu muhimmanci.
Na farko, kwayar cutar korona ta mutum tana kama da lokacin da take cikin jariri da kuma lokacin da take da cutar.
A wannan batun, SARS-CoV-2 na bin tsarin sauran kwayar cutar korona guda shida.
Na biyu, cutar ta COVID-19 tana da tsanani tsakanin SARS-CoV da kuma kwayar cutar HCoVs guda hudu da aka samu daga al'umma (wato HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A wani bangare, kamuwa da SARS-CoV-2 yana nuna halaye da suka fi kowa a cikin kamuwa da kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cuta.
A wani bangare kuma, ana iya ganin ƙaramin ƙaramin rukunin mutane masu cutar COVID-19 kamar yadda ake ganin SARS-CoV, ko da yake adadin ya ɗan ragu.
Na uku, SARS-CoV-2 yana nuna wasu abubuwa masu ban sha'awa game da SARS-CoV da kuma kwayar cutar korona.
A wani bangare, SARS-CoV-2 yana da yaduwa sosai fiye da kwayar cutar korona ta mutum da aka samu daga al'umma.
A gefe guda, ana ci gaba da bincika ko SARS-CoV-2 zai iya kamuwa da mutane bayan an kai shi ga mutane kamar yadda yake a SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano SARS-CoV-2 a cikin fitsari kamar yadda ake iya ganowa a cikin sauran kwayar cutar korona ta mutum.
Ana bukatar ƙarin bincike a nan gaba don a gano ko SARS-CoV-2 na iya yin tasiri a kan SARS-CoV-2 a wasu yanayi.
Abin sha'awa ne ko SARS-CoV-2 zai iya nuna yaduwar yanayi kamar yadda yake a cikin cututtukan da ake samu daga al'umma.
Duk da haka, halayen SARS-CoV-2, ciki har da yiwuwar yaduwa, tsarin kamuwa da cuta da kuma ci gaba da yaduwa bayan kamuwa da mutane zai yi tasiri a kan makomar barkewar COVID-19 ta yanzu.
Dukkanin kwayar cutar korona guda huɗu da aka samu daga al'umma da ke haifar da ƙananan cututtuka sun daidaita da kyau ga mutane.
Akwai wani ra'ayi kuma, wanda kuma zai iya zama gaskiya, shi ne cewa mutane sun daidaita da kyau ga wadannan kwayar cutar HCoVs huɗu.
A wata ma'anar, su biyun za su iya tsira daga tsoffin annobar cutar korona.
An kawar da kwayar cutar korona ta mutum da ke sa mutane kamuwa da cututtuka masu tsanani da kuma mutane da suka kamu da kwayar cutar korona ta mutum.
Don hakan ya faru, dole ne kwayar cutar ta HCoVs ta yi kwafi a cikin mutane yadda za ta ba da damar tarin canjin yanayi da ke fuskantar abubuwan da ke hanawa a cikin mai masaukin.
A wannan yanayin, idan cutar SARS-CoV-2 ta ci gaba da ƙaruwa, kuma yawan mutane da ke kamuwa da ita ya ƙaru, za a iya cewa za ta iya daidaitawa da 'yan Adam.
Idan ya daidaita sosai, yana da wuya a dakatar da yaduwarsa tsakanin mutane ta hanyar keɓewa ko wasu matakan hana kamuwa da cuta.
Kwayoyin cutar korona guda huɗu da aka samu daga al'umma suna yaɗuwa tsakanin mutane na tsawon shekaru, suna sa mutane masu garkuwar jiki su kamu da sanyi.
Waɗannan ƙwayoyin cuta ba sa bukatar ajiyar dabbobi.
Akasin haka, SARS-CoV da MERS-CoV da suke da nasaba mai tsanani da mutane ba su daidaita sosai ba, kuma ba su iya ci gaba da yaduwa tsakanin mutane ba.
Suna bukatar su zauna a cikin gidajensu su haifa a wurin, sa'an nan su nemi zarafi su kai ga mutane masu saurin kai hari, wataƙila ta hanyar ɗaya ko fiye da masu watsa shiri na matsakaici da kuma masu faɗaɗa.
SARS-CoV-2 tana da halaye masu kama da SARS-CoV/MERS-CoV da kuma kwayar cutar korona guda huɗu da aka samu daga al'umma.
Yana da saurin yaduwa kamar kwayar cutar korona ta mutane, a yanzu.
Duk da haka, yana sa mutane su kamu da cutar fiye da kwayar cutar korona da aka samu daga al'umma, kuma ya fi SARS-CoV ko MERS-CoV ƙasa.
Ba a san ko za su iya daidaitawa da kuma yaɗuwa tsakanin mutane ba tare da bukatar wani mai ajiye abubuwa ko kuma mai watsawa ba.
Kafin mu tattauna asalin dabbobi na kwayar cutar ta korona, zai taimaka mana mu sake nazarin ma'anar da kuma halayen masu watsa labaran kwayar cutar ta korona, masu halitta, masu ajiya, masu matsakaici, da masu yaduwa.
Dabba na iya zama mai watsa shiri na kwayar cutar ta HCoV idan ta ƙunshi kwayar cutar ta asali da ke da alaƙa da ita kuma suna da kamanceceniya sosai a matakin jerin nucleotides.
Kwayar cutar ta asali tana da sauyi, tana da sauyi sosai kuma ba ta haifar da cutar ga wannan mai masaukin.
Hakazalika, mai watsa labaran yana riƙe da kwayar cutar korona na ɗan adam a kai a kai kuma na dogon lokaci.
A kowane hali, masu watsa labaran suna kamuwa da cutar kuma su ne masu watsa labaran kwayar cutar ta HCoV ko kuma kwayar cutar ta asali.
Akasin haka, idan kwayar cutar korona ta mutum ta shiga cikin mai watsa shiri na baya-bayan nan kafin ko kusa da kai hari ga mutane, ba ta daidaita da kyau ga sabon mai watsa shiri kuma sau da yawa tana haifar da nakasa.
Wannan mai watsawa na iya zama tushen kwayar cutar ta dabbobi ga mutane kuma yana yin aikin mai watsawa ta hanyar barin kwayar cutar ta kwafa na ɗan lokaci kuma ta haka ne ta watsa shi ga mutane don faɗaɗa yaduwar kamuwa da cuta tsakanin mutane.
Cutar korona ta mutum na iya kaiwa ga matsi idan cutar ta kasa yaduwa daga cikin mai watsawa.
Akasin haka, kwayar cutar korona ta mutum tana iya daidaitawa da mai masaukin ta matsakaici har ma ta iya zama a cikinta na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na ɗakunan ajiya.
Bayan haka, bayanan da aka samu daga cikin cutar sun nuna cewa cutar SARS ta farko tana da tarihin haɗuwa da dabbobi.
Binciken yaduwar da aka yi daga baya ya nuna cewa masu sayar da dabbobi suna da yawan maganin SARS-CoV IgG fiye da mutane.
An fara gano cewa kwayar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da dabbobi da suka kama da dabbobi.
Abin da ya taimaka wa wannan shi ne, babu wani sabon kamuwa da cutar SARS da aka ba da rahoto bayan da aka kashe dukan kuliyoyin da ke kasuwa.
Koyaya, an ba da rahoton cewa sakamakon binciken SARS-CoV a cikin mascara na dabino wanda ke rayuwa a cikin daji ko gonaki ba tare da fallasa ga kasuwannin dabbobi masu rai ba ya kasance mai illa, yana nuna cewa mascara na dabino na iya zama kawai matsakaiciyar rundunar rundunar, amma ba ta zama wurin ajiyar SARS-CoV ba.
Ya lura cewa, yayin da kashi 80 cikin 100 na dabbobi a kasuwar Guangzhou suna da rigakafin SARS-CoVs, ba a iya yin watsi da yiwuwar cewa wasu ƙananan dabbobi masu shayarwa suna da babban matsayi na SARS-CoVs.
Kamar dai su duka ba masu dauke da cutar SARS-CoV ba ne.
Binciken da aka yi daga baya game da mai watsa shiri na SARS-CoV-2 ya haifar da gano kwayar cutar bat-corona mai alaƙa da juna, wanda ake kira HKU3 (HKU3), wanda ke cikin kwayar cutar HKU3.
An gwada kwayoyin cutar SARS-CoV a cikin waɗannan bat da kuma kwayar cutar HKU3 da ke da nasaba da cutar.
Wannan da sauran kwayar cutar bat korona suna da kamanceceniya tsakanin kashi 88 zuwa kashi 92 cikin dari na jerin nucleotides da SARS-CoV.
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa batutuwan suna da alaƙa da cututtukan mutane.
An gano wasu kwayar cutar korona mai kama da cutar mai saurin numfashi mai saurin kamuwa da cuta (Acute Respiratory Syndrome Virus-like coronaviruses) daga batsa, amma ba za a iya ware ko ɗaya daga cikinsu a matsayin kwayar cutar mai rai ba sai dai WIV1.
An san enzyme mai canzawa na Angiotensin 2 na mutum a matsayin mai karɓar SARS-CoV.
An tabbatar da cewa WIV1 da aka cire daga samfurin farji na bat yana amfani da enzyme mai canzawa zuwa angiotensin 2 a cikin bat, da cats, da mutane a matsayin mai karɓar shiga cikin kwayar halitta.
Abin sha'awa, maganin rigakafi na waɗanda suka warke daga matsanancin ciwon numfashi yana da ikon daidaita WIV1.
Har zuwa yanzu, WIV1 ita ce kwayar cutar da ta fi dacewa da SARS-CoV a cikin batsa, suna da kashi 95% na daidaiton jerin nucleotides.
Duk da irin kamance tsakanin wadannan ƙwayoyin cuta biyu, ana yawan gaskata cewa WIV1 ba ita ce kwayar cutar SARS-CoV ba kuma cewa batsa ba ita ce mai watsa shiri ta SARS-CoV ba.
Binciken juyin halittar nau'in MERS-CoV a cikin kwayar cutar korona-HKU4 a cikin batsa da kwayar cutar korona-HKU5 a cikin batsa kanta.
Kwayar cutar korona-HKU4 a cikin bat da kuma MERS-CoV mai zuwa suna amfani da mai masaukin baki guda, bipeptide peptidase4, don shiga kwayar cutar.
Ma'anar Mairs-Kowf RNA-based RNA polymerization ya fi kusa da irin nau'in kwayar cutar beta-corona a cikin bat-virus da aka gano a Turai da Afirka.
Har yanzu ba a gano cewa Merce-Cove yana zaune a cikin namun daji ba.
MERS-CoV da HKU25 suna da kashi 87% na kamanceceniya tsakanin jerin nucleotides a cikin batsa.
Saboda haka, ƙila ba batutuwan da ke kula da Mairs-Cove ba.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa kamal din ne kawai ke da kwayar cutar antibody mai kyau da ke da daidaiton MERS-CoV, kuma kamal din na Gabas ta Tsakiya ne a wasu ƙasashen Afirka.
An ware kwayar cutar ta Mers-Cov mai rai daga hanci na kamal mai launin toka, wanda ke nuna cewa kamal yana aiki a matsayin mai masaukin gidan ajiyar Mers-Cov.
Ya kamata a lura cewa a cikin Jamal, wadda ta kamu da cutar ta MERS-CoV, an sami ƙananan cututtuka, amma an gano cewa cutar ta yadu sosai.
Cats masu cutar suna yada ƙwayoyin cuta sosai ba kawai ta hanyar numfashi ba amma kuma ta hanyar hanyar bakin, wanda shine hanyar farko da cutar ke yaduwa daga bat.
Duk da haka, har yanzu akwai tambayoyi saboda yawancin mutanen da aka tabbatar da cutar MERS ba su da tarihin hulɗa da fata kafin bayyanar cututtuka, kuma an danganta waɗannan lokuta ne da ma'anar mutum zuwa mutum ko kuma hanyoyin da ba a san su ba na watsawa wanda ya haɗa da nau'in dabbobi da ba a gano su ba.
SARS-CoV-2 RaTG13 yana da kashi 96.2% na kwayar cutar nucleotide a cikin ƙwayoyin da aka ware daga ƙwayoyin da ke da ƙwayoyin halittar doki.
Bambancin jerin SARS-CoV-2 da RaTG13 yana da tsawo sosai da zai yi wuya a gano dangantaka da uba, kamar yadda yake a SARS-CoV da MERS-CoV.
Wannan yana nufin cewa batsa ba za ta iya zama mai watsa shiri na SARS-CoV-2 ba sai dai idan an sami kusan iri ɗaya na bat coronaviruses a nan gaba.
An yi imanin cewa dabbobi masu watsawa na SARS-CoV-2 sun kasance daga cikin nau'ikan dabbobin daji da aka sayar da kashe a kasuwar abincin teku ta Wuhan, wanda aka danganta da yawancin cututtukan farko na COVID-19, wanda ke nuna yiwuwar kamuwa da cutar daga dabba zuwa mutum.
Yawancin binciken kwanan nan da aka yi bisa jerin metagenomics sun ba da shawarar cewa wani rukuni na ƙananan dabbobi masu shayarwa da ke cikin hatsari da aka sani da Manis javanica na iya zama gida ga beta coronaviruses da ke da alaƙa da SARS-CoV-2.
Kwayar cutar coronavirus ta wannan mai cin tururuwa da SARS-CoV-2 suna da kamanceceniya tsakanin kashi 85 zuwa 92 cikin dari.
Duk da haka, suna da dangantaka sosai da RaTG13 da kusan kashi 90 cikin ɗari na kamanceceniya a matakin jerin nucleotides.
An tattara su cikin ƙwayoyin cuta guda biyu na SARS-CoV-2 a cikin bishiyar juyin halitta, ɗayan yana da yankin haɗuwa da masu haɗuwa da SARS-CoV-2, tare da daidaiton amino acid na 97.4%.
Akasin haka, yankunan da ke haɗa masu karɓa na SARS-CoV-2 sun bambanta da RaTG13, duk da cewa daidaiton jerin kwayoyin halitta gaba ɗaya ya fi girma.
Wani bincike da aka yi a baya a kan wani ɗan adam da ya ci wani abu ya nuna cewa akwai ƙwayoyin cuta a cikin huhu, kuma hakan ya nuna cewa suna da alaƙa da cutar SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tattarawa da kuma sarrafawa ta hannu don samar da jerin kwayoyin halitta na kashi 86.3% na cikakken kwayar cutar.
Ba za mu iya ware yiwuwar cewa mai cin naman ƙuda yana ɗaya daga cikin dabbobi masu watsawa na SARS-CoV-2.
Duk da haka, a halin yanzu babu wata hujja da ke nuna cewa cin naman alade ne tushen SARS-CoV-2 saboda bambancin jerin SARS-CoV-2 da SARS-CoV-2 beta coronaviruses a cikin naman alade.
Bugu da ƙari, bambancin SARS-CoV-2 da RaTG13 ya fi bambancin SARS-CoV-2 da SARS-CoV-2 beta coronaviruses a cikin masu cin tururuwa.
Ana ci gaba da gano hanyar da SARS-CoV-2 zai bi a cikin namomin kaza, da kuma wasu dabbobi masu shayarwa.
Yayin da aka sami mafi girman daidaiton masu karɓar karɓa tsakanin SARS-CoV-2 da mai cin naman alade, SARS-CoV-2, SARS-CoV-2 da RaTG13 beta coronaviruses suna da daidaiton mafi girma na cikakken jerin kwayoyin.
An yi hasashen cewa babban matakin kamance tsakanin yankunan haɗin masu karɓar SARS-CoV-2 a cikin masu cin naman kaza na beta-coronavirus da SARS-CoV-2 sun haifar da haɓaka haɓaka.
Akwai wani ƙira da ke nuna yiwuwar sake haɗuwa tsakanin SARS-CoV-2 a cikin cinyewar tururuwa na beta-coronaviruses da RaTG13 a cikin nau'in dabbobi na daji na uku.
Ana samun sauyin halittar a tsakanin beta-coronaviruses a matsayin abin motsa juyin halitta.
Ba a tabbatar da asalin dabba na SARS-CoV-2 ba tukuna.
Baya ga kwayar cutar HCoVs mai saurin kamuwa da cuta, an kuma yi nazarin asalin kwayar cutar HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Bayanan juyin halitta sun nuna cewa HCoV-NL63 da HCoV-229E na iya samo asali daga cutar batirin, yayin da aka sami kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin beraye.
An bayar da rahoton cewa kwayar cutar Corona a cikin bat da ake kira ARCoV.2 (kwayar cutar Corona a tsaunukan Appalachian) da aka gano a cikin kwayar cuta mai launin uku a Arewacin Amurka tana da dangantaka da kwayar cutar Corona ta ɗan adam-NL63.
A gefe guda, an gano cewa kwayar cutar ta COVID-229E ta ɗan adam tana da alaƙa da kwayar cutar ta COVID-19 a cikin bat, da ake kira Hipposideros/ GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana zargin cewa ana iya samun kwayar cutar a cikin dabbobi masu rarrafe.
Don bayyanawa, an taƙaita bayanin da ake da shi a yanzu game da asalin dabbobi na ƙwayoyin cuta na coronaviruses na mutum a siffa 1 da kuma tebur 2.
Binciken juyin halitta ya ba da tabbaci game da yaduwar kwayar cutar corona tsakanin jinsuna a tarihi.
Lokacin da kwayar cutar ta COV-OC43 ta wuce daga dabbobi zuwa mutane a wajen 1890, an yi annobar kamuwa da cuta ta hanyar numfashi.
Tarihin yaduwar kwayar cutar HCoV-229E tsakanin jinsuna har yanzu ba a bayyana ba.
An gano cewa alpha coronaviruses a cikin bat sun yi daidai da HCoV-229E.
Daga cikinsu akwai Alpha coronavirus a cikin Alpaca.
Akwai tabbaci da yawa da ke nuna cewa cutar tana iya wucewa daga bat zuwa ga mutane kai tsaye.
Na farko, mutane, ba alpacas ba, suna iya yin hulɗa da batsa a cikin mazaunin da suke da shi.
Amma mutane suna da dangantaka ta kusa da alpacas.
Na biyu, kwayar cutar korona ta mutum-229E na alpha-coronaviruses a cikin batutuwan yana da yawa kuma ba ya haifar da cuta a cikin batutuwan, yayin da alpha-coronaviruses a cikin alpaca ke haifar da barkewar cututtukan numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano cutar coronaviruses na alpha da ke da nasaba da alpaca ba a cikin namun daji.
Saboda haka, ba za a iya ware yiwuwar cewa alpaca ta kamu da cutar coronavirus-229E na mutum ba.
A gaskiya ma, batsa ce tushen ƙwayoyin cuta da ke haddasa cututtuka ga mutane, har da cutar zazzabin cizon sauro, cutar Ebola, cutar Nipah, da kuma cutar Hendra.
Ba abin mamaki ba ne cewa batutuwan na iya kaiwa mutane kwayar cutar HCoV-229E kai tsaye.
Yayin da alpha coronaviruses a cikin batutuwan ke aiki a matsayin masu tsara kwayar cutar ta mutum-229E, alpacas da kuma kamal guda ɗaya na iya zama masu watsawa na matsakaici don watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin MERS-CoV.
Misalin Myres-Cove na canja wurin halittu ne daga batutuwan zuwa unicorns da kuma unicorns zuwa mutane.
An san asalin juyin halitta na Mers-Cove daga batsa tun lokacin da aka fara gano shi kuma an kuma inganta shi ta hanyar sakamakon da aka samu.
Babu shakka, batsa tana ba da tarin ƙwayoyin cuta masu yawa don a iya canja wurin su a cikin jinsinsu da kuma tsakanin jinsuna.
Doguwar rayuwa, zama a cikin ƙauyuka masu yawa, hulɗa da mutane sosai, da kuma iyawar tashi-tsalle, duk yanayi ne da ke sa su zama masu rarraba ƙwayoyin cuta.
A wani bangare kuma, Mairiss-Cove ta zama kyakkyawa ce kawai a cikin shekaru da yawa.
Za ta iya daidaitawa da wannan kyan sosai har ta zama mai watsa shiri na matsakaici zuwa mai watsa shiri na ɗakunan ajiya na al'ada.
Ya sa mutane su yi rashin lafiya sosai kuma ya rage yawan juyin halitta a cikin waɗannan dabbobi.
Shigar da shi a lokaci-lokaci zuwa ga mutane ya kasance abin haɗari kuma mutum ba mai watsawa ba ne ga MERS-CoV inda ba za a iya ci gaba da watsa shi ba.
A maimakon kamala a cikin cutar MERS-CoV, aikin mai cin naman gwari, idan ya wanzu, a cikin SARS-CoV-2 ya bambanta.
Musamman, kwayar cutar beta-corona da ke da nasaba da cin naman alade na sa ya yi rashin lafiya sosai.
Suna iya zama baƙi marasa yaduwa ga SARS-CoV-2 na kwayar cutar beta-corona, kamar yadda cats ke da cutar SARS-CoV.
Bincike na gaba zai ƙayyade yiwuwar SARS-CoV-2 tsakanin dabbobi zuwa mutane ta hanyar tabbatarwa ko ƙin yarda.
Na farko, ƙila batutuwan suna da gidan ajiyar cutar SARS-CoV-2, wanda ya yi daidai da SARS-CoV-2.
Mutane da kuma damisa suna iya raba mazaunin su ta wajen yanka da kuma hakar kwal.
Na biyu, masu cin tururuwa na iya zama ɗaya daga cikin masu watsa labaran da ke da alaƙa da SARS-CoV-2 da aka gano kwanan nan.
Mutane suna kamuwa da cutar ta wajen yanka da cin naman dabbobin.
Wataƙila dabbobi masu shayarwa da yawa, har da dabbobin gida, suna da saurin kamuwa da cutar SARS-CoV-2.
Akwai dalilai da suka sa ya kamata a bincika dabbobi masu dabbobi da kuma dabbobin daji don a gano kwayoyin cutar.
Na uku, kamar yadda aka ambata a sama, SARS-CoV-2 na iya sake haɗuwa da kuma daidaitawa zuwa nau'i na uku wanda ke da alaƙa da batsa da kuma mai cin tururuwa.
Ana ci gaba da neman asalin SARS-CoV-2.
Baya ga nau'ikan dabbobin da ke cikin dabbobi, akwai abubuwa uku da ke da muhimmanci a wajen kamuwa da kwayar cutar korona.
Na farko, suna da yawan canji a yawan ribosome DNA.
Kimanin ƙimar kwayar cutar coronaviruses, idan aka kwatanta da sauran kwayar cutar RNA guda ɗaya, ana iya ɗaukar su a matsayin "matsakaici" ko "mai girma" tare da matsakaicin canjin canji na ~ 10-4 sauye-sauye a kowace shekara don wuri na 2, dangane da matakin daidaitawar kwayar cutar corona zuwa sabbin runduna.
Kwayar cutar korona tana da kwayar ribonuclease mai gyarawa, wanda ke sa ta zama mai sauyawa sosai ko kuma ba ta iya girma.
Abin sha'awa, maganin Remdesivir na nucleotide ya san da iyawar sa na hana kwafin kwayar cutar ta Corona ta hanyar hana ribonuclease na waje da kuma ribose-based DNA polymerase.
Remdesivir yana cikin masu ba da labari game da SARS-CoV-2 kuma ana shirin gwada shi a gwaji.
Duk da haka, yawan juyin halittar kwayar cutar korona ya ninka na masu garkuwa da mutane sau miliyan.
Bugu da ƙari, yawan canjin halittar yana ƙaruwa sosai idan kwayar cutar korona ba ta daidaita da mai masaukin ba.
Matsakaicin SARS-CoV-2 yana da ƙananan canji idan aka kwatanta da SARS-CoV mai saurin canji, wanda ke nuna matakin daidaitawa mafi girma ga ɗan adam.
Kamar dai ya riga ya daidaita da wani mai masaukin da ya yi kusa da ɗan adam.
Ban da SARS-CoV-2, wannan ma ya shafi MERS-CoV, wanda ya dace da kamal guda ɗaya.
A ka'ida, ba zai yiwu ba cewa kwayar cutar SARS-CoV-2 za ta iya rage tasirin rigakafin cutar da maganin rigakafin cutar da sauri.
Na biyu, babban ribosome DNA din kwayar cutar korona yana ba da ƙarin damar gyara kwayar halitta da kuma sake tsarawa, hakan yana kara yiwuwar juyin halittar juna tsakanin jinsuna, wanda hakan zai iya haifar da sabbin kwayar cutar korona idan yanayi ya dace.
Wannan yana da goyon baya ta hanyar samfurori masu yawa na budewa da kuma ayyukan da aka sanya sunadarai a kusa da ƙarshen 3′ na genomic.
Na uku, kwayar cutar korona tana sauya tsari a kai a kai yayin da take kwafin DNA ta hanyar tsarin "zaɓar kwafi" na musamman.
A cikin wani masaukin da yake kamar kwano, canjin jerin abubuwa yana faruwa a kai a kai yayin da ake yin kwafin kwayar cutar RNA ta kwayar cutar korona.
Babban nau'in RNA mai tsawon tsawon jini da kuma na biyu zai iya sake tsarawa don samar da sabbin ƙwayoyin cuta.
An gano hujja na ci gaba na juyin halitta a cikin kwayar cutar HKU1 da HKU-OC43, da kuma kwayar cutar ta Corona ta dabbobi, da kuma cutar HKU9 a cikin ƙudaje.
Haɗin kai da kwayar cutar da mai watsawa da aka haɗa
Baya ga abubuwa uku da ke sa kamuwa da cutar, hulɗa da mai karɓar mai watsawa wani abu ne mai muhimmanci da ke shafar yaduwar ƙwayoyin cuta tsakanin jinsuna.
A wannan batun, muna ɗaukan sake fasalin SARS-CoV a matsayin misali, wanda kuma ya nuna tabbaci na zaɓin mai kyau a lokacin haɗuwa tsakanin nau'in.
Dangane da kwatancen bincike tsakanin samfuran SARS-CoVs da aka ware a cikin ɗan adam da cats, an yi imanin cewa SARS-CoVs yana fuskantar saurin daidaitawa a cikin runduna daban-daban, musamman ta hanyar jujjuyawar da ke faruwa a cikin yankin S-protein receptor binding.
A gaba ɗaya, yankin da masu karɓar S na kwayar cutar korona ke da alaƙa da mai karɓar kwayar halitta kuma ana zaɓa sosai ta hanyar amsawar kwayar cutar mai masaukin baki.
A SARS-CoV, yankin haɗuwa na masu karɓa a cikin amino acid daga 318 zuwa 510 yana faruwa a sashin S1, wanda ke haɗuwa da enzyme mai canza angiotensin 2 da masu karɓa don taimakawa shiga kwayar cutar.
Ƙungiyar masu karɓa a SARS-CoV tana iya gano makomar enzyme mai sauya angiotensin 2 a cikin dabbobi daban-daban, ciki har da bat, cat butterfly, mice, da raccoon, wanda ke ba da damar yaduwar kwayar cutar tsakanin jinsuna.
A gaskiya, amino acid guda shida ne kawai aka gano sun bambanta da na mutum da kuma na dabbobi masu kama da mai a cikin mahadar mai karɓa, kuma huɗu daga cikinsu suna cikin tsarin haɗuwa da mai karɓa don hulɗa da mai karɓar enzyme mai canza angiotensin 2.
K479N da S487T suna cikin yankin da ke ɗaure masu karɓar SARS-CoV a cikin butterflies, wanda zai iya ƙara yiwuwar hulɗar protein spike a cikin enzyme mai canzawa na Angiotensin 2 na mutum.
A wasu kalmomi, waɗannan nau'i biyu na amino acid na iya zama muhimmiyar maye gurbin ƙwayoyin cuta a cikin mutane.
Abin lura shi ne SARS-CoV-2 tana da irin wannan mai karɓar kwayar cutar da SARS-CoV ke da ita.
Akwai bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S protein, wanda ke nuna cewa yiwuwar S protein a cikin enzyme mai canza Angiotensin 2 na mutum ya canza.
A gaskiya ma, wani binciken da aka yi da lantarki mai saurin dubawa ya nuna cewa akwai yiwuwar sau 10 zuwa 20 na wannan haɗin da ya fi na enzyme mai canzawa na angiotensin 2 na mutum da kuma furotin S na SARS-CoV.
Yana da ban sha'awa kuma a gano ko waɗanne nau'ikan masu karɓar taimako ne ake buƙata don watsa SARS-CoV-2.
Abin sha'awa kuma shine cewa kwayar cutar ta NCV-NL63 tana da alaƙa da enzyme mai canza angiotensin 2 amma a wani ɓangare na furotin S.
Akwai wasu masu tsinkaye na kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cuta.
Suna iya zama masu alhakin nasarar daidaitawar waɗannan coronaviruses a cikin mutane bayan sun shiga tsakanin nau'in dabbobin da suka yi masa baƙunci.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon yaduwar kwayar cutar ta HCoVs tsakanin jinsuna kuma yana ƙarƙashin wasu abubuwan dogara da ƙuntatawa a cikin mai masaukin.
Tsararren waɗannan sunadarai na mai masaukin baki tsakanin mutane da masu masaukin gidajen ajiyar kwayar cutar korona, kamar su batsa, monarchs, da kuma masu yin fashin daji na iya zama cikas ga yaduwar kwayar cutar tsakanin jinsuna.
Kwayar cutar korona ta bukatar sarrafa abubuwan da ke sa a dogara da mai watsawa da kuma rage abubuwan da ke hana shi don samun nasara a yaduwar tsakanin jinsuna.
A wannan yanayin, za a iya gano da kuma gano ƙwayoyin halittar da ke cikin wannan muhimmin wuri na hulɗa da kwayar cutar da mai masaukin.
Za a iya amfani da bincike mai zurfi na kwayar halitta don bincika abubuwan dogara da ƙuntatawa na mai masaukin SARS-CoV-2 ta amfani da fasahar CRISPR mai ci gaba.
Tashin sabon kwayar cutar korona: komawarmu ga inda muka fara
Bambancin kwayar cutar korona a cikin batsa yana ba da dama mai yawa ga sabon kwayar cutar korona ta mutum.
A wannan tunanin, coronaviruses na bat ne tsarin kwayoyin halittar coronaviruses na mutum.
Bugu da ƙari, saurin canji da kuma sake tsara kwayoyin halittar mutum suna motsa ci gaban kwayar cutar ta HCoV, kuma su ne muhimman abubuwa biyu a wannan tsari.
Alal misali, samun ko rasa sabon kwayar halitta na gina jiki yana da ikon canja tsarin kwayar cutar sosai.
Daga cikin sunadarai masu daidaita SARS-CoV, ORF8 an yi imanin yana da mahimmanci wajen daidaitawa ga mutane, inda aka ware SARS-CoV mai alaƙa da ƙwayoyin cuta a cikin batsa amma an gano cewa yana ɓoye sunadarai daban-daban na ORF8.
An gano cewa ana samun halayen kawar da nucleotides guda 29 na SARS-CoV a cikin jinsuna da aka ware a farkon annobar cutar.
Wannan sharewar ya haifar da ORF8 ya rabu zuwa ORF8a da ORF8b, kuma ana tsammanin canjin canjin yanayi ne wanda ke inganta sauyawar mai masaukin baki.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗawa ta hanyar ƙwayoyin cutar coronaviruses na alpha da gamma, inda aka gano ƙananan ƙananan wuraren sake haɗawa a cikin ribosome-based DNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, mafi yawan nsp10, da sassan nsp14.
Hakazalika, bincike ya nuna cewa annobar Mers-Cov ta ga wasu nau'o'in da suka sake haɗuwa, wanda ya faru ne a cikin kamal mai suna Sunam a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma rubuta sake haɗuwa a cikin wasu ƙwayoyin cuta na mutum, inda ƙwayoyin cuta na mutum suka haɗu da wasu ƙwayoyin cuta na dabbobi a cikin ƙwayoyin halittarsu.
Ya kamata a lura cewa zaɓin wucin gadi zai iya taimakawa wajen sauyawar da ba a so ba a cikin kwayar cutar, wanda mafi yawanci ana haifar da shi ne ta hanyar kawar da ƙwayoyin cuta daga matsin lamba, kamar wanda tsarin garkuwar jiki na mai masaukin baki ke yi.
Rashin cikakken tsawon furotin ORF4 a cikin kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cutar ta kwayar cuta.
Ko da yake ana iya ganin ORF4 mai kyau a cikin kwayar cutar camel da bat da ke da alaƙa da kwayar cutar HCoV-229E, kwayar cutar albic corona tana nuna alpha wanda ke kamuwa da ƙwayoyin nucleotide guda ɗaya, wanda ke haifar da juyin halitta na tsarin.
A ƙarshe, kuma mafi muhimmanci, ci gaban sababbin ƙwayoyin cuta na coronaviruses ana motsa su ne ta hanyar matsin lamba a cikin ɗakunan ajiya na masu masaukin su.
An gano wasu cututtuka marasa alamun cutar ko kuma marasa alamun cutar a lokacin da batutuwan suka kamu da kwayar cutar Corona, wanda ke nuna cewa kwayar cutar Corona tana daidaitawa da batutuwan.
Ya nuna cewa batutuwan sun dace da kwayar cutar corona, a zahiri da kuma a zahiri.
Alal misali, rashin ƙarfafa amsa mai taimakawa kamuwa da cuta a cikin batsa ya rage cututtukan da coronaviruses ke haifarwa.
Bugu da ƙari, an hana aikin kwayar halitta mai kisa a cikin batsa saboda ƙaruwar mai karɓar kwayar halitta mai kisa mai hanawa NKG2/CD94 da kuma ƙarancin magana game da kwayar halitta mai haɗuwa da jiki na Class I.
Bugu da ƙari, yawan nau'in oxygen mai aiki da juna (RCO) da ke haifar da ƙaruwar aikin ƙwayar cuta na batsa na iya haifar da hana kwafin kwayar cutar corona da kuma tasiri a kan gyaran da enzyme na ribonuclease na waje ke yi, don haka yana ba da matsin lamba don samar da nau'ikan kwayar cutar da ke haifar da cuta sosai lokacin da sabon mai masaukin ya kamu.
Ƙarin nau'in cutar na coronaviruses na iya haifar da sake fasalin, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawa da mai masaukin.
Saboda haka, ba abin mamaki ba ne cewa an samu sababbin ƙwayoyin cuta guda uku na mutum a cikin shekaru ashirin da suka shige.
Coronaviruses ba su haifar da cuta ko kuma su haifar da wasu ƙananan cututtuka a cikin masu masaukin gida kamar su bat da kuma camels.
Suna yin kwafi sosai ba tare da jawo amsa mai ƙarfi daga jikin mai masaukin ba.
A nan ne asirin da ke bayyana dalilin da ya sa ake ganin masu dauke da cutar da ba su da alamun cutar da kuma dalilin da ya sa ake samun kamuwa da cutar a cikin mutane.
Alamun cutar suna da tsanani sosai domin hawan jini da kuma ciwon cytokine, kuma idan hawan jini ya fi ƙarfi, cutar tana da tsanani.
Akasin haka, a cikin masu dauke da cutar da ba su da alamun cutar, amsawar garkuwar jiki ta rabu da kwafin kwayar cutar ta corona.
Irin wannan dabarar na kawar da amsawar garkuwar jiki na iya samun sakamako mai amfani a maganin SARS-CoV-2.
Amsar Interferon tana da ƙarfi musamman a cikin bat.
Saboda haka, ana iya amfana daga shan maganin mai suna Interferon Type I aƙalla a matakin farko na kamuwa da cutar SARS-CoV-2 a cikin mutum.
Bugu da ƙari, a cikin batsa, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
A cikin wannan tunanin, hana ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Tushen SARS-CoV-2 ya biyo bayan ra'ayin SARS-CoV da MERS-CoV.
A lokacin da aka gano cewa beta-coronavirus a cikin bat ne ke da kashi 95% na SARS-CoV-2 nucleotide kama, akwai kuma beta-coronavirus a cikin bat da ke da kashi 96% na SARS-CoV-2 nucleotide kama.
Yayin da aka gano cewa cats da sauran dabbobi a kasuwa suna da irin wannan kwayar cutar SARS-CoV-2 ba su gano ba.
An gano beta-coronaviruses a cikin mai cin tururuwa wanda ya yi kama da SARS-CoV-2, wanda ke nuna cewa mai cin tururuwa na iya zama daya daga cikin masu watsa shirye-shiryen ko kuma beta-coronaviruses a cikin mai cin tururuwa sun ba da gudummawa ga yankewar kwayar halitta wanda ya haifar da sigar SARS-CoV-2 ta ƙarshe.
Ko da yake ana ta yin tambayoyi, babu tabbacin cewa SARS-CoV-2 na mutum ne da gangan ko kuma ta hanyar haɗari.
Coronaviruses sun sake zama abin lura saboda barkewar SARS-CoV-2 na baya-bayan nan.
Binciken kwayar cutar korona a cikin namomin kaza da sauran dabbobi ya canza tunaninmu sosai game da mahimmancin asalin cutar da kuma taskar dabbobi na kwayar cutar korona ta mutum a cikin yaduwar zuwa ga mutane.
Tabbacin da aka samu ya nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun samo asali ne daga bat da kuma zuwa ga mutane ta hanyar masu watsawa.
Tun da yake cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da cats a kasuwa, rufe kasuwanni na kayan abinci da kashe cats ya kamata ya kawo ƙarshen cutar SARS.
Haka kuma, ya kamata a kawar da masu cin naman alade daga kasuwar kayan lambu don hana yaduwar cutar da ke samo asali daga dabbobi, saboda an gano wasu nau'o'in beta-coronaviruses a cikin masu cin naman alade da ke da kusanci da SARS-CoV-2.
Ko da yake, ko SARS-CoV-2 ya kai ga mutane ko a'a, kuma ko ta yaya aka kai shi, ta hanyar masu cin nama da sauran dabbobi masu shayarwa, batun da ake bukata a bayyana shi ne a nan gaba.
A wani bangaren kuma, an sami Mairs-Cove a cikin kyawawan kyawawan ƙwayoyin cuta na dogon lokaci.
Waɗannan duwatsun suna da muhimmanci a hanyar sufuri kuma suna da muhimmanci a samar da nama, madara, fata, da kuma kayan ɗamara ga mazauna yankin.
An yadu a ko'ina a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a sadaukar da duk wani abu mai kyau don a sarrafa MERS ba, kamar yadda jami'an kasuwar namun daji na kasar Sin suka yi don hana yaduwar SARS-CoV-2 da SARS-CoV-2.
Don dakatar da barkewar cutar ta MERS, ya kamata a bi tsarin da ya dace wajen samar da rigakafin cutar ta MERS-CoV mai tasiri ga ƙuda, tare da sauran matakan hana kamuwa da cuta.
Idan ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, za su iya haifar da sababbin tsarin halittarsu kuma su sa su yadu.
Akwai nau'o'in kwayar cutar korona da ke da nasaba da cututtukan da suka samo asali daga namun daji.
Musamman, coronaviruses suna da bambancin gaske a cikin batsa wanda ke nuna yiwuwar haifar da cututtukan da suka samo asali daga dabbobi.
Akwai damar da yawa na sake fasalin kwayar cutar corona da ke da alaƙa da cututtukan da suka samo asali daga dabbobi, wanda ke haifar da sabon kwayar cutar corona da ke da saurin yaduwa da kuma/ko kisa a cikin mutane a nan gaba.
Ya kamata a daina cin namun daji a wasu wurare a kasar Sin domin rage hulda da dabbobi.
A cikin wahala da SARS, MERS da COVID-19 suka jawo wa 'yan Adam, ya kamata a shirya shiri da kuma shirin amsawa.
Gaskiyar ita ce, yawancin ƙwayoyin cuta sun daɗe suna wanzuwa a duniya.
Suna zama a cikin ɗakunan ajiyarsu har sai sun sami damar yaduwa da kuma haifuwa.
Ko da yake batutuwan suna da halaye da yawa da suke sa mutane su yaɗa ƙwayoyin cuta, za a iya rage haɗuwa da batutuwan da sauran dabbobi idan mutane suka yi al'adar guje musu.
Kulawa da dabbobi masu shayarwa a kai a kai hanya ce mai muhimmanci don fahimtar yanayin da kwayar cutar korona take ciki da kuma yadda take zama, wanda hakan ya nuna cewa yana da amfani wajen hana yaduwar cutar daga dabbobi zuwa mutane da kuma hana sake bayyana a nan gaba.
A ƙarshe, hanya mafi kyau na hana cututtukan ƙwayoyin cuta na dabbobi ita ce a nisanta mutane daga wuraren da suke da ƙwayoyin cuta na dabbobi.
A yau, akwai tambayoyi da yawa da za a amsa game da asalin SARS-CoV-2.
Da farko, idan dabbobin da ke fama da cutar SARS-CoV-2 sun kai su ga masu cin nama, yana da muhimmanci mu san yanayin da ya sa dabbobin da kuma masu cin nama su shiga irin wannan yanayi.
Na biyu, idan da akwai wani abu da ake yi da cewa batsa tana da hannu wajen kai cutar ga mutane, to, ya kamata a yi bincike a kan yadda mutane suke hulɗa da su.
Na uku, idan dabba mai shayarwa ta uku ce take da ainihin matsayin mai masaukin baki, to ya kamata a bayyana yadda take hulɗa da dabbobi dabam dabam, har da mutane, da batsa, da kuma masu cin ƙwaya.
A ƙarshe, tun da yake ana iya zargin dabbobi masu shayarwa da yawa, har da dabbobin gida, da ke da SARS-CoV-2, ya kamata a yi bincike da kuma gwaji.
Ko mai masaukin bat ne, mai cin tururuwa, ko kuma wani dabba mai shayarwa, ana sa ran za a gano SARS-CoV-2 ko kuma wanda ya haifar da shi wanda ya yi kama da sauran masu masaukin su na gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, tare da muhimman matakan da za a iya ɗauka don hana COVID-19 a cikin mutane.
Dole ne a sabunta ka'idodin "abin da ake zargi" da "abin da aka tabbatar" a lokacin da aka gano cutar COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta wallafa jagora mai sauri game da ganewar asali da maganin cutar Coronavirus na 2019 (Coronavirus 2019), wanda ya ba da kwarewarmu da kuma bayanan da suka dace don magance annobar a duniya.
Ko da yake cutar korona 2019 (COVID-19) sabuwar cuta ce, hankali da sani suna ƙaruwa a hankali bisa sakamakon bincike da ake yi da kuma gwajin asibiti; saboda haka ana sabunta dabarun ganewar asali da magani a kai a kai.
A cikin wannan wasika, mun amsa wani bayani da aka yi game da jagorarmu kuma mun gabatar da sababbin ka'idojin ganewar asali na "abin da ake zargi" da kuma "abin da aka tabbatar" bisa ga sabon jagorar ganewar asali da magani na COVID-19 (Sashe na 7) na Hukumar Lafiya ta Ƙasa ta Jamhuriyar Jama'ar Sin.
A watan Disamba na shekarar 2019, cutar coronavirus na 2019 (Coronavirus Novel 2019) ta bulla, wanda yanzu aka sani da sunan cutar coronavirus na 2019 (COVID-19) kuma an kira cutar SARS-CoV-2.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta rubuta jagora mai sauri kuma ta buga shi a kan layi a cikin mujallar Military Medical Research a ranar 6 ga Fabrairu, 2020.
An yi masa ba'a sosai tun bayan da aka buga shi.
Lura cewa ko da yake COVID-19 sabuwar cuta ce, hankali da sani suna ƙaruwa a hankali bisa sakamakon bincike da ake yi da kuma gwajin asibiti; kuma ana sabunta dabarun ganewar asali da magani a kai a kai.
Misali, a cikin jagororin ganewar asali da magani na COVID-19 da Hukumar Lafiya ta Ƙasa ta Jamhuriyar Jama'ar Sin (/http://www.nhc.gov.cn) ta bayar, tsakanin 16 ga Janairu, 2020 da 3 ga Maris, 2020, an fitar da juzu'i bakwai tare da sauya wasu mahallin da canji mai mahimmanci.
Yanzu, bayan mun sami wannan jagorar, sai Chu da wasu suka ba da shawara mai sauƙi na lura da maki bisa gwajin asibiti.
Ƙoƙarinsu ya ba da sabon ja-gora ga ja-gorarmu kuma ya zama abin amfani ga wannan annobar a dukan duniya.
Muna godiya da ƙoƙarinsu.
Duk da haka, aikin su na bukatar sabuntawa bisa ga sabon jagorar ganewar asali da magani na COVID-19 (Gwaji na bakwai) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (3 Maris 2020), tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan fasalin tarihin cutar da abubuwa biyu na bayyanar asibiti don isa ga cikakken bincike, ko yana buƙatar tabbatar da abubuwa uku na bayyanar asibiti idan babu bayyanar tarihin cutar:
Tarihin cutar: (1) Tarihin da ya hada da tafiya zuwa Wuhan da ke kewaye da shi, ko kuma wasu al'ummomin da aka bayar da rahoton cutar COVID-19 a cikinsu, ko zama a ciki, a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin da ya hada da hulɗa da masu kamuwa da cutar SARS-CoV-2 (tare da sakamako mai kyau na gwajin DNA); (3) Tarihin da ya hada da hulɗa da marasa lafiya da ke da zazzabi ko alamun numfashi daga Wuhan da ke kewaye da shi ko kuma wasu al'ummomin da aka bayar da rahoton cutar COVID-19 a cikinsu a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin da ya hada da hulɗa da masu kamuwa da cutar (kamar 2 ko fiye da haka) a cikin gida, ko kuma a cikin ofisoshin yara, ko kuma a cikin ƙananan wuraren da ake gudanar da bincike.
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da siffofin da aka tabbatar da su ta hanyar hoto na kamuwa da cutar COVID-19; (3) yawan ƙwayoyin jini na farin jini na nuna matakin al'ada, kaɗan, ko kuma ƙarancin ƙwayoyin lymphatic a farkon farkon kamuwa da cutar.
Tabbatar da yanayin cutar ya kamata ya dogara da yanayin da ake zargi wanda ya ƙunshi kowane ɗayan alamun alamun cutar ko hulɗar jini kamar haka: (1) tabbatacce a sakamakon gwajin PCR na lokaci na SARS-CoV-2; (2) babban daidaiton cikakken kwayar cutar tare da sanannun halayen sabbin ƙwayoyin cuta na coronaviruses; (3) tabbatacce a cikin ƙwayar jini na IgM da IgG SARS-CoV-2; ko kuma IgG SARS-CoV-2 ya canza daga mara kyau zuwa tabbatacce, ko kuma ƙimar ma'auni a cikin farfadowa ta zama ko sama da sau 4 a matakin.
Mun ga cewa an ƙara gwajin DNA mai rikitarwa na polymerase a cikin lokaci na numfashi ko kuma samfurin jini a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara gano abubuwan da ke haifar da cuta a cikin samfurin jini zuwa na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020); sannan an ƙara jagorar hulɗar jini zuwa na bakwai.
Waɗannan gyare-gyare sun dogara ne da ci gaba da aikin masu bincike don tsara cikakkun kayan aikin gano DNA don saurin ganewar asali, da kuma samfuran hanyoyin numfashi ciki har da samfuran jini, wanda ya haifar da ƙarin samfurori daban-daban, da kuma tallafawa canja wurin sakamako mai kyau na kwayar cutar zuwa ma'aunin yanayin tabbatarwa.
Bugu da ƙari, akwai ƙarin tabbaci da ke ƙarfafa mu mu mai da hankali sa'ad da muke bi da marasa lafiya da suke da alamun rashin lafiya da kuma yanayin da ba su da alamun.
Saboda haka, ya kamata a sabunta tsarin da Shaw da wasu suka yi, inda suka saka mutumin da ba shi da alamun cutar a matsayin "mai ƙarancin hadari".
Ƙarin gwaji da kuma gwaji na asibiti suna bukatar a tabbatar da tsarin sa ido na maki.
A ƙarshe, muna fatan samun ƙarin jagororin kai tsaye kuma muna gayyatar masu karatu su ba mu ra'ayoyinsu.
Don gane "matsalolin da ake zargi" da kuma "matsalolin da aka tabbatar", muna ƙarfafa a bi kuma a bi sababbin jagororin da aka bayar daga ƙasashen da mutane suke zama.
Ƙungiyarmu za ta kuma sabunta umurninmu a kan lokaci don ba da taimako.
Bangladesh ta samu sabbin mutuwar COVID-19 guda biyar, wanda shi ne mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da mutuwar mutane biyar da suka kamu da cutar COVID-19.
Wannan shi ne adadin mutane da suka mutu a rana guda saboda cutar.
Cibiyar Kula da Cututtuka da Kula da Cututtuka da Bincike (IEDCR) a Bangladesh ta ruwaito cewa, har zuwa jiya, adadin masu kamuwa da cutar da aka samu ya kai mutum 114 da ke aiki da kuma mutane 33 da suka warke da ke zama a gida.
An samu mutuwar mutane 17.
Daraktan Cibiyar Kula da Cututtuka da Kula da Cututtuka, Dokta Mirjadi Sabrina Flora, ta bayyana a wani taron manema labarai ta yanar gizo cewa, wadanda suka mutu sun hada da maza hudu da mace daya.
Kamar yadda Dr. Mirjadi ya ruwaito, akwai mutane biyu da suka wuce shekara 60, biyu da suke tsakanin shekara 51 zuwa 60, kuma mutum ɗaya da ke tsakanin shekara 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda suka mutu daga birnin Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana annobar COVID-19 a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa hukumar Anadolu, wata kamfanin dillancin labarai na gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saif Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke karbar magani a asibitin Kuwait Maitri.
Ministan sufuri da gadaje na Bangladesh, Obid Kadir, ya ce a cikin wata sanarwa ta bidiyo a ranar Asabar cewa, sufuri na jama'a zai tsaya na tsawon lokaci fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a ne a ranar 26 ga watan Maris kuma an shirya za a kawo karshen ranar Asabar, 4 ga watan Afrilu.
Har ila yau, ana ƙyale jigilar kayayyaki na asali, watau kayayyakin kiwon lafiya, man fetur da abinci.
An fara samun mutane biyu da suka dawo daga Italiya a ranar 8 ga watan Maris, da kuma matar wani daga cikinsu.
A ranar 19 ga Maris, dukan su uku sun warke.
An samu fiye da miliyan biyu da suka kamu da cutar SARS-CoV-2 a duniya
Bayanai daga Jami'ar Johns Hopkins a ranar Alhamis sun nuna cewa adadin masu kamuwa da cutar SARS-CoV-2 ya zarce miliyan daya a duniya.
Cutar COVID-19 da ke haifar da kwayar cutar korona ta yi sanadiyar mutuwar mutane akalla dubu 52.
Wannan mummunan ci gaba ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko, kuma an sami mutuwar farko a Zambia.
Koriya ta Arewa ta yi ikirarin cewa, tun ranar Alhamis, tana daya daga cikin 'yan kasashen da har yanzu ba su da kamuwa da cutar korona.
Hukumar Lafiya ta Duniya ta sanar da kamuwa da cutar 1051635, har zuwa jiya, ciki har da 79332 a cikin awanni 24 da suka gabata kafin karfe 10 na safe na tsakiyar Turai (karfe 0800 na duniya) a ranar 4 ga Afrilu.
An samu fiye da mutane 244,000 da suka kamu da cutar a Amurka, kuma akalla mutane 5,900 sun mutu.
CBS News ta ruwaito, ta yi ƙaulin bayanan Jami'ar Johns Hopkins, cewa fiye da mutane 1,000 ne suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar korona.
Kasashe a duniya sun sanar da tsauraran matakai don hana yaduwar cutar.
Magajin garin Moscow, Mr. Sergey Sobyanin, ya sanar a ranar Alhamis cewa an tsawaita dokar kulle birnin har zuwa ranar 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa za a ci gaba da biyan albashi ga mutanen Rasha da ba sa zuwa aiki har zuwa ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci na tsawon kwanaki 15; an amince da kuri'ar da kuri'u 215, goma suka ki, kuma daya ya ki.
Saudiyya ta tsawaita dokar hana zirga-zirga a Makka da Madina zuwa duk rana, inda tun da farko ta kasance daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand na shirin kafa dokar hana fita daga karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan jihar Ohio, Mr. Mike D. Wayne, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
Shaguna a Ostiraliya suna rage yawan takardar wanka da ake sayarwa a kowane lokaci
A ranar Asabar da Lahadi, manyan shagunan sayar da kayayyaki na Australia, Wal-Worth da Coles sun tsaurara takunkumin sayen takardar bayan gida, inda suka rage takardun zuwa takardun biyu daga shagunan Wal-Worth da takarda guda daga shagunan Coles a kowane ma'amala a duk shaguna a fadin kasar.
Na kuma zaɓi shagunan Aldi don buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen buɗaɗɗen.
An wallafa waɗannan ƙuntatawa na sayayya a matsayin saƙonni a wurin biya a shaguna da kuma a shafukansu na Facebook.
An bayar da rahoton cewa masu saye sun yi niyyar adana su saboda damuwar cutar COVID-19 idan mutane suna bukatar keɓe kai.
A ranar Laraba, kantunan Wallworths sun kafa takunkumi kan isar da takardar bayan gida zuwa gida, wanda ya kai takarda guda ne kawai ga kowane sayayya.
Waɗannan canje-canjen sun zo ne bayan ƙuntatawa da aka kafa a baya a kantunan Wallworth a ranar 4 ga Maris da kuma na Coles a ranar 5 ga Maris, inda aka ƙyale mutane su sayi takardun huɗu kawai a kowane ma'amala.
Shagunan Coles a cikin sanarwarsu ta 8 ga Maris ta ce duk da cewa an aiwatar da takunkumin na'urar, "yawancin shagunan har yanzu suna sayar da duk abin da suke da shi a cikin awa daya da karɓar sa", kuma an bayyana bukatar a matsayin "marasa misaltuwa", kuma an kuma bayyana ta a cikin wani sakon Facebook na Aldi a ranar Talata a matsayin "marasa tsammani".
Tallace-tallace sun yi "babban ci gaba" a makon da ya gabata, in ji mai magana da yawun kantin sayar da kayayyaki na Wall Worth.
A makon da ya gabata, kantin sayar da kayayyaki na Costco a Canberra ya ce za a iya sayen fam biyu.
Don rage karancin, shagunan Coles sun nemi masu samar da manyan buhunan kuma sun kara yawan isar da kayayyaki, kuma shagunan Wallworths sun nemi ƙarin kaya, yayin da shagunan Aldi suka buɗe kayan su don gabatarwar musamman da aka shirya a ranar Laraba da wuri.
Russell Zimmerman, babban daraktan kungiyar 'yan kasuwa na Australia, ya ce 'yan kasuwa suna kokarin kara yawan kayayyaki, amma dokar da hukumar ke kafawa kan lokacin da za a kai motocin, na sa hakan ya zama da wuya.
Ana sa ran farashin samarwa zai yi yawa, inda masu samarwa ke kokarin biyan bukatar, tare da karancin kayayyakin da ake samarwa.
A ranar Talata, shagunan Aldi sun sanar da cewa saboda samun kayayyaki da wuri, wasu shagunan ba za su iya ba da tayin ranar Laraba ba.
Wani masani a fannin sayar da kayayyaki a jami'ar Queensland ta Technology, Dr. Gary Mortimer, ya ba da rahoto ga News.com.au cewa, shaguna suna cika da mutane kowane dare.
Ya ce takardar bayan gida kaya ce mai girma, wanda ke rage yawan kayayyaki, kuma idan aka sayar, zai bar sarari a kan ɗakunan ajiya, wanda ke ƙara jin ƙarancin kayayyaki.
Russell Zimmerman, kamar yadda ABC News ta ruwaito, ya ce: "Kalle da Wallworth suna da ra'ayin cewa idan akwai kayayyaki da yawa a kan ɗakunan ajiya, kuma idan za a iya [saya] kayayyakin kamar su wando na bayan gida da kuma na'urar kashe ƙwayoyin cuta, hakan zai iya rage fargaba".
Kamfanin Who Gives a Crap, wanda ke samar da takardar bayan gida da ake sake amfani da ita, ya ce a ranar Laraba da ta gabata cewa sun ƙare.
A cewar rahoton News.com.au, Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kamfanin Kam
Wani shafin yanar gizo na dukiya mai suna Domain.com ya ce wasu 'yan kasuwa na sayar da kayayyaki suna ba da takardar wanka kyauta ga mai gabatar da kara a wajen sayar da kayayyaki a Melbourne, yayin da aka yi karancin sayarwa saboda masu sayen sun daina aiki a karshen mako na ranar ma'aikata.
Jaridar N.T. News ta ranar Alhamis, wata jarida da ake bugawa a Darwin, ta ƙunshi shafuka takwas na talla da aka yi da za a iya yanka da kuma amfani da su a matsayin takardar bayan gida.
A farko, shagunan sun yi jinkirin sanya takunkumi, a cewar wani rahoto da ABC Australia ta fitar a ranar 3 ga watan Maris, inda suka ce ba su da shirin sanya takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa akwai kuma bukatar da yawa ga wasu kayayyaki, ciki har da magunguna, maganin kashe ƙwayoyin cuta, kayan bushewa, wanke hannu da gari.
Hakazalika, a waje da Australia, an lura da cewa a daren Lahadi, wani shagon yanar gizo na Birtaniya mai suna Okado yana rarraba takardun bayan gida na Andres da aka saya da kwalabe biyu na nau'i 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
Hukumar Lafiya ta Duniya (WHO) ta sanar a ranar Laraba cewa barkewar cutar COVID-19, cutar da ke haifar da kwayar cutar korona mai nasaba da cutar mai saurin numfashi mai saurin kamuwa da cuta, wadda aka fi sani da SARS-CoV-2, ta kai matakin annoba.
Ko da yake kalmar nan " annobar" tana nuna yadda cutar ta yadu, ba yadda wasu cututtuka suke da tsanani ba, WHO ta yi kira ga gwamnatoci su dauki matakan da suka dace:
"Dukkanin kasashe na iya canza yanayin wannan annobar.
Daraktan WHO Tedros Adhanom Ghebreyesus ya ce, "Idan kasashe suka gano kuma suka gudanar da gwajin mutane, da maganin su, da keɓe su, da bin diddigin yanayin su, da kuma tattara su don magance matsalar".
"Dukanmu muna matukar damuwa game da yaduwar cutar da kuma hadarin da ke damunmu da kuma rashin kulawa da ke nuna cewa akwai hadari".
A cewar Dokta Tom Friedden, tsohon darektan Cibiyar Kula da Cututtuka da Rigakafin Cutar a Amirka, wannan annoba "ba ta taɓa kasancewa ba".
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce, "Ba a iya gano hanyar kowace kwayar cutar numfashi ba daga farkon bayyanarta zuwa ci gaba da yaduwar ta a duniya, sai dai mura".
Gebreussus ya bayyana irin wannan ra'ayi, yana cewa: "Ba mu taɓa fuskantar annobar da wata kwayar cutar corona ta haifar ba".
Ya ci gaba, "Ba mu taɓa ganin annobar da za a iya shawo kanta ba".
An bayyana sabon yanayin a matsayin annoba bayan shawarar da WHO ta yanke a watan Janairu na ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a da ke haifar da damuwa ta duniya.
"Ainihin abin da za mu iya cewa shi ne, abubuwa za su ƙara muni", in ji Dokta Anthony Fauci, darektan Cibiyar Kula da Cututtuka da Ciwo Mai Saurin Yaduwa a Amirka.
Kamfanin dillancin labarai na Associated Press ya ruwaito cewa a kalla mutane 126,000 ne suka kamu da cutar COVID-19 a duniya tun ranar Alhamis, kuma sama da mutane 4,600 ne suka mutu.
Cutar cutar korona 2019-20 cuta ce mai gudana ta cutar korona 2019 (COVID-19), wadda cutar korona 2 ke haifarwa, wadda ke da nasaba da cutar numfashi mai tsanani (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, kuma an ayyana ta a matsayin dokar ta baci ta duniya a ranar 30 ga Janairu, 2020, kuma an amince da ita a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu, 2020, an samu rahoton kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, wanda ya haifar da mutuwar mutane 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta cewa yawan mutuwar mutane a China ya kai kashi 4 cikin dari, yayin da a duniya ya kai 13.04% a Aljeriya da 0.08% a New Zealand.
Alamun da suka fi kowa sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Ƙari ga haka, za a iya samun ciwon huhu da kuma ciwon numfashi mai tsanani.
Lokaci tsakanin kamuwa da cutar da bayyanar cututtuka yawanci kwanaki biyar ne, amma yana iya wucewa daga kwana biyu zuwa kwana goma sha huɗu.
Babu wani rigakafi ko magani na musamman da aka sani game da cutar.
Magani na farko shi ne magani na tallafi da kuma na bayyanar cututtuka. Matakan rigakafi da aka ba da shawara sun haɗa da wanke hannu, rufe baki idan ka yi tari, nisantar mutane, sa ido, da kuma ware kai daga waɗanda ake zargin suna da cutar.
Hukumomi a dukan duniya suna amsa wannan barazanar ta wajen kafa takunkumin tafiye-tafiye, keɓewa, ƙuntatawa, da kuma hana haɗari a wuraren aiki da kuma rufe wuraren aiki.
Wannan annobar ta haifar da rikice-rikicen zamantakewa da tattalin arziki na duniya, an jinkirta ko soke wasanni, addini, siyasa, da al'adu, kuma an sami karancin kayayyaki da yawa wanda ya kara tsanantawa saboda tsoratar da sayayya.
Makarantu da jami'o'i sun rufe a kasa ko kuma a cikin gida a kasashe 193, wanda ya shafi kusan kashi 99.4 cikin 100 na yawan daliban duniya.
Rashin gaskiya game da cutar ya bazu a intanet, kuma akwai wasu abubuwan da suka shafi tsoratar da baƙi da nuna bambanci ga Sinawa, da kuma wasu mutanen da suka fito daga Gabas da Kudu maso gabashin Asiya, da kuma wasu yankuna da ke da yawan kamuwa da cutar.
Sakamakon rage yawan tafiye-tafiye da rufe manyan masana'antu, an rage gurɓataccen iska da iskar carbon.
Hukumomin kiwon lafiya a birnin Wuhan (babban birnin lardin Hubei na kasar Sin) sun bayar da rahoton wasu mutane da suka kamu da cutar huhu da ba a san dalilin da ya sa ba a ranar 31 ga watan Disamba, 2019, kuma an fara bincike a farkon watan Janairu, 2020.
Yawancin cututtuka suna da nasaba da kasuwar cin abincin teku ta Wuhan, saboda haka ana ganin cewa cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da barkewar cutar an san ta da SARS-CoV-2, sabuwar cutar da aka gano wacce ke da alaƙa da coronaviruses a cikin bat, coronaviruses a cikin masu cin tururuwa, da SARS-CoV. An gano cewa mutumin da ya fara nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da alaƙa da rukunin kasuwar da aka gano daga baya.
Daga cikin rukunin farkon shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba da jaridar South China Morning Post ta wallafa ya nuna cewa wata mace mai shekaru 55 daga lardin Hubei, wacce ta fara kamuwa da cutar a ranar 17 ga Nuwamba, 2019, na iya zama ta farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa duk da cewa an samu raguwar sabbin cututtuka a China, amma ba zato ba tsammani sun tashi a Italiya, Iran da Koriya ta Kudu, inda sabon adadin wadanda suka kamu da cutar a wajen kasar Sin ya zarce na sabon wadanda suka kamu da cutar a cikin gida a karon farko.
Akwai ƙarancin rahoton cututtuka, musamman ma a tsakanin waɗanda ke da ƙananan alamu.
A ranar 26 ga Fabrairu, an samu rahotanni na ƙarancin ƙwayoyin cuta a tsakanin matasa, waɗanda shekarunsu suka kai 19 zuwa ƙasa da haka sun kai kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa ana buƙatar kamuwa da kashi 60% na 'yan Burtaniya kafin a yi rigakafin garken da ya dace.
Lamuran sun nuna adadin mutanen da aka gwada wa COVID-19 kuma aka tabbatar da su a matsayin masu kamuwa da cutar bisa ga ka'idojin hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa suna da manufofin hukuma na rashin gwada waɗanda ke da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga watan Maris ya gano cewa kusan kashi 86 cikin 100 na masu kamuwa da cutar COVID-19 ba a gano su ba a kasar Sin, har zuwa ranar 23 ga watan Janairu, kuma wadannan cututtuka da ba a samu ba ne suka haifar da kashi 79 cikin 100 na masu kamuwa da cutar.
Wani bincike na kididdiga da aka buga a ranar 30 ga watan Maris ya nuna cewa adadin wadanda suka kamu a Italiya ya fi na waɗanda aka samu.
Ƙididdigar farko na R0 na COVID-19 ya kasance tsakanin 1.4 da 2.4.
Wani bincike da aka wallafa daga Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka ya ce zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su warke ba, lokaci daga ciwon ya yi muni zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, mafi yawan kwanaki 14 ne.
Ya zuwa 10 ga Afrilu, 2020, COVID-19 ya yi sanadiyyar mutuwar mutane kusan 97,000.
Kusan kashi 80 cikin dari na mutuwar da aka yi a China tun daga ranar 5 ga Fabrairu sun kasance a cikin waɗanda suka haura shekaru 60, kuma kashi 75 cikin dari suna da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, domin ba su haɗa da mutanen da suka mutu ba tare da an gwada su ba - misali, a gida, ko a gidan kula da tsofaffi, da sauransu.
Bayanai na Italiya sun nuna cewa adadin mutuwar da aka samu a lokacin annobar ya wuce adadin mutuwar COVID da aka samu a hukumance sau hudu zuwa biyar.
Mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (CDC) a Amurka ta yarda cewa "mun san cewa [yawan mutuwar da aka sanar] ya nuna ƙarancin kimantawa", wata sanarwa da ke tallafawa rahotanni na almara da ke nuna rashin daidaito a cikin Amurka. Irin wannan rashin kimantawa yana faruwa a cikin annobar annoba; kamar annobar cutar sankarar naman alade ta H1N1 a shekarar 2009.
Mutuwa ta farko a waje da babban yankin China a ranar 1 ga Fabrairu a Philippines, kuma ta farko a wajen Asiya a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da goma sha biyu a kasashen waje na kasar Sin, a Iran, Koriya ta Kudu da kuma Italiya.
A ranar 13 ga watan Maris, sama da kasashe da yankuna arba'in ne suka bayar da rahoton mutuwar, a duk nahiyoyi ban da Antarctica. Ana amfani da matakai da yawa don tantance yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da kuma lokaci, kuma suna shafar girman gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani da lokacin da ya ɗauka tun barkewar cutar, da halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar jama'a. Matsayin mutuwa zuwa kamuwa da cuta yana nuna yawan mutuwar da aka raba da adadin waɗanda aka gano a cikin wani lokaci.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar da raunin cutar a duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Adadin ya bambanta bisa ga yankin.
A China, kimantawar mutuwar cutar ta sauka daga kashi 17.3% (ga waɗanda ke da alamun cutar daga 1 zuwa 10 ga Janairu 2020) zuwa 0.7% (ga waɗanda ke da alamun cutar bayan 1 ga Fabrairu 2020). Sauran ma'auni sun nuna yawan mutuwar cutar (CFR), wanda ke nuna yawan waɗanda suka kamu da cutar da suka mutu, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan waɗanda suka kamu da cutar (wanda aka tabbatar da cutar da wanda ba a tabbatar da cutar ba) da ke mutuwa daga cutar.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin wani takamaiman rukunin jama'a daga kamuwa da cutar zuwa sanin makomar cutar.
Masana kimiyya da yawa sun yi ƙoƙarin yin lissafin waɗannan adadi don wasu mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar annobar a matsayin duka ya kai tsakanin kashi 0.1 zuwa 0.39 bisa ɗari.
Ƙididdigar da ta fi wannan girma ta yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus, da kuma nazarin ƙididdiga da ke bincika tasirin gwajin a ƙididdigar yawan mutuwar.
Hukumar Lafiya ta Duniya ta tabbatar da cewa za a iya shawo kan annobar.
Ba a san lokacin da cutar za ta fi yaduwa ba kuma za ta iya bambanta da wuri.
Masage Bonney na Jami'ar Jihar Pennsylvania ya ce: "Yadda ake yawan samun cututtuka da ba a iya sarrafawa ba, sukan kai ƙarshensu kuma su fara raguwa sa'ad da cutar ba ta da masu masaukin kai.
Amma ba shi yiwuwa a yi wani zato mai kyau game da lokacin da hakan zai faru".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China, Chung Nanchan ya ce "za a iya kawo karshen cutar nan da watan Yuni" idan aka karfafa dukkan kasashe su bi shawarar Hukumar Lafiya ta Duniya kan matakan dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kocharski na Makarantar Kula da Lafiya da Magunguna ta London ya ba da rahoton cewa SARS-CoV-2 "zai kasance mai yaduwa wataƙila shekara ɗaya ko biyu".
A cewar wani bincike da kwalejin Imperial College London ta gudanar karkashin jagorancin masanin kimiyya Neil Ferguson, za mu dogara ne da nisantar jiki da sauran matakan "har sai an samu rigakafi (watakila bayan watanni 18 ko fiye).
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar ta corona za ta ɓace gaba ɗaya, domin tana da saurin yaduwa, kuma tana iya "mai da kanta ta zama wata cuta ta yanayi da ke dawowa kowace shekara".
Yadda cutar take dawowa zai dangana ne akan garkuwar jikin mutum da kuma yadda aka yi canjin.
Alamun COVID-19 na iya zama marasa ma'ana kuma waɗanda suka kamu da cutar ba sa nuna alamun.
Abubuwa biyu da suka fi faruwa su ne zazzabi (88%) da kuma tari mai bushe (68%).
Alamun da ba su da yawa sun haɗa da gajiya, ɓacin rai, rashin jin ƙanshi, ƙarancin numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, ciwon hauka, amai, zub da jini, zawo, ko kuma ƙyamar jini. Hukumar Lafiya ta Duniya ta tabbatar da cewa kusan mutum ɗaya cikin shida yana da ciwo mai tsanani kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Rigakafi (CDC) a Amurka ta iyakance alamun gaggawa zuwa wahalar numfashi, ciwo ko matsi na kullum a cikin kirji, rikicewar kwatsam, wahalar farkawa, da kumburi na fuska ko lebe. Ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun sun bayyana. Ƙarfafa ci gaban cutar na iya haifar da cututtukan huhu, cututtukan numfashi, kamuwa da cuta, rauni na kamuwa da cuta, da mutuwa.
Wasu mutane da ba su da alamun cutar amma sakamakon gwajin ya tabbatar da cutar, saboda haka masana sun ba da shawara cewa a kula da mutanen da suka kamu da cutar kuma a duba su sosai domin a iya guje wa kamuwa da cutar.
Kimanin mutanen China da ba su da alamun cutar sun kai kashi 44 cikin dari.
Lokacin da aka saba da shi (tsakanin kamuwa da cutar da bayyanar cututtuka) ya kasance tsakanin kwana 1 zuwa 14; sau da yawa kwanaki biyar. A matsayin misali na rikicewa, an kiyasta cewa kashi na COVID-19 waɗanda suka rasa ƙanshin ƙanshi sun kasance 30% da farko sannan kwanan nan suka ragu zuwa 15%.
Ana ci gaba da bincike kan yadda cutar ta yaɗu.
An yi imanin cewa cutar tana yaduwa ne a lokacin da ake tsotsa ko kuma ta hanyar watsawa lokacin da ake tari, hancin ko magana; a lokacin da ake tsotsa a nesa na mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya nuna cewa tari ba tare da rufe baki ba zai iya haifar da feshi mai nisa daga mita 4.5 (mita 15) zuwa mita 8.2 (mita 27).
Wasu sun yi imanin cewa cutar na iya yaduwa ta hanyar fesawa da ke cikin iska na dogon lokaci, wanda zai iya haifar da magana. Hakanan yana iya haifar da fesawa ta numfashi yayin aikin numfashi, gami da magana, kodayake ba a yadu da cutar ta iska.
Ana iya samun fesa a bakin ko hancin mutane da ke kusa ko kuma a sha shi cikin huhu.
Wasu hanyoyin jinya kamar su tubal nephritis da cardiopulmonary resuscitation (CPR) suna iya sa abubuwa masu guba daga cikin numfashi su fito kamar yadda ake yayyafa su kuma su yaɗu ta hanyar iska.
Yana kuma iya yaɗuwa sa'ad da mutum ya taɓa wani gurɓataccen abu, har da fata, sa'an nan ya taɓa idanunsa, hanci, ko baki.
Ko da yake akwai damuwa game da yiwuwar yaduwar jini daga farfajiya zuwa baki, ana ganin cewa wannan hadarin bai kai na tsawon lokaci ba.
Gwamnatin China ta musanta yiwuwar watsa SARS-CoV-2 daga fitsari zuwa baki. Kwayar cutar tana da kamuwa sosai a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake tana iya yaduwa kafin bayyanar cututtuka da kuma a lokacin matakan cutar.
An gano cewa mutane suna da cutar har kwana uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya yada cutar kafin bayyanar cututtuka.
Rahotanni kaɗan ne kawai na lab da aka tabbatar da cewa ba su da alamun cutar, amma wasu ƙasashe sun gano cewa ba su da alamun cutar a lokacin binciken da aka yi na gano masu cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta tabbatar da cewa duk da cewa akwai wasu rashin tabbas game da yadda sauƙin cutar ke yaɗuwa, mutum ɗaya na iya yaɗa cutar daga mutane biyu zuwa uku a gaba ɗaya. Kwayar cutar tana wanzuwa a kan rufi daga sa'o'i zuwa kwanaki.
Musamman, an gano cewa za a iya gano cutar har tsawon kwanaki uku a kan filastik na polypropylene da kuma bakin karfe mai tsayayyen 304 da rana ɗaya a kan takarda mai wuya da kuma tsawon sa'o'i huɗu a kan tagulla.
Duk da haka, wannan ya bambanta dangane da zafi da zafin jiki. An tabbatar da cutar COVID-19 a cikin dabbobin gida da sauran dabbobi.
Babu tabbacin cewa dabbobi na iya yada cutar zuwa ga mutane, duk da haka hukumomin Birtaniya sun bada shawara a wanke hannu bayan an yi hulɗa da dabbobi, kamar yadda ake yi idan aka taɓa wasu wurare da wanda ya kamu da cutar ya taɓa.
SARS-CoV-2 wani sabon kwayar cutar ne, wanda aka fara ganowa daga mutane uku da ke fama da ciwon huhu a Wuhan.
SARS-CoV-2 yana da duk halayen da yake da su tare da kwayar cutar corona da ke wanzuwa a yanayi. A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, inda yake narkar da membrane mai kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imanin cewa asalinsa daga dabbobi ne.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar korona tana da alaƙa da kwayar cutar beta, kuma tana ƙarƙashin kwayar cutar corona Sarbi (B-type) da kuma nau'ikan da suka samo asali daga bat.
Ya yi daidai da kashi 96 cikin dari na sauran kwayoyin cutar Corona a cikin Bat Cove Ratt G13.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a cikin amino acid a wasu sassan jerin kwayoyin halittar mutum tsakanin ƙwayoyin cuta na ciwon hauka da kuma na ɗan adam.
A yanzu haka, idan aka gwada dukan kwayoyin halittar mutum, an gano cewa akwai kashi 92 cikin 100 na irin kwayoyin halittar da ke tsakanin cutar SARS-CoV-2 da kuma cutar coronavirus, kuma wannan bai isa ba don tabbatar da cewa cutar ta samo asali ne daga cutar.
Ana iya gane kamuwa da kwayar cutar a ɗan lokaci bisa ga alamun cutar, ko da yake an tabbatar da hakan ne ta hanyar yin amfani da kwayar cutar ta hanyar yin amfani da maganin RT-PCR (reverse transcriptase polymerase).
Wani bincike a birnin Wuhan da ya kwatanta yadda polymerase da CT ke aiki ya nuna cewa CT na da saukin kamuwa da cutar fiye da yadda polymerase ke aiki, duk da cewa ba shi da kyau, saboda yawancin halayen da ke tattare da shi suna shafar ciwon huhu da kuma wasu cututtuka.
Tun daga Maris 2020, Kwalejin Hoto ta Amurka ta ba da shawarar "kada a yi amfani da CT don gano COVID-19 ko kuma a yi la'akari da shi a matsayin gwajin farko na ganewar asali".
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwajin SARS-CoV-2 na RNA, a karon farko a ranar 17 ga watan Janairu.
Gwajin yana amfani da halayen polymerase chain reaction (RRT-PCR) a ainihin lokacin.
Ana iya yin gwajin ne da samfurin numfashi ko jini.
Sakamakon yana samuwa cikin sa'o'i da yawa zuwa kwanaki.
Ana yin wannan gwajin ne ta hanyar shafawa da hanci, kuma ana iya yin amfani da shafawa daga hanci. Wasu dakunan gwaje-gwaje da kamfanoni suna yin gwajin da ke nuna cewa akwai kwayoyin cutar.
Tun daga 6 ga Afrilu, 2020, babu wani daga cikinsu da aka tabbatar da ingancinsa da ya isa a yi amfani da shi a ko'ina.
An amince da gwajin da aka yi da siliki don amfani da shi a gaggawa a Amurka a dakunan gwaje-gwaje da aka amince da su ne kawai.
Abubuwan da ke cikin hotunan rediyo da CT na mutanen da suke da alamun cutar sun haɗa da rashin daidaituwa na gefen kamar su gilashin da aka yi da kuma ɓoyayyen ƙyalli.
Ƙungiyar Radiation ta Italiya tana tattara bayanai na kan layi na duniya na sakamakon hoton da aka tabbatar da cutar.
Radiation imaging ba tare da yin polymerase chain reaction ba, hanya ce mai iyakacin daidaito wajen gano COVID-19, saboda haɗuwa da wasu cututtuka kamar cutar kwayar cutar nan.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da kuma hawan polymerase da ya tabbatar da cewa ko da yake ba shi da inganci a wajen gano cutar, amma ya fi sauri kuma ya fi saurin ganewa, wanda ya ba da shawarar a yi amfani da shi a matsayin kayan aikin bincike a wuraren da cutar ta kama.
An tsara hanyoyin sadarwa na jijiyoyin da ke amfani da fasaha na wucin gadi don gano halayen hoto na cutar a cikin hoton rediyo da kuma CT.
Dabaru na hana yaduwar cutar sun haɗa da kiyaye tsabtace jiki, wanke hannu, guje wa taɓa idanu, hanci, ko baki da hannuwa marasa wankewa, amfani da tawul lokacin da ka tari ko kuma ka sassaka, sannan ka jefar da shi kai tsaye cikin kwandon shara.
Ana ba da shawara ga waɗanda suka riga sun kamu da cutar su sanya abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar nisantar jiki don hana yaduwar kamuwa da cuta. Gwamnatoci da yawa sun hana tafiye-tafiye marasa mahimmanci daga ƙasashe da yankuna da cutar ta shafa ko kuma sun ba da shawarar kada a yi tafiya.
Duk da haka, cutar ta kai ga yaɗuwa a cikin al'umma a ɓangarori da yawa na duniya.
Wannan yana nufin cewa cutar tana yaɗuwa a cikin al'umma, kuma wasu mutane ba su san inda ko yadda suka kamu da ita ba. Masu ba da kiwon lafiya, waɗanda ke kula da wanda ke da yiwuwar kamuwa da cutar, ana ba da shawara su yi amfani da matakan da aka yarda da su, da kariya daga haɗuwa da kariya ta ido. Binciken waɗanda suka yi hulɗa da waɗanda suka kamu da cutar hanya ce mai tasiri da hukumomin kiwon lafiya ke amfani da ita wajen gano tushen kamuwa da cutar da kuma hana yaduwar ta.
Amfani da gwamnati ke yi da bayanan wurin da ake kira location data daga wayoyin salula domin bin diddigin mutane ya tada fargaba game da sirrin mutane, inda Amnesty International da fiye da wasu kungiyoyi 100 suka fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
An tsara aikace-aikacen wayar hannu da yawa ko kuma an jefa su don amfani da son rai, kuma a ranar 7 ga Afrilu, 2020, sama da ƙungiyoyi goma sha biyu sun yi aiki don samar da mafita na sirri, kamar amfani da Bluetooth don yin rikodin kusancin mai amfani da sauran wayoyin hannu.
Masu amfani suna samun saƙo idan sun kusanci mutumin da aka tabbatar yana da cutar COVID-19. Yana yaɗa ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar; misali, wanke hanci da gurguntar baki ba mafita ba ce.
Har yanzu babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da dama suna aiki wajen samar da rigakafi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
Cibiyar Kula da Cututtuka da Rigakafinta ta ba da shawarar mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun yi tsatsa, kafin cin abinci, bayan sun kwantar da hanci, sun yi tari ko kuma sun yi tari.
Wannan saboda sabulu na gida yana kashe kwayar cutar a waje da jiki; yana lalata garkuwar kariya.
Cibiyar Kula da Cututtuka ta kuma ba da shawarar yin amfani da maganin kashe ciwon hannu da ke da kashi 60 cikin 100 na barasa a lokacin da babu ruwa da sabulu.
Hukumar Lafiya ta Duniya ta shawarci mutane su guji taɓa idanunsu, hanci, ko baki da hannuwansu da ba a wanke ba.
Za a iya tsabtace farfajiyar ta amfani da kayan shafawa da yawa (a cikin minti ɗaya na sanya kayan shafawa a saman karfe mai tsayayyen tsatsa, gami da; ethanol 6271%, isopropanol 50100%, sodium hypochlorite 0.1%, hydrogen peroxide 0.5%, da iodopophedon 0.27.5%.
Akwai wasu kayan shafawa, kamar su benzalkonium chloride da chlorhexidine gluconate, da ba su da inganci sosai.
Cibiyar Cutar da Cututtuka ta ba da shawara cewa idan ana zargin ko kuma an tabbatar da cewa mutum yana da cutar ta COVID a wurin aiki, kamar ofishi ko cibiyar kula da marasa lafiya, ya kamata a yi amfani da maganin kashe ƙwayoyin cuta a wurare kamar su ofisoshi, banɗaki, wuraren da mutane suke zama tare da su, da kuma na'urorin lantarki da ake amfani da su kamar su kwamfutar hannu, allon taɓawa, allon maɓalli, na'urorin sarrafawa na nesa, da na'urorin ATM da mai haƙuri yake amfani da su.
Ƙungiyoyin kiwon lafiya sun shawarci mutane su rufe bakinsu da hancinsu sa'ad da suke tari ko kuma hancin su ko dai su lanƙwasa gwiwoyin su a gaban bakinsu da hancinsu ko kuma su yi amfani da tawul ɗin takarda kuma su kawar da duk wani tawul nan da nan.
Ana ba da shawarar cewa waɗanda za su iya kamuwa da cutar su yi amfani da abin rufe fuska, tun da yin hakan zai rage yawan iska da za a iya sha da kuma nisan da za a iya yi sa'ad da aka yi magana, da gumi, da kuma tari.
Hukumar Lafiya ta Duniya ta fitar da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, "saka abin rufe fuska zai iya rage sha'awar [mutane] su taɓa fuskokinsu, wanda babban tushen kamuwa da cuta ne idan ba a wanke hannayensu yadda ya kamata ba". Ana ba da shawarar masu kula da mutanen da ke da yiwuwar kamuwa da cutar su yi amfani da abin rufe fuska.
Hukumar Lafiya ta Duniya ta ba da shawarar kada a sanya abin rufe fuska ga mutanen da suke da lafiya sai dai idan suna da babban haɗari, kamar waɗanda ke kula da waɗanda ke da COVID-19, ko da yake ta kuma yarda cewa sanya abin rufe fuska zai iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafa wa talakawa gwiwa su sanya abin rufe fuska.
Cibiyar Kula da Cututtuka da Rigakafin cuta ta Amurka ta ba da shawarar sanya abin rufe fuska na masana'anta wanda ba na likita ba. China ta ba da shawarar musamman ga masu lafiya su yi amfani da abin rufe fuska na likita wanda za a iya zubar da shi, musamman idan sun yi hulɗa kai tsaye (a nesa da mita 1 (ƙafa 3 ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska lokacin amfani da sufuri na jama'a ko kuma lokacin da kake zama a wuraren da mutane suke da yawa.
Masu kula da lafiyar Thai suna ƙarfafa mutane su yi abin rufe fuska da tufafi a gida kuma su wanke su kullum.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska yayin fita waje don kare kansa da wasu.
Gwamnatin Austria ta tilasta wa duk wanda ya shiga kantin sayar da kayan masarufi ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna yankin su sanya abin rufe fuska a wuraren jama'a.
Taiwan, wadda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da motocin bas da ke tafiya tsakanin birane su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta sanya sanya abin rufe fuska a waje ya zama dole, tare da bayar da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya sayan abin rufe fuska ba.
Ana amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisa nesa (wanda kuma ake kira da nisantar jiki) ya ƙunshi matakan hana kamuwa da cuta da nufin rage yaduwar cuta ta hanyar rage haɗuwa tsakanin mutane zuwa ƙarami.
Hanyoyin sun haɗa da keɓewar mutane; ƙuntatawa kan tafiye-tafiye; rufe makarantu, wuraren aiki, filayen wasa, wuraren wasan kwaikwayo, ko cibiyoyin kasuwanci.
Mutane za su iya yin amfani da hanyoyin nisantar juna ta wajen zama a gida, rage tafiye-tafiye, guje wa wuraren da mutane suke da yawa, yin gaisuwa ba tare da tuntuɓar juna ba, da kuma nisantar mutane.
Gwamnatoci da yawa a yanzu suna tilasta ko kuma ba da shawarar nisantar mutane a yankunan da cutar ta bulla.
An rage yawan taron jama'a da hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya suka ba da shawarar daga mutane 250 (idan ba a gano yaduwar COVID-19 a yankin ba) zuwa mutane 50, kuma mutane 10 daga baya.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a sama da mutane biyu. Manya da waɗanda ke da cututtuka na yau da kullun kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma tsarin rigakafi suna fuskantar haɗarin kamuwa da cuta da rikitarwa masu haɗari kuma Cibiyar Kula da Cututtuka da Rigakafi ta shawarce su da su zauna a gida kamar yadda zai yiwu a wuraren da cutar ta barke tsakanin al'ummomi. A ƙarshen Maris 2020, WHO da sauran kungiyoyin kiwon lafiya sun fara amfani da kalmar "nesa" tare da kalmar "nesa ta jiki", don bayyana cewa manufar ita ce a tabbatar da hulɗa da mahaukaciyarta ta hanyar kiyaye alaƙa da zamantakewa, ko kuma ta hanyar nesa.
Amfani da kalmar "rabuwa da jama'a" ya nuna cewa mutane su shiga cikin keɓewa gaba ɗaya, maimakon ƙarfafa su su yi hulɗa da wasu ta wasu hanyoyin. Wasu hukumomi sun ba da umarnin kiwon lafiya na jima'i don amfani da su yayin annobar.
Wannan ya haɗa da shawarwari game da yin jima'i da wanda ba shi da cutar ko kuma yana da alamun cutar.
Ana ba da shawarar a ware mutane a gida ga waɗanda ke da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai game da keɓe kai. Gwamnatoci da yawa sun kafa ko kuma sun ba da shawarar keɓe kai ga dukan mazauna yankunan da cutar ta shafa.
An ba da umarni mafi ƙarfi na keɓe kai ga waɗanda suke cikin rukunin haɗari.
An shawarci waɗanda suka yi hulɗa da wanda ke da COVID-19 da waɗanda suka yi tafiya kwanan nan zuwa ƙasa ko yanki da cutar ke yaduwa su keɓe kansu na kwanaki 14 kafin a yi musu ɓarna.
Dabaru na sarrafa cutar su ne su hana ko kuma hana yaduwar cutar.
Ana amfani da tsare a farkon ɓarkewar cutar kuma an yi niyyar gano waɗanda suka kamu da cutar da ware su da kuma gabatar da wasu matakan hana kamuwa da cuta da alluran rigakafi don hana cutar ya yaɗu ga sauran jama'a.
Idan ya zama ba zai yiwu a hana yaduwar cutar ba, sai a mai da hankali ga sauƙaƙa cutar: ana yin matakan rage saurin yaduwar cutar da rage tasirinta a kan tsarin kiwon lafiya da kuma al'umma.
Za a iya yin hada-hadar tsare-tsare da kuma rage su a lokaci guda.
Dakatar da cutar na bukatar a dauki matakai masu tsauri don juyawa hanyar annobar ta hanyar rage yawan haifuwa zuwa kasa da 1. Wani bangare na gudanar da barkewar cutar yana kokarin rage girman annobar, a cikin abin da aka sani da flattening curve.
Wannan zai rage wahalar da ake samu a kula da lafiyar jama'a kuma zai ba da lokaci mai yawa don samar da alluran rigakafi da hanyoyin magani.
Sauran hanyoyin da ba na magani ba da za su iya magance barkewar cutar sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan al'umma da ke nufin nisantar jiki kamar rufe makarantu da soke manyan tarurruka; hadin kai na al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan hanyoyin; da kuma matakan muhalli kamar tsabtace rufi. An ɗauki tsauraran matakai da aka yi niyya don shawo kan barkewar cutar a China da zarar cutar ta bayyana, kamar rage keɓewar jiki a kan birane baki ɗaya da sanya takunkumin hana zirga-zirga.
Sauran ƙasashe ma sun ɗauki matakai da dama da suka yi niyyar rage yaduwar cutar.
Koriya ta Kudu ta kafa gwajin taro da keɓewar kai a gida, kuma ta ba da gargadi game da motsin waɗanda suka kamu.
Singapore ta ba da tallafi na kuɗi ga waɗanda suka keɓe kansu kuma ta ci tarar waɗanda ba su yi hakan ba.
Taiwan ta kara samar da abin rufe fuska kuma ta yi ta matse kayayyakin kiwon lafiya. Kwatancen da aka yi wa Birtaniya da Amurka ya nuna cewa rage (rage yaduwar cutar, ba dakatar da ita) da kuma hana (daidaita ci gaban cutar) suna fuskantar manyan kalubale.
Manufofin rage yawan cuta na iya rage yawan bukatar kiwon lafiya da kashi biyu cikin uku da kuma mutuwar mutane da rabi, amma har ila yau suna haifar da dubban dubban mutuwar mutane da kuma matsin lamba ga tsarin kiwon lafiya.
Ya kamata a ci gaba da hana kamuwa da cutar har sai cutar ta yaɗu a cikin mutane (ko kuma har sai an samu rigakafin cutar, idan hakan ta fara faruwa), amma ana iya kawar da kamuwa da cutar idan aka rage matakan.
Saurin hana annobar yana da tsada a fannin tattalin arziki da zamantakewa.
Babu takamaiman maganin rigakafin cutar da aka amince da shi don COVID-19, amma ana ci gaba da ƙoƙarin ci gaba, ciki har da gwajin magungunan da ake da su.
Shan magungunan sanyi da ba a rubuta wa likitanci ba, shan ruwa da hutawa na iya taimaka wajen rage ciwo.
Dangane da tsananin cutar, za a iya bukatar maganin oxygen, ruwan jini, da kuma taimakon numfashi.
Yin amfani da maganin hana ci zai iya sa sakamakon ya yi muni.
Ana gwada magungunan da yawa da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta don a yi amfani da su wajen maganin COVID-19.
Ƙungiyar Lafiya ta Duniya ta kuma ce wasu "magani na gargajiya da na gida" na iya rage alamun cutar SARS-CoV-19.
Ƙarfafa iya aiki da daidaita cibiyoyin kiwon lafiya don biyan bukatun marasa lafiya na COVID-19 an bayyana su ta WHO a matsayin manyan matakan magance barkewar cutar.
Cibiyar Kula da Cututtuka ta Turai da Ofishin Yankin WHO na Turai sun ba da jagororin asibitoci da ayyukan kiwon lafiya na farko don canja wurin albarkatu a matakai da yawa, gami da mayar da hankali kan gwajin COVID-19, kawar da zaɓin inda zai yiwu, warewa da ware COVID-19, haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka yawan kayan numfashi da gadaje.
Akwai ra'ayoyi da yawa game da inda yanayin farko ya samo asali (wanda ake kira Mai haƙuri Zero).
An fara gano sabon cutar korona a ranar 1 ga Disamba, 2019 a birnin Wuhan, Hubei, a kasar Sin.
A cikin wata guda, adadin masu kamuwa da cutar korona a Hubei ya karu a hankali.
Wannan ya kasance mafi yawa game da kasuwar cin abincin teku ta Wuhan, wanda ke sayar da dabbobi masu rai, kuma daya daga cikin ka'idodin ya ce kwayar cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma a wasu kalmomin, ta samo asali ne daga dabbobi. An lura da wani rukuni da ke fama da cutar huhu don dalilin da ba a sani ba a ranar 26 ga Disamba kuma an kula da shi a asibitin lardin Hubei ta hanyar Dr. Zhang Jixian, wanda ya sanar da Cibiyar Kula da Cututtuka ta Jianghan Buhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wasu likitoci a asibitin Wuhan na tsakiya sun gargadi abokan aikinsu game da "kwayar cutar korona mai kama da SARS".
An gargadi takwas daga cikin wadannan likitoci, ciki har da Li Wenliang, saboda yada jita-jita, kuma wani likita, Ai Wen, ya sha azaba daga shugabanninta don faɗakar da jama'a.
Daga baya kwamitin kiwon lafiya na birnin Wuhan ya fitar da sanarwa a ranar 31 ga watan Disamba kuma ya sanar da WHO.
An samu isassun rahotanni na kamuwa da cutar huhu da ba a san ko su waye ba ga hukumomin kiwon lafiya a Wuhan, wanda ya sa suka fara bincike a farkon watan Janairu. A farkon lokacin barkewar cutar, adadin masu kamuwa da cutar ya ninka kusan sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, tare da taimakon tafiye-tafiye a lokacin Sabuwar Shekarar Sin da kuma Kun-Wuhan, cibiyar sufuri da kuma wurin da manyan layin dogo ke haɗuwa.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da daya a birnin Shenzhen.
Bayanai na hukuma da aka sanar daga baya sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu, 2020. Ya zuwa ranar 26 ga Maris, Amurka ta zarce China da Italiya a kan yawan wadanda suka kamu da cutar a duniya. Ya zuwa ranar 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya, tare da mutane sama da 97,000 da suka mutu, kuma sama da mutane 364,000 sun warke.
Kimanin ƙasashe 200 da yankuna sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun ƙuntata 'yancin motsi kuma sun kafa takunkumin kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan hanawa, kamar su keɓewa (wanda aka fi sani da umarnin zama a gida, ko umarnin ɓoyewa, ko rufewa) da kuma dokar hana fita. Ya zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, sun shiga cikin wani nau'in kulle-kulle a Amurka, sama da mutane miliyan 50 sun shiga cikin kulle-kulle a Philippines, kusan mutane miliyan 59 sun shiga cikin kulle-kulle a Afirka ta Kudu, kuma mutane biliyan 1.3 sun shiga cikin kulle-kulle a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun shiga wani irin kulle-kullen, wanda ya kai biliyan 2.6 kwana biyu bayan haka - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An fara tabbatar da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an fara gano cutar ne a ranar 17 ga Nuwamba.
A ranar 26 ga watan Disamba, Dr. Zhang Jixian ta lura da wasu cututtukan ciwon huhu da ba a san dalilin su ba, kuma asibitinta ya sanar da Cibiyar Kula da Cututtuka ta Jianghan Wuhan a ranar 27 ga watan Disamba.
Gwajin farko na kwayoyin halittar marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai kwayar cutar SARS.
Kwamitin Kiwon Lafiya na birnin Wuhan ya fitar da sanarwa a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
A yayin da ake samun irin wannan sanarwar, 'yan sanda sun gargadi likitoci a birnin Wuhan game da "rashin jin labarin" game da barkewar cutar.
A farko hukumar lafiya ta kasar Sin ta ce babu "bayyanannen shaida" na kamuwa da cutar daga mutum zuwa mutum.
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da wani babban kamfen wanda daga baya Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping ya kira "yaƙin jama'a" don hana yaduwar cutar.
A cikin abin da aka kwatanta da "mafi girman tsaftacewa a tarihin ɗan adam", an sanar da dokar hana zirga-zirga daga Wuhan a ranar 23 ga Janairu, wanda ya kai ga birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekarar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huishan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti, asibitin Lichenshan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka kafa, kasar Sin ta kuma mayar da wasu wurare 14 a birnin Wuhan, kamar cibiyoyin taro da filayen wasa, asibitoci na wucin gadi. A ranar 26 ga watan Janairu, gwamnati ta dauki wasu matakai don shawo kan barkewar COVID-19, ciki har da bayar da sanarwar kiwon lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a duk fadin kasar.
An ɗauki matakai da yawa a Hong Kong da Macau, musamman game da makarantu da jami'o'i.
An yi amfani da hanyoyin yin aiki daga nesa a yankuna da dama na kasar Sin.
An kafa takunkumin hana tafiye-tafiye a cikin da kuma wajen Hobby.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk ƙasar Sin.
An kafa takunkumin hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wani nau'i na takunkumin fita. Bayan barkewar cutar ta zama ta duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana "kawo" cutar daga wasu ƙasashe.
Misali, Beijing ta sanya wa duk waɗanda suka dawo daga wasu ƙasashe keɓewar kai na kwanaki 14. A ranar 23 ga Maris, an sami mutum ɗaya da ya kamu da cutar a cikin ƙasar Sin a cikin kwanaki biyar da suka gabata, ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Shugaban Majalisar Jiha ta Sin Li Ke Chiang ya bayyana raguwar yaduwar cututtukan da ke yaduwa a cikin gida da kuma sarrafa barkewar cutar a China.
An sassauta takunkumin tafiye-tafiye a Hubei a wannan ranar, ban da Wuhan, bayan watanni biyu da sanya dokar kulle. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar masu riƙe da biza ko izinin zama daga ranar 28 ga Maris, ba tare da takamaiman bayani game da lokacin da wannan manufar za ta ƙare ba.
Waɗanda suke son shiga ƙasar Sin za su nemi biza a ofishin jakadancin ƙasar Sin.
Gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu su ci gaba da aiki a ranar 30 ga Maris, kuma ta ba da wasu kudade na karfafa gwiwa ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki da za a fara da minti uku na shiru a ranar 4 ga Afrilu da karfe 10:00 na dare, daidai da bikin Qingming, duk da cewa gwamnatin tsakiya ta bukaci iyalai su nuna girmamawarsu ta yanar gizo don kiyaye nisantar jiki don gujewa sake barkewar COVID-19.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar Lafiya ta kasa ta sanar da karuwar wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda hakan ya danganta ne da taron da aka yi a Daegu na wani sabon addini da ake kira Shincheonji Jesus Church.
Ana zargin cewa mabiya Shincheonji da ke ziyartar Daegu daga Wuhan ne suka haddasa annobar.
Ya zuwa ranar 22 ga Fabrairu, mutane 1,261 ko kuma kusan kashi 13 cikin dari na masu bin coci 9,336 sun ba da rahoton alamun. Koriya ta Kudu ta sanar da matakan tsaro mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an bayar da rahoton fiye da mutane 2,000 da aka tabbatar da su a Koriya, inda suka haura zuwa 3,150 a ranar 29 ga Fabrairu.
An sanya dukkan sansanonin sojin Koriya ta Kudu a killace bayan gwajin da aka yi ya tabbatar da cewa sojoji uku sun kamu da cutar.
Lokaci na tashi daga jirgin ya shafi shi ma, kuma ya canza. Koriya ta Kudu ta aiwatar da shirin da aka ce shi ne mafi girma kuma mafi kyau a duniya don bincika mutane don cutar, ware duk wanda ke da cutar, da kuma gano waɗanda suka yi musu illa da kuma sanya su cikin keɓewa.
Hanyoyin gwajin sun hada da tilastawa sabbin masu shigowa kasashen duniya su bayar da rahoton alamun cutar ta wayar salula, a gwada mutane a cikin motocinsu da za a samu sakamakon gwajin a rana mai zuwa, da kuma kara yawan gwajin zuwa mutane 20,000 a rana.
Shirin na Koriya ta Kudu ya nuna nasara wajen shawo kan barkewar cutar duk da cewa ba a sanya dukkan biranen keɓewa ba. Da farko al'ummar Koriya ta Kudu sun rabu game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a cire Moon, suna zargin gwamnati da rashin kulawa da annobar, ko kuma suna yaba masa saboda yadda ya amsa.
A ranar 23 ga Maris, an sanar da cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu kamuwa da cutar a rana guda a cikin makonni huɗu.
A ranar 29 ga watan Maris, an sanar da cewa daga ranar 1 ga watan Afrilu, duk sabbin da suka shigo daga kasashen waje za a killace su na tsawon makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta samu buƙatun daga ƙasashe daban-daban 121 don taimakawa wajen gwajin cutar.
Iran ta bayar da rahoton farkon tabbataccen cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qum, inda mutane biyu suka mutu daga baya a ranar, a cewar Ma'aikatar Lafiya da Ilimin Kiwon Lafiya.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran al'adu da wasanni, sallar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware tiriliyan biyar na Riyal don yaki da cutar.
Shugaba Hassan Rouhani ya bayyana a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, za a killace mutane ne kawai.
An sanar da tsare-tsaren rage tafiye-tafiye tsakanin birane a watan Maris, duk da cewa ana ci gaba da samun cunkoson zirga-zirga tsakanin birane kafin sabuwar shekara ta Farisa ta Nuwruz.
An ci gaba da bude wuraren ibadar Shia a Gumi har zuwa ranar 16 ga Maris, 2020. A watan Fabrairu, Iran ta zama cibiyar yaduwar cutar bayan China.
A cikin zargin cewa Iran na rufe yaduwar cutar, sama da kasashe goma sun bi diddigin wadanda suka dawo daga Iran tun daga ranar 28 ga watan Fabrairu, wanda ke nuna cewa yaduwar cutar na iya wuce adadin mutane 388 da gwamnatin Iran ta ruwaito zuwa wannan ranar.
An rufe majalisar dokokin Iran, inda aka bayar da rahoton cewa mambobi 23 daga cikin 290 sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin gidan yari na Iran da su saki masu kare hakkin dan adam da aka tsare saboda adawa ta lumana ba tare da wani sharadi ba, da kuma 'yan fursunoni masu cancanta da za a sake su na wucin gadi.
Ta ce akwai babban hadarin yaduwar cutar a wuraren da aka rufe kamar gidajen yari, wanda kuma ba su da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shi ne mafi girma a kasar tun lokacin da annobar ta fara.
Aƙalla 'yan siyasa 12 da tsoffin jami'an gwamnati sun mutu sakamakon cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran na samun sabbin kamuwa da cutar 50 a kowace awa, da kuma mutuwar mutum daya a kowane minti goma saboda cutar korona.
A cewar wani jami'in WHO, adadin masu cutar a Iran zai iya ninka na baya sau biyar.
An kuma yi imanin cewa takunkumin Amurka akan Iran na iya shafar ikon kudi na kasar wajen magance barkewar cutar.
Hukumar kare hakkin dan adam ta Majalisar Dinkin Duniya ta bukaci a sassauta takunkumin tattalin arziki kan kasashen da cutar ta fi shafawa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da gwajin SARS-CoV-2 na 'yan yawon bude ido na kasar Sin a Rome ya nuna cewa suna da cutar.
Lamarin ya fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma fita daga China kuma ta ayyana dokar ta baci.
Daga baya an gano wasu marasa alaƙa da COVID-19, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar ministoci ta ba da sanarwar sabon doka don hana barkewar cutar, gami da keɓewa sama da mutane 50,000 daga gundumomi 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "Ba za a yarda da kowa ya shiga ko ya fita daga yankunan da cutar ta bulla ba.
An riga an ba da umarnin dakatar da ayyukan kasuwanci da wasanni a waɗannan yankuna". A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, inda mutuwar mutane 100 a Italiya.
An shirya gudanar da dukkan manyan wasannin wasanni, ciki har da wasannin Premier League, a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasannin wasa gaba daya na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Kula da Magunguna, Mai ba da magani, Mai ba da taimako da kulawa mai zurfi (SIAARTI) ta buga shawarwarin ɗabi'a na likita game da hanyoyin da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasa da ta fi kowacce mace-mace da ke da nasaba da cutar korona a duniya bayan ta bayar da rahoton mutane 3,405 da suka mutu sakamakon annobar.
A ranar 22 ga watan Maris, Rasha ta aika da jiragen sama tara na soja dauke da kayan aikin kiwon lafiya zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, an samu mutane 128,948 da suka kamu da cutar, mutane 15,887 sun mutu, kuma mutane 21,815 sun kamu da cutar a Italiya, mafi yawansu a yankin Lombardy.
Rahoton CNN ya nuna cewa haɗuwa da yawan tsofaffi da rashin iya gwada duk waɗanda ke da cutar a Italiya ya zuwa yanzu na iya taimakawa wajen ƙaruwar mutuwar.
Amsar Burtaniya ga cutar ta fara bayyana a matsayin mafi sassaucin ra'ayi a cikin ƙasashe da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta ba da wani nau'i na nisantar zamantakewa ko matakan keɓewa ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin saurin da kuma tsananin amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar kauce wa balaguro ko hulɗa da jama'a ba dole ba, yana ba da shawarar mutane suyi aiki daga gida kamar yadda zai yiwu kuma su guji wurare da yawa, kamar mashaya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa za ta rufe dukkan wuraren shakatawa kamar mashaya da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata har zuwa £2,500 a wata don rage rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar da jama'a, inda aka hana tarurruka sama da mutane biyu kuma aka hana tafiye-tafiye da aiki a waje da gida sai dai idan ya zama dole.
Ba kamar yadda aka saba ba, 'yan sanda sun yi amfani da wannan dokar ta hanyar ba da tarar da kuma tarwatsa taron jama'a.
An ba da umarnin rufe yawancin kamfanoni, ban da ayyukan kasuwanci "mahimmanci", ciki har da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma wuraren ajiye motoci.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da aka sani da cutar COVID-19 a jihar Washington ta arewa maso yammacin Pacific a cikin wani mutum da ya dawo daga birnin Wuhan a ranar 15 ga watan Janairu.
An kafa rukunin aiki na fadar White House kan cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta jama'a, kuma ta sanya takunkumi kan shigowar matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka (CDC), babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta kirkiro gwajin kanta.
Duk da haka, Amurka ta jinkirta fara gwajin, ta rufe ainihin yaduwar cutar a lokacin.
Gwajin ya lalata gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga rukunin gwajin da ba na gwamnati ba (ta hanyar ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma takunkumin ƙa'idodin mutane don cancantar gwajin har zuwa farkon Maris (an buƙaci umarnin likita bayan haka).
A ranar 27 ga Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwaje-gwaje kasa da 4,000 a Amurka.
A ranar 13 ga Maris, The Atlantic ta ba da rahoton cewa an yi gwaje-gwaje kasa da 14,000.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Mutane da yawa da ke da alamun cutar kuma suna da umarnin likita suna jiran sa'o'i ko kwanaki don yin gwaji". Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Insley ya ayyana dokar ta baci, matakin da wasu jihohi suka bi.
Makarantu a birnin Seattle sun soke karatu a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, masana ilmin cututtuka na Jami'ar Imperial College London sun sanar da Amurka game da hasashen tasirin sabon kwayar cutar ta Corona a kasar.
A wannan ranar ne Shugaba Trump ya sanya hannu kan dokar samar da karin tallafi don shirye-shiryen cutar korona da kuma mayar da martani, wanda ya samar da dala biliyan 8.3 na kudade na gaggawa ga hukumomin tarayya don magance annobar.
Kamfanoni sun hana ma'aikata tafiya, sun soke taro, kuma sun bukaci ma'aikata su yi aiki daga gida.
An soke ayyuka da kuma wasannin motsa jiki. A ranar 11 ga watan Maris, Trump ya sanar da hana tafiye-tafiye zuwa mafi yawan Turai, ban da Burtaniya, na tsawon kwanaki 30, daga ranar 13 ga watan Maris.
Washegari, an ƙara takunkumi zuwa Birtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci, wanda ya ba da damar amfani da kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko rage lokutan aiki a duk faɗin Amurka don a rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da kuma gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton kamuwa da cutar ta COVID-19 10,700 a birnin New York, wanda ya fi adadin masu kamuwa da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce ya yi kama da nesa da jama'a ya yi nasara, inda kimantawa ta nuna raguwar ninki biyu daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa ranar 28 ga Maris, an tabbatar da mutane 32,308 a birnin New York, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, an bayar da rahoton cewa akwai ƙarin tabbatar da cutar coronavirus a Amurka fiye da kowace ƙasa a duniya, gami da China da Italiya. Ya zuwa ranar 8 ga Afrilu, an tabbatar da mutane 400,335 a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotannin kafofin watsa labarai na ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita dokokin nisantar juna har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin USS Comfort, wani jirgin asibiti mai gado 1,000, ya sauka a New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 da cutar korona ta yi a cikin sa'o'i 24.
A jihar New York, adadin masu kamuwa da cutar ya zarce 100,000 a ranar 3 ga Afrilu. An soki fadar White House kan rage barazanar da kuma sarrafa yada labarai ta hanyar umarci jami'an kiwon lafiya da masana kimiyya da su daidaita bayanan jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
Gwamnatin Trump ba ta samu karbuwa ba saboda rikicin da ta haifar da rashin jituwa tsakanin jam'iyyun.
Wasu jami'an Amurka da masu sharhi sun soki yadda Amurka ke dogara da shigo da kayayyakin da ake bukata, ciki har da kayayyakin kiwon lafiya, daga China.
An yi amfani da nazarin yanayin tafiye-tafiye na iska don tsara fasalin yanayin yaduwar da kuma hasashensa, wanda aka buga a cikin mujallar Travel Medicine a tsakiyar watan Janairu na 2020.
Dangane da bayanan da aka samu daga Tarayyar Jirgin Sama ta Duniya na 2018, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan fasinjojin da suka fito daga Wuhan.
An kuma bayar da rahoton cewa Dubai, Sydney, da Melbourne sune wuraren da matafiya daga Wuhan ke zuwa.
An bayar da rahoton cewa Bali ita ce mafi ƙarancin ƙarfi a cikin shahararrun wurare sama da 20 don yin shiri, yayin da biranen Ostiraliya suka fi ƙarfin. Ostiraliya ta fitar da tsarin gaggawa na gaggawa na sabon kwayar cutar ta COVID-19 a ranar 7 ga Fabrairu.
Ya ce ba a gano abubuwa da yawa game da cutar COVID-19 ba, kuma cewa Ostiraliya za ta ƙarfafa kula da kan iyakoki da sadarwa a cikin amsa cutar.
A ranar 21 ga watan Maris, an ayyana dokar ta-baci ta kare lafiyar dan adam a Australia.
Saboda tasirin keɓewar jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasashensu da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen da aka yi haya daga ƙasashensu, tare da samar da izini daga hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand suna cikin ƙasashe na farko da suka fara shirin kwashe 'yan ƙasarsu.
Pakistan ta sanar da cewa ba za ta fitar da 'yan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko mutanen da aka kama, ban da 'yan Poland hudu, wani dan China, da kuma wani dan Indiya.
'Yan Poland, Sin da Indiya sun sauka daga jirgin a Poland, inda jirgin na Brazil ya tsaya kafin ya koma Brazil.
An ware 'yan Brazil da suka tafi Wuhan a wani sansanin soji da ke kusa da Brazil.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko, 39 daga na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa sansanin sojojin Kanada na Trenton don ware su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a sansanin sojojin Kanada na Trenton.
Hukumomin Australiya sun kwashe mutane 277 a ranar 3 da 4 ga Fabrairu zuwa wani wurin tsare da ake kira tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin wurin keɓewa, inda suka zauna na kwanaki 14.
Jirgin saukar jiragen ruwa na New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma an keɓe fasinjojinsa (ciki har da mutanen da suka fito daga Australia da Pacific) a sansanin sojan ruwa na Whangaparaoa a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama ya sauka a Trenton, Ontario dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, wani jirgin saman kamfanin jiragen sama na Afirka ta Kudu da gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan kasar Afrika ta Kudu 112.
An yi wa 'yan Afirka ta Kudu huɗu gwajin lafiya kafin su tashi, kuma an bar su da alamun cutar korona don rage haɗarin.
An mayar da 'yan Afirka ta Kudu da suka yi gwajin rashin lafiya.
Sakamakon gwajin ya tabbatar da cewa 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji, waɗanda duk suka kasance, a matsayin matakan kariya, a karkashin sa ido da keɓewa a wurin shakatawa na Ranch na kwanaki 14, ba su da rauni.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen Sin ta ruwaito cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad, Tobago, Misira, da Iran) sun aika da agaji zuwa China.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don aika da agaji zuwa yankunan da cutar ta addabi kasar Sin. Wani rukuni na hadin gwiwa a yankin Chicago ya samu nasarar aika da takunkumin N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga watan Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwar FedEx, ta aika da takunkumin 200,000 tare da sauran kayan kariya na mutum, ciki har da safofin hannu da tufafin ma'aikatan asibitoci, ta hanyar gadar jirgin sama, zuwa asibitin Wuhan Yunnan a ranar 30 ga watan Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken rigakafi da kokarin magani, tare da kare "mutane masu hadarin gaske a Afirka da Kudancin Asiya".
Interaction ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa birnin Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta aika da dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba Wuhan abin rufe fuska miliyan, Turkiyya ta aika kayan aikin likita, Rasha ta aika da kayan kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu ta kiwon lafiya miliyan 18 ga China, Jamus ta ba da kayan aikin likita da suka hada da rigunan kariya 10,000, Amurka ta ba China tan 17.8 na kayan aikin likita, kuma ta yi alkawarin bayar da tallafin kuɗi na dala miliyan 100 ga ƙasashen da abin ya shafa. Bayan an daidaita yanayin a China, kasar tana aika da taimako ga ƙasashe daban-daban da cutar ta shafa.
A watan Maris, Sin, Cuba, da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya wajen magance barkewar cutar korona.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa, Habasha, da abin rufe fuska miliyan 6, da kuma riguna na kariya dubu 60,000, inda kungiyar tarayyar Afirka ta dauki nauyin rarraba su.
Daga baya ya aika da kayan gwaji 5,000 zuwa Panama, da abin rufe fuska 100,000, da kuma na'urorin numfashi guda biyar.
Ma kuma ta ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwajin da aka yi a China.
Misali, Spain ta janye kayan gwajin cutar korona 58,000 da aka yi a China, wadanda suke da kashi 30 cikin 100 na daidaito, kuma a halin yanzu, Netherlands ta mayar da 600,000 na kayan rufe fuska da aka yi a China, wadanda suke da lahani.
Belgium ta mayar da abin rufe fuska 100,000 da aka yi zaton daga China ne, amma a zahiri daga Colombia ne.
A gefe guda, sassan Latin Amurka da Afirka sun yi maraba da karɓar taimakon na Sin da kyau. A ranar 2 ga Afrilu, Bankin Duniya ya ƙaddamar da ayyukan tallafi na gaggawa ga ƙasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da hukumomin China ke yi wajen sarrafa cutar.
Hukumar Lafiya ta Duniya ta lura da bambanci tsakanin barkewar cutar SARS tsakanin 2002 da 2004, inda ta zargi hukumomin China da rufewa wanda ya hana rigakafin da kuma hanawa, da kuma rikicin na yanzu, inda gwamnatin tsakiya ta ba da "sabuntawa na yau da kullun don kauce wa firgita kafin hutun sabuwar shekara".
A ranar 23 ga Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da dokar hana zirga-zirga a Wuhan, wakilin WHO Gudden Galleya ya lura cewa yayin da "ba shawarar WHO ba ce", amma "lambar da ke da matukar muhimmanci ga bin dokar hana yaduwar cutar a inda ta fi karkata", kuma ya bayyana ta a matsayin "marasa misaltuwa a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan tabbatar da yaduwar mutum zuwa mutum a wajen China, da kuma karuwar adadin masu kamuwa da cutar a wasu kasashe, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a da ke da muhimmanci a duniya (PHEC), lamarin na shida na gaggawa a kiwon lafiyar jama'a tun lokacin da aka fara gudanar da wannan bincike a shekarar 2009.
Darakta Janar na WHO ya ce, an dauki annobar a matsayin gaggawa ta lafiyar jama'a a duniya saboda "hadarin yaduwar ta a duniya, musamman a ƙasashe masu karancin kuɗi da matsakaitan kuɗi waɗanda ba su da tsarin kiwon lafiya mai ƙarfi.
Da yake mayar da martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya ce "babu wani dalili da zai sa a dauki matakan da ba dole ba ne su sabawa tafiye-tafiye da cinikayya ta kasa da kasa" kuma "Kungiyar Lafiya ta Duniya ba ta ba da shawarar rage kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 ga asusun dabarun da aka shirya a ƙasashe masu ƙarancin kuɗi, inda ta nuna gaggawa ga tallafa wa ƙasashen da "ba su da tsarin gano mutanen da ke da cutar, ko da ta bayyana".
Tedros ya kuma yi jawabai inda ya bayyana cewa "an auna ƙarfinmu ne ta hanyar ƙarfin wanda ya fi rauni a cikinmu" kuma ya bukaci al'ummar duniya da su "saka hannun jari a yau ko kuma su biya babbar farashin daga baya". A ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya, a wani taron manema labarai, ta sanya sunan cutar COVID-19.
A wannan ranar, Tedros ya ruwaito cewa Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da gabatar da "dukkanin tsarin Majalisar Dinkin Duniya a cikin martani".
Sakamakon haka, an kafa ƙungiyar kula da rikice-rikice ta Majalisar Dinkin Duniya, wanda ya ba da damar daidaita amsar Majalisar Dinkin Duniya gaba ɗaya, kuma zai ba da damar WHO "ta mai da hankali kan amsawar kiwon lafiya yayin da za a iya amfani da ƙwarewar sauran hukumomi don sanin tasirin zamantakewa, tattalin arziki, da ci gaba na barkewar cutar".
A ranar 14 ga Fabrairu, an kafa tawagar hadin gwiwa ta WHO tare da China don kawo masana na duniya da na WHO a kan farfajiyar kasar Sin don taimakawa wajen gudanar da gida da kuma kimanta "taurin cutar da yaduwar ta" ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin kasa, da kuma gudanar da ziyarar filin don kimanta "tasirin ayyukan mayar da martani a larduna da birane, gami da birane da karkara". A ranar 25 ga Fabrairu, WHO ta sanar da cewa "ya kamata duniya ta yi ƙarin shiri don yiwuwar barkewar cutar coronavirus", tana mai cewa tun da farko an bayyana ta a matsayin annoba, amma ya kamata ƙasashe su kasance "a cikin matakin kulawa".
Yayin da ake amsa yaduwar cutar a Iran, WHO ta aika da tawagar hadin gwiwa a can don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara kimanta barazanar cutar coronavirus a duniya daga "babba" zuwa "mai matukar tsananin tsananin", wanda shine mafi girman matakin da take da shi na gargadi da kimanta hadari.
Mike Ryan, babban daraktan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin cewa "wannan gwaji ne na gaske ga kowace gwamnati a duniya: saboda haka dole ne mu kasance a shirye.
Wannan cuta na iya zuwa kuma ya kamata ku kasance a shirye don hakan", ya bukaci a dauki matakan da suka dace da za su iya taimakawa duniya ta guji "mafi muni".
Ryan ya kuma ce bayanan da ake da su yanzu ba su ba da hujjar cewa jami'an kiwon lafiyar jama'a su ayyana cutar a matsayin annoba ta duniya ba, yana mai cewa irin wannan sanarwar na nufin "mun amince da cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana annobar korona a matsayin annoba.
Darakta Janar ya ce WHO "tana da matukar damuwa game da matakan yaduwar cutar da kuma tsananin cutar, da kuma matakan rashin kulawa". WHO ta fuskanci sukar matuka game da abin da ake ganin rashin magance cutar, ciki har da jinkirin sanar da dokar ta baci ta kiwon lafiya, da kuma rarraba cutar a matsayin annoba.
Amsar ta hada da takardar neman murabus daga mukamin daraktan WHO Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a kai, a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, masana 'yancin bil'adama da dama a Majalisar Dinkin Duniya sun tabbatar da girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun taimakon da zai ceci ransa kuma gwamnati ce ke da wannan hakkin.
Ƙungiyar ta nanata cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama hujja don nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, 'yan tsiraru, tsofaffi, marasa gida, marasa gida, waɗanda ke rayuwa cikin mawuyacin yanayi, da waɗanda ke tsare, da kuma 'yan gudun hijira da sauran rukunin da ba a bayyana su ba da suke bukatar tallafin gwamnati.
Ƙungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewa na rikicin COVID-19.
Kungiyar Tattalin Arziki ta kafa wani dandamali na samar da cikakken bayani a kan lokacin da ya dace game da martanin manufofin kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofin inganta tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kulle-kulle da takunkumin tafiye-tafiye, jigon dijital ya haɗa da kayan aikin bin diddigin manufofin ƙasa, kuma an yi niyyar taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya don magance cutar coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan ofishin Firayim Minista na Burtaniya Michael Goff, da Edward Bolsonaro dan shugaban Brazil Jair Bolsonaro game da yadda suka magance annobar, wacce ta fara a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) a bangarori daban-daban saboda yadda suka bi da kokarin killace mutane a tsakiyar kasar, a wani bangare na nuna rashin jin dadin yadda hukumomin siyasa ke amsa annobar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar su Zhao Lijian, sun ki amincewa da cewa annobar ta fara ne a birnin Wuhan, suna goyon bayan ka'idodin makircin da Amurka ko Italiya ke da shi game da cutar COVID-19.
Gwamnatin Donald Trump ta Amurka ta kira kwayar cutar korona "kwayar cutar Sin" ko "kwayar Wuhan", tana mai cewa, China ta "sanya dokar hana fitar labarai da ta sa cutar ta kara muni, wanda yanzu ya zama annoba ta duniya", wanda wasu masu sukar suka soki saboda wariyar launin fata "kuma ya karkatar da [hankali] daga gazawar gwamnatinsa wajen shawo kan cutar".
Daily Beast ta samu wani sakon waya daga gwamnatin Amurka da ke nuna tsarin sadarwa daga majiyoyin da ke cikin majalisar tsaron kasa, tare da bayanin da ke cewa "dukkanin ya shafi kasar Sin.
An nemi mu yi kokarin yada wadannan sakonni ta kowace hanya, ciki har da taron manema labarai da kuma fitowar talabijin. "Wasu kafofin watsa labarai kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin wani yunkurin da nake yi na yin tasiri a duniya.
Jami'in harkokin wajen Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa na geopolitical wanda ya hada da gwagwarmayar tasiri ta hanyar yin amfani da karkatacciyar manufa da kuma siyasa".
Borrell ya kuma ce, "Sin tana tura saƙo da ƙarfi cewa, ba kamar Amurka ba, tana da alaƙa mai kyau da abin dogara".
China ta kuma bukaci Amurka ta dage takunkumin da ta kafa kan Syria da Venezuela da kuma Iran, yayin da ake cewa tana tura taimakon agaji ga kasashen biyu na karshe.
Takunkumin Amurka ya hana Jack Ma ba da gudummawar masks 100,000 ga Cuba a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da tura taimakon da aka tura wa wasu kasashe zuwa kasarsu.
An kuma samu rigima game da abin rufe fuska a wasu ƙasashe, kamar Jamus, Austria, Switzerland, Czech Republic, da Italiya.
Bugu da ƙari, Turkiyya ta kwace ɗarurruwan na'urorin numfashi na roba da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kan Tarayyar Turai da Italiya da cutar korona ta shafa.
Mauritsu Massari, jakadan Italiya a Tarayyar Turai ya ce, "China ce ta amsa a matakin biyu kawai.
Hakika, wannan ba alama ce mai kyau ba ga haɗin kan Turai".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su aika da jami'an agaji, motocin tsabtace jiki na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta nakalto wani "babban jami'in siyasa" da ba a bayyana sunansa ba cewa kashi 80 cikin 100 na taimakon Rasha "ba shi da amfani ko kuma bai yi amfani da shi sosai ba ga Italiya".
Majiyar ta zargi Rasha da kaddamar da wani harin siyasa da diplomasiyya.
Shugaban Lombardy, Atilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahoton manema labarai kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin ruwa mai dauke da kayan kiwon lafiya zuwa Amurka.
Mai magana da yawun Kremlin Dmitry Peskov ya ce "a wajen ba da taimako ga takwarorinsa na Amurka, [Butin] yana tunanin cewa lokacin da kamfanonin samar da kayan aikin likitanci na Amurka suka sake aiki, su ma za su iya mayar da alheri idan ya zama dole".
Za a gudanar da atisayen sojin NATO na "Gun 2020" a Jamus, Poland, da kuma ƙasashen Baltic, wanda shi ne mafi girma a cikin ayyukan soji da NATO za ta gudanar tun ƙarshen Yakin Cacar.
Babban sakataren kamfen din na kawar da makaman nukiliya Kate Hudson ya soki atisayen bindigogi na 2020 yana cewa: "A cikin rikicin kiwon lafiyar jama'a na yanzu, atisayen ba wai kawai suna sanya rayukan dakarun Amurka da na kasashen Turai da dama da ke shiga cikin hadari ba amma har da al'ummomin kasashen da za a gudanar da su". Gwamnatin Iran ta sha wahala sosai daga cutar, inda kusan 'yan majalisa ashirin da wasu tsoffin' yan siyasa goma sha biyar suka kamu da cutar.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya a ranar 14 ga Maris, 2020, yana neman taimako, yana mai cewa kasarsa tana fama da cutar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka da aka sanya wa Iran. Barnar ta haifar da kira ga Amurka da ta amince da manufofin zamantakewar da suka zama ruwan dare a wasu ƙasashe masu arziki, ciki har da kiwon lafiya na kowa, kula da yara, izinin iyali da aka biya, da kuma matakan mafi girma na kudaden kiwon lafiya.
Masu sharhi na siyasa sun yi hasashen cewa hakan na iya shafar damar Donald Trump na sake zabarsa a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare saboda annobar.
Koriya ta Kudu ta soki "ƙoƙarin keɓewar kai da rashin fahimta" na Japan bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi a wasu wuraren gwamnati na tsawon makonni biyu.
Da farko dai al'ummar Koriya ta Kudu sun nuna rashin amincewa da yadda shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a cire Moon saboda zargin da suka yi cewa gwamnati ta yi rashin kulawa da barkewar cutar ko kuma sun yaba da yadda ta amsa. Cutar ta ba da izinin ƙasashe su zartar da dokokin gaggawa yayin amsawa.
Wasu masu sharhi sun nuna fargabar cewa hakan na iya bai wa gwamnatoci damar karfafa ikon su.
A Hungary, majalisar dokoki ta kada kuri'ar barin Firayim Minista, Viktor Orban, ya yi mulki ta hanyar doka har abada, dakatar da majalisar da kuma zaben, da kuma hukunta wadanda suka yada bayanan karya game da cutar da kuma yadda gwamnati ke magance matsalar.
An zargi barkewar cutar ta corona da ta haifar da karancin kayayyaki da dama saboda karuwar amfani da kayan aiki a duniya don magance barkewar cutar, sayayya da fargaba, da kuma katse masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin kiwon lafiya saboda karuwar bukatar masu amfani da su da kuma katsewar masu samar da kayayyaki.
Yankunan da dama kuma sun ga sayayya da ke haifar da fargaba, wanda ya sa aka rasa kayayyakin masarufi kamar abinci, takardar wanka, da kwalaben ruwa, wanda hakan ya haifar da karancin kayayyaki.
Masana fasaha musamman sun yi gargadin jinkirin jigilar kayayyakin lantarki.
A cewar Darakta Janar na WHO Tedros Adhanom, bukatar kayan kariya ta mutum zai ninka sau 100.
Wannan bukatar ta sa farashin ya karu har sau ashirin fiye da na al'ada kuma ta sa a jinkirta samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Har ila yau, ya haifar da karancin kayan kariya na mutum a duniya, tare da WHO ta yi gargadin cewa hakan zai sanya ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen kayayyaki na Diego su sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin madara a wasu manyan kantuna kuma daga baya gwamnatin Australiya ta hana shi. Duk da yaduwar COVID-19 a arewacin Italiya da yankin Wuhan, da kuma saurin bukatar kayayyakin abinci, yankunan biyu sun tsira daga tsananin karancin abinci.
Matakan da China da Italiya suka ɗauka don magance ajiyar kayayyakin ƙwayoyin cuta da kuma cinikin su ba bisa ka'ida ba sun yi nasara wajen kauce wa tsananin karancin abinci da ake tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya, da yawan amfanin gona, ba ta ga raguwa sosai ba, amma farashin zai iya tashi bisa ga tsammanin wakilan masana'antu.
Shagon abinci sun kasance a banza na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin China suka saki naman alade don tabbatar da cewa jama'a suna da isasshen abinci.
A Italiya, akwai irin wannan doka da ta bukaci masu samar da abinci su ajiye kayan abinci domin irin wannan gaggawa.
China ta ji asarar da tattalin arzikin duniya ya yi: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya yi rauni sosai a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka na rage yaduwar cutar, kuma tallace-tallace na sayar da kayayyaki ya ragu da kashi 20.5%.
Tun da babban yankin kasar Sin babban cibiyar tattalin arziki da masana'antu ne, an lura cewa barkewar cutar ta zama babbar barazana ga zaman lafiyar tattalin arzikin duniya.
Agatha Demaris na hukumar bincike ta tattalin arziki ta ce kasuwannin za su ci gaba da zama masu saurin tashi har sai an ga sakamakon da za a iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arziki na annobar a kan ci gaban duniya na iya wuce abin da ya faru sakamakon barkewar cutar SARS tsakanin 2002 da 2004.
Wani masani a Jami'ar Washington da ke St. Louis ya kimanta cewa, tasirin da aka yi wa sarkar samar da kayayyaki a duniya ya kai dala biliyan 300, wanda zai iya ci gaba har tsawon shekaru biyu.
Rahotanni sun ce kungiyar kasashen da ke fitar da man fetur ta OPEC ta samu "taɓawa" bayan faduwar farashin mai saboda karancin bukatar da ake samu daga China.
Kasuwannin hannun jari na duniya sun yi kasa a ranar 24 ga watan Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a kasashen waje.
A ranar 27 ga Fabrairu, saboda karuwar fargabar barkewar cutar coronavirus, yawancin alamun hannun jari na Amurka, ciki har da Nasdaq-100, Standard & Poor's 500, da Dow Jones Industrial Average sun yi raguwa mafi girma tun shekara ta 2008, tare da raguwar Dow da maki 1,191, mafi girma a rana guda tun bayan rikicin kuɗi a 2007-08.
Ƙididdigar uku sun ƙare mako da raguwa fiye da kashi goma.
A ranar 28 ga watan Fabrairu, kamfanin Scop Ratings GmbH ya tabbatar da darajar bashi na kasar Sin, amma ya ci gaba da kasancewa mai mummunan fata.
Hannun jari sun sake faduwa saboda fargabar cutar korona, mafi girma a ranar 16 ga watan Maris.
Mutane da yawa sun gaskata cewa tattalin arziki zai koma baya.
Masanin tattalin arziki Mohammed Al-Arian ya yaba da matakan gaggawa da manyan bankuna da jihohi ke dauka a kan lokaci.
Bankunan tsakiya sun amsa da sauri fiye da yadda suka yi a lokacin da aka yi tattalin arzikin duniya a shekara ta 2008.
Yawon shakatawa na ɗaya daga cikin fannonin da suka fi fuskantar matsalar ta hanyar hana tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren jan hankali, da kuma gargadin tafiye-tafiye na gwamnatoci a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da dama sun soke zirga-zirgar su saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Kantus, yayin da kamfanin jiragen sama na yankin Birtaniya, Flybe ya fadi.
Tasirin da ya yi wa masana'antar jiragen ruwa ya kai matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da yawa.
Cutar ta yi daidai da lokacin tafiya a lokacin bikin bazara da aka sani da Chunyun, babban lokacin tafiya da ke da alaƙa da hutun Sabuwar Shekarar Sin.
Gwamnatocin ƙasa da na yanki sun soke ayyuka da yawa da ke tattare da taron jama'a, gami da bikin Sabuwar Shekara, tare da kamfanoni masu zaman kansu suna rufe shagunan su da wuraren jan hankali kamar Disneyland Hong Kong da Disneyland Shanghai.
An rufe ayyukan Sabuwar Shekara da wuraren shakatawa da yawa don hana manyan tarurruka, ciki har da birnin haram na Beijing da kuma wuraren baje kolin haikalin gargajiya.
A larduna 24 daga cikin 31 da kuma garuruwa da yankuna a kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara har zuwa 10 ga watan Fabrairu, kuma sun ba da umarni ga yawancin wuraren aiki da kada su sake buɗewa har zuwa wannan kwanan wata.
Wadannan yankuna suna wakiltar kashi 80 cikin 100 na GDP na kasar da kuma kashi 90 cikin 100 na fitar da kayayyaki.
Hong Kong ta ɗaga matakin amsa cututtukan cututtuka zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris kuma ta soke bikin Sabuwar Shekara. An shafi sashen sayar da kayayyaki a duniya ta hanyar rage lokutan aiki a shaguna ko rufewar wucin gadi.
Ziyarar 'yan kasuwa a Turai da Latin Amurka ta ragu da kashi 40 cikin dari.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar kashi 50 zuwa 60 cikin ɗari.
Wannan kuma ya haifar da raguwar zirga-zirgar mutane zuwa cibiyoyin cin kasuwa tsakanin kashi 33 zuwa 43 cikin dari a watan Maris idan aka kwatanta da watan Fabrairu.
Masu sarrafa manyan kantuna a duniya sun aiwatar da ƙarin matakai, kamar ƙara tsabta, shigar da na'urorin duba zafin jiki na masu siye, da soke ayyuka. A cewar kimantawa na Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan annobar na iya barin mutane tsakanin miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda za su sha wahala ba tare da annobar ba.
A watan Janairu da Fabrairu na shekarar 2020, lokacin da annobar ta yi zafi a birnin Wuhan, mutane kusan miliyan biyar a kasar Sin suka rasa ayyukansu.
Yawancin ma'aikatan karkara na kasar Sin masu zuwa gida kusan miliyan 300 suna cikin gidajensu a lardunan cikin gida, ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar ta Corona za ta iya janyo asarar ayyuka miliyan 47 a Amurka, kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar da bankin Reserve na St. Louis ya yi. A Indiya, kulle-kullen ya bar dubun-dubatar bakin haure na Indiya (waɗanda ke samun albashi ta hanyar albashi na yau da kullun) ba su da aiki. Binciken da Cibiyar Angus Reed ta gudanar ya gano cewa kashi 44% na iyalai na Kanada sun sha wahala daga wani nau'in rashin aikin yi.
A rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi taimakon rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na gaba daya. Kusan kamfanoni miliyan biyu a Jamus sun tura ma'aikatansu cikin shirye-shiryen aiki na gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbet.
Faransa da Ingila sun amince da tsarin biyan diyya na ɗan lokaci na Jamus.
Yaduwar cutar ta shafi bangaren wasan kwaikwayo da al'adun gargajiya, wanda ya shafi ayyukan kungiyoyi da kuma mutane masu zaman kansu a duniya.
Cibiyoyin fasaha da al'adu sun nemi tallafawa aikinsu (yawanci ana tallafawa da gwamnati) don samar da damar zuwa al'adun al'umma, kiyaye lafiyar ma'aikatansu da jama'a, da kuma tallafawa masu zane-zane kamar yadda zai yiwu.
A watan Maris na shekarar 2020, a duk faɗin duniya, a matakai dabam dabam, gidajen tarihi, ɗakunan karatu, wuraren nunawa, da sauran cibiyoyin al'adu sun rufe har abada tare da soke ko jinkirta nune-nunen su, abubuwan da suka faru, da kuma nuna su.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Sauran abubuwan da suka faru na kwanan nan na cutar sun haɗa da soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa na kiɗa da kide-kide, taron fasaha, da nunin tufafi.
Har ila yau, masana'antar fim ta yi taɓarɓarewa. Vatican ta sanar da soke bikin Makon Mai Tsarki a Roma, wanda ke faruwa a makon ƙarshe na lokacin tuba na Kirista a cikin Lent.
Yawancin majami'u na Kirista sun ba da shawarar tsofaffi su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun sanya sabis na coci a kan rediyo, ko kuma watsa shirye-shiryen kai tsaye ta yanar gizo ko talabijin yayin da wasu ke ba da bauta ba tare da barin motocinsu ba.
Tare da Diocese na Roman Katolika na Roma rufe majami'u da masallaci, da kuma kwance filin St. Peter daga masu aikin hajji na Kirista, sauran hukumomin addini sun soke ayyuka da iyakance taron jama'a a majami'u, masallatai, majami'u, majami'u, da gurduras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa sannan ta rufe wuraren ibadar, yayin da Saudi Arabiya ta hana baƙi da mazauna wajen zuwa wuraren ibadar a Makka da Madina.
Wannan annoba ta kawo babbar matsala a tsarin lissafi na duniya tun lokacin yakin duniya na biyu.
An soke ko kuma dage yawancin manyan wasannin wasanni, gami da 2019-20 Champions League, 2019-20 Premier League, 2020 Europa League, 2019-20 NBA, da kuma 2019-20 National Hockey League.
Cutar ta kawo cikas ga shirin gasar Olympics ta 2020 da aka shirya fara a karshen watan Yuli, kuma kwamitin wasannin Olympic na duniya ya sanar a ranar 24 ga watan Maris cewa za a "sake tsara gasar zuwa bayan shekarar 2020 amma ba a baya ba lokacin bazara na 2021".
Wannan ya haifar da yawancin masu caca zuwa caca ta kan layi, inda yawancin rukunin caca na kan layi suka ba da rahoton ƙaruwa mai yawa a cikin sabbin rajista. Har ila yau, masana'antar nishaɗi ta sha wahala, inda aka dakatar da ƙungiyoyi daban-daban ko kuma soke rangadin kide-kide.
Manyan gidajen wasan kwaikwayo kamar su na Broadway sun dakatar da duk wani wasan kwaikwayon.
Wasu masu zane-zane sun gano hanyoyin da za su ci gaba da samar da aikin su kuma raba shi ta hanyar yanar gizo a matsayin madadin wasan kwaikwayon gargajiya, kamar wasan kwaikwayon raye-raye ko ƙirƙirar "hutu" ta yanar gizo don masu zane-zane su yi aiki, rarraba su da kuma buga su.
An yi wasu abubuwan ban dariya game da cutar korona a yanar gizo, inda mutane da yawa suka juya zuwa abin dariya da nishaɗi a cikin rashin tabbas.
Tun barkewar COVID-19, an lura da tsattsauran ra'ayi, ƙiyayya da wariyar launin fata ga mutanen da suke da asalin Sin da Asiya ta Gabas, da kuma mutanen da ke da ciwon kai a Turai, Amurka da wasu ƙasashe.
An lura da aukuwar tsoro, shakka da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da yankin Asiya da Fasifik.
Rahotanni da aka fitar a watan Fabrairu (lokacin da aka tsare mafi yawan masu cutar a China) sun nuna wariyar launin fata da kungiyoyi daban-daban a duniya suka nuna wa Sinawa cewa sun cancanci cutar ko kuma suna karbar abin da ake ganin ya cancanci hukunci.
An kuma ga ƙiyayya da Sin a wasu ƙasashen Afirka.
Mazauna Wuhan da Hubei da yawa sun ba da rahoton nuna bambanci saboda asalin yankin su.
Akwai tallafi ga Sinawa a kan layi da wajen layi, da kuma waɗanda suke zaune a yankunan da cutar ta shafa.
Bayan barkewar sabon yanayin zafi, mutane daga Italiya, ƙasar Turai ta farko da ta fara fuskantar mummunan barkewar COVID-19, na iya fuskantar shakku da ƙiyayya ga baƙi. 'Yan ƙasa a ƙasashe ciki har da Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takardun hana shiga na Sinawa a ƙoƙarin dakatar da cutar.
A Japan, #ChineseDontComeToJapan yana fitowa a shafin Twitter.
Sinanci da kuma wasu mutanen Asiya a Birtaniya da kuma Amurka sun ba da rahoton karuwar cin zarafin launin fata, da kuma cin zarafi.
An soki shugaban Amurka Donald Trump saboda kiran cutar korona "ta kasar Sin", kalmar da masu sukar suka yi la'akari da wariyar launin fata da kuma rashin son Sinawa.
Masu zanga-zanga a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da' yan kasashen waje da ake kwashewa daga Wuhan zuwa Novi Sanzari.
Dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya, sun fuskanci tsangwama saboda barkewar cutar korona.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal, Dilip Ghosh ya ce Sinawa sun lalata yanayi kuma "saboda haka Allah ya rama musu".
Daga baya ofishin jakadancin China a Kolkata ya la'anci wannan furucin, yana mai cewa "ba daidai ba ne". A China, annobar ta haifar da ƙiyayya da wariyar launin fata ga mazauna ƙasar da ba Sinawa ba, inda aka kira baƙi "ƙazamar ƙasashen waje" kuma aka yi niyya "a kawar da su".
Jaridu da dama sun cire wasu ko kuma duk shafukan da suka biya domin yin bayani game da cutar korona.
Masu wallafa littattafan kimiyya da dama sun ba da takardun kimiyya game da annobar a bude.
Wasu masana kimiyya sun zaɓi su raba sakamakon su da sauri a kan sabobin da aka riga aka buga kamar bioRxiv.
Sau da yawa cututtuka masu saurin kamuwa da cuta  cututtuka masu saurin kamuwa da cuta, suna da sabon salo, ko kuma hanyar watsa su.
Duniya da Cututtuka  Bayani game da duniya da kuma yaduwar cuta
Jerin annoba da annoba  Jerin mutuwar cututtukan da ke haddasa cututtuka
Cinikin namun daji da cututtukan dabbobin da suka samo asali  Haɗarin kiwon lafiya da ke tattare da cinikin namun daji
Gwajin gwaji na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 sun haɗa da hanyoyin gano cutar inda za a gane kwayoyin cutar da ke haifar da amsa ga kamuwa da cuta.
RT-PCR tana tabbatar da cewa akwai ƙwayoyin cuta a cikin samfur, inda DNA mai ƙwayoyin cuta ke gano kwayar cutar korona.
Wannan gwajin yana da kyau kuma an tsara shi ne don gano SARS-CoV-2 ribosomal DNA.
Ana amfani da shi don tabbatar da sabon ko kuma na aiki.
Ana amfani da binciken ƙwayoyin cuta (vascular) don ganewar asali da kuma lura da al'umma.
Gwajin rigakafin yana nuna yawan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Za a iya sanin ainihin adadin mutuwar da kuma yawan garkuwar jiki a cikin jama'a bisa ga sakamakon wannan gwajin.
Saboda iyakancewar gwaji, babu wata ƙasa da ke da ingantaccen bayanai game da yaduwar cutar a cikin al'ummarta a watan Maris na shekarar 2020.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambanci sosai a yawan gwajin da ƙasashe daban-daban suka yi.
Wannan bambancin zai iya shafar yawan mutuwar da ake bayar da rahoto, wanda a wasu ƙasashe za a iya yin ƙari sosai.
Ana iya yin amfani da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Sakamakon yana samuwa cikin sa'o'i kadan zuwa kwana biyu.
RT-PCR da ake yi ta yin amfani da allurar hanci, ba ya dogara sai a makon farko na rashin lafiya.
Bayan haka, ƙwayoyin cuta za su iya ɓace daga cikin makogwaro yayin da suke ci gaba da yin yawa a cikin huhu.
Ga waɗanda suka kamu da cutar da ake gwadawa a mako na biyu, za a iya ɗaukar samfurin daga cikin hanyoyin numfashi ta hanyar tsotsa ko kuma yin amfani da kayan tari (plum).
An kirkiro gwajin PCR na farko a Charité a Berlin a watan Janairun 2020 ta amfani da kwayar cutar ta RT-PCR, kuma ya zama tushen kayan gwajin 250,000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Har ila yau, Burtaniya ta haɓaka gwaji a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya kirkiro na'urar gano kwayar cutar SARS-CoV-2 mai aminci (PowerChek Coronavirus) don amfanin asibiti kuma ya dogara da PCR a ranar 28 ga Janairu, 2020.
Ana neman kwayar "E" da ke tattare da dukkanin kwayar cutar SARS-CoV-2 beta da kuma RdRp. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Samfuran Kiwon Lafiya ta China don yin amfani da kayan bincike na SARS-CoV-2 bisa PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) suna rarraba allon ganewar asali na COVID-19 (COVID-2019) na kansa wanda ya dogara da RT-PCR na gaggawa a dakunan gwaje-gwaje na kiwon lafiya ta hanyar Hukumar Kula da Abubuwan Guda ta Duniya.
Ɗaya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin kayan aikin gwajin ya haifar da sakamako mara kyau saboda ƙwayoyin cuta masu lalacewa, kuma an jinkirta wani matakin gwaji a CDC a Atlanta; wannan ya haifar da gwajin ƙasa da samfuran 100 a kowace rana a matsakaita don kammala nasarar duk watan Fabrairu na 2020.
Gwaje-gwaje masu amfani da sinadarai biyu ba su da tabbaci har zuwa 28 ga Fabrairu, 2020, kuma har zuwa lokacin ba a ba da izinin gwaje-gwaje na gwamnati da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a iya yin gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Hakazalika, Quest Diagnostics ya ba da damar gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu wani ƙuntatawa na yawa da aka sanar; dole ne a cire da kuma sarrafa samfurori bisa ga bukatun CDC.
A Rasha, Cibiyar Bincike kan Kwayoyin Cutar cuta da Fasaha ta halitta ta kirkiro gwajin COVID-19 mai suna Victor.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta haɓaka gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Rosh Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a kan adadi mai yawa, yana ba da damar na'ura ɗaya ta yi kusan gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Labs don yin gwaji akan tsarin Abbott m2000; FDA ta ba da izini iri ɗaya ga Hologic, Lab Corp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Civied ta sami izinin amfani da gaggawa iri ɗaya daga Hukumar Abinci da Magunguna don gwajin da ke ɗaukar kimanin minti 45.
Hukumar Abinci da Magunguna ta amince da gwajin da ke amfani da fasahar kara girman DNA maimakon PCR.
Tun da wannan ba ya bukatar jerin zagayen zafin jiki, wannan hanyar za ta iya nuna sakamako mai kyau cikin ƙasa da minti biyar da kuma sakamako mara kyau cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka kuma Abbott yana sa ran kara masana'antu don yin gwaje-gwaje 50,000 a kowace rana. Taiwan tana kuma haɓaka gwajin da ke amfani da kwayar cutar ta atomatik wacce ke da alaƙa ta musamman da furotin na kwayar cutar (Protein N) na sabon kwayar cutar korona, da fatan za ta iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin hanzari na mura.
Wani bita na nazarin da aka yi a watan Maris na shekarar 2020 ya kammala da cewa "hotunan kirji ba su da ƙimar ganewar asali a farkon, yayin da sakamakon CT [computed tomography] na iya bayyana ko da kafin bayyanar cututtuka".
Abubuwan da aka saba gani a CT sun haɗa da hatimin gilashin da aka yi da bangarorin biyu masu yawa tare da rarraba kewayon da ba daidai ba da kuma baya.
Ana samun ɓarna a ƙarƙashin fuska, kuma a kan samu ɓarna da ke ƙara tsanani yayin da cutar take ci gaba.
Wani bincike a birnin Wuhan da ya kwatanta PCR da CT dangane da asalin annobar ya nuna cewa CT ya fi PCR saukin ganewa, ko da yake ba shi da cikakken bayani, tare da halayen hoto da yawa da ke tsoma baki tare da cututtukan huhu da sauran cututtuka.
A watan Maris na 2020, Kwalejin Radiography ta Amurka ta ba da shawarar "kar a yi amfani da CT don gano COVID-19 ko a ɗauka azaman gwajin farko don gano cutar". A watan Maris na 2020, CDC ta ba da shawarar yin amfani da PCR don gwajin farko.
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta ya ƙunshi samar da ƙwayoyin cuta, ciki har da IgM da IgG.
Ana iya amfani da su wajen gano kamuwa da mutane a cikin kwanaki 7 ko bayan bayyanar cututtuka, don tantance rigakafi, da kuma idan aka yi wa jama'a sa ido. Ana iya yin bincike a cibiyar bincike ta tsakiya (CLT) ko ta hanyar gwajin asibiti (POCT).
Tsarin sarrafa abubuwa mai kyau a yawancin dakunan gwaje-gwaje zai iya yin waɗannan bincike, amma yadda za a iya yin hakan zai dangana ne a kan yadda tsarin yake aiki.
A cikin lab na tsakiya, ana amfani da kwayar jini guda ɗaya, ko da yake ana iya amfani da wasu a jere don a lura da yadda jikin mutum yake amsa.
Don gwajin asibiti, ana yawan samun jini guda ta hanyar hudawa a cikin fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar yin matakin cirewa kafin a yi gwajin. A ranar 26 ga Maris, 2020, FDA ta gano cibiyoyi 29 da suka ba da sanarwar ga hukumar bisa ga buƙatu kuma saboda haka waɗannan cibiyoyin za su iya rarraba abin da suke da gwajin antibody.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, wanda zai iya gano IgG da IgA a cikin samfuran jini.
Wannan gwajin yana ɗaukan ɗarurruwan samfurori cikin sa'o'i kaɗan, kuma yana da sauri fiye da na gargajiya na PCR don RNA.
Ana iya gano kwayoyin cutar bayan kwanaki 14 da kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa kayan gwajin kwayoyin cutar da ta saya ba su isa ba.
Hong Kong ta kafa wani shiri wanda a karkashinsa marasa lafiya da ake zargin sun kamu da cutar za su iya zama a gidajensu, "suna ba wa sashen gaggawa bututun samfurin marasa lafiya", su tofa a cikin bututun, kuma su sake dawowa don samun sakamakon gwajin bayan ɗan lokaci. Hukumar Kula da Lafiya ta Burtaniya ta sanar da cewa tana gwada shirin don gwada yanayin da ake zargin suna da cutar a gida, don haka ya kawar da haɗarin kamuwa da cuta daga waɗanda suka kamu da cutar lokacin da suka zo asibiti ko buƙatar kashe motar motar da ake amfani da ita. Lokacin da aka gwada COVID-19 don yanayin da ake zargin ba tare da barin motar ba, mai kula da lafiyar zai cire samfurin da aka ɗauka don kiyaye canjin da ya dace.
Cibiyoyin binciken motoci na Koriya ta Kudu sun ba da damar yin wasu gwaje-gwaje mafi sauri da cikakke a duniya. A Jamus, Ƙungiyar Likitocin Lafiya ta Kasa ta bayyana a ranar 2 ga Maris cewa sun gudanar da gwaje-gwaje kusan 12,000 a kowace rana ga marasa lafiya na waje kuma mutane 10,700 sun yi gwaji a makon da ya gabata.
In likita ya ba da umurni a yi gwajin, inshorar lafiya za ta biya kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwaji kusan 160,000 a mako.
A ranar 19 ga watan Maris an fara gwajin cutar a manyan birane da dama.
A ranar 26 ga Maris, 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, domin an sanar da sakamakon masu cutar ne kawai.
Wani binciken farko na dakin gwaje-gwaje ya bayyana cewa tun daga makon kalanda na 12/2020, an gwada samfurori 483,295 har zuwa karshen makon 12/2020, kuma 33,491 (6.9%) sun nuna cewa suna da cutar SARS-CoV-2. A Isra'ila, masu bincike a cikin cibiyar maganin rigakafi da asibitin Rambam sun kirkiro hanyar da za su bincika samfurori da aka karɓa daga marasa lafiya 64 a lokaci guda, kuma sun gwada wannan hanyar ta hanyar tattara samfurori, ba tare da yin ƙarin bincike ba sai lokacin da samfurin ya nuna cewa yana da kyau. A Wuhan, BGI ta buɗe wani dakin gwaje-gwaje na musamman don gano yanayin tashin hankali a cikin murabba'in mita 2000 tare da "Huo-Yan Eye" (Huo-Yan Fire) ko "Fire" a cikin Turanci, wanda zai iya bincika sama da 10,000 a cikin 2020 kuma ya ba da damar yin gwaji.
Tare da Wang Jian, wanda ya kafa BGI, yana kula da aikin gina kuma ya ɗauki kwanaki biyar, ƙirar ta nuna cewa a cikin Hubei, shari'o'in za su ƙaru da kashi 47% kuma farashin keɓewar da ke da alaƙa da hakan zai ninka idan ba a yi wannan gwajin ba.
Nan take Wuhan Lab ta kafa Huo-Yan Labs a Shenzhen, Tianjin, Beijing, Shanghai da kuma sauran birane 12 a duk fadin kasar Sin.
A ranar 4 ga Maris, 2020, jimlar yawan gwajin yau da kullun ya kai 50,000. Origami Assays ya fitar da buɗe tushen, ƙirar watsawa da yawa waɗanda zasu iya gwada har zuwa samfurin mai haƙuri 1,122 don gano COVID-19 ta amfani da gwaje-gwaje 93 kawai. Waɗannan ƙirar daidaitawa za a iya amfani da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa ruwa ba.
A watan Maris, karancin kayan bincike da rashin isassun su ya haifar da matsala yayin da ake gudanar da gwaje-gwaje da yawa a Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu masana suka binciki hanyoyin samar da samfurori da suka hada da dumama samfurori a 98 °C (208 °F) na tsawon minti 5 don gyara kwayar halittar RNA don gudanar da ƙarin gwaje-gwaje. A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa tana kan gaba a duniya dangane da yawan gwajin cutar coronavirus ga yawan jama'arta, kuma tana kan hanyar inganta matakin gwajin don isa ga yawancin jama'a.
Wannan ta hanyar haɗuwa da kunna ƙarfin gwajin cikin mota, da siyan dakin gwaje-gwaje mai yawan aiki mai girma daga Group 42 da BGI (bisa ga dakunan gwaje-gwajen gano gaggawa na "Huo-Yan" a China).
An kafa wannan dakin gwaje-gwaje cikin kwanaki 14, yana ba da damar yin dubun dubatan gwajin RT-PCR a kowace rana, kuma shi ne na farko a duniya da ya yi aiki a waje da China.
An kirkiro hanyoyin gwaji daban-daban da ke niyya ga bangarori daban-daban na kwayar cutar korona a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da shirin Jamus na kera kayayyakin da za a tura zuwa ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatun da za su ƙirƙiri nasu kayayyakin.
An sanar da shirin na Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka suka tsara ba ta kasance ba har zuwa 28 ga Janairu, wanda ya haifar da jinkirin gwajin da ake samu a Amurka. China da Amurka sun fuskanci matsaloli game da yadda za a iya amincewa da kayan aikin gwaji a farkon barkewar cutar, kuma waɗannan ƙasashe biyu da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙata da bin shawarwarin gwajin da masana kiwon lafiya suka bayar ba.
A maimakon haka, masana sun ce yawan gwajin da ake yi a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar.
Gwamnatin Koriya ta Kudu ta inganta gwajin gwaji a cikin dakunan gwaje-gwaje masu zaman kansu a tsawon shekaru.
A ranar 16 ga Maris, WHO ta yi kira ga a kara yawan shirye-shiryen gwaji a matsayin mafita mafi kyau don rage yaduwar cutar COVID-19. Karin bukatar gwaji sakamakon yaduwar cutar ya haifar da ɗaruruwan dubban gwaje-gwaje a dakunan gwaje-gwaje na Amurka, kuma ya rage wadatar allurar rigakafi da kayan bincike.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton cewa akwai matsaloli game da daidaito na kayan gwajin.
A Amurka, an sami "aibi" a cikin kayan gwajin da CDC ta kirkira; sannan gwamnati ta cire shingen da suka hana gwajin musamman. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Ltd na kasar Sin, amma ta gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya kasancewa saboda rashin samun samfurin ko kuma rashin amfani da kayan aikin yadda ya kamata.
Ma'aikatar Spain ta ce za ta janye sayan na'urorin da suka ba da sakamako mara kyau, kuma za ta maye gurbin su da wasu na'urorin gwaji daga Shenzhen Bioeasy. 80% na na'urorin gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi na'urorin gwaji miliyan 1.2 daga China waɗanda suka nuna cewa ba su da kyau.
Firayim Minista Matović ya ba da shawarar jefa su a cikin kogin Danube. Farfesa Ajat Kara na Ma'aikatar Lafiya ta Turkiyya ya ba da rahoton cewa kayan gwajin da Turkiyya ta saya daga China suna da "babban kuskuren kuskure" kuma an "hana amfani da su". Har ila yau, Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma a farkon Afrilu 2020 ta ayyana cewa ba su dace da amfani ba.
Gwaje-gwajen, da aka yi wa waɗanda suka kamu da cutar SARS-CoV-2 da kuma waɗanda suka yi wa masu cutar cuta, sun nuna cewa suna da cutar.
Masu bincike a birnin Fu na Italiya, inda aka samu mutuwar COVID-19 ta farko a Italiya, sun gwada dukan mazauna kusan 3,400 sau biyu, kuma sun ɗauki kusan kwanaki goma a kowane lokaci.
Kusan rabin mutanen da suka gwada ba su nuna alamun cutar ba, kuma an ware duk waɗanda aka gano.
Sakamakon hana zirga-zirga tsakanin garuruwa, an kawar da sabbin kamuwa da cuta.
Cutar cutar korona ta 2020 a Singapore ta ga raguwar yaduwar cutar idan aka kwatanta da sauran ƙasashe masu tasowa, amma ba tare da tsauraran takunkumi ba kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki; ta hanyar bin diddigin masu kamuwa da cutar da kuma takunkumin tafiye-tafiye na cikin gida, gwaji da keɓewa.
An soke ayyuka da yawa, kuma Singapore ta fara roƙon mutane su zauna a gidajensu a ranar 28 ga Maris, amma an sake buɗe makarantu a ranar 23 ga Maris a kan lokaci bayan hutun.
Wasu ƙasashe da dama sun kuma sarrafa wannan annobar ta hanyar bin diddigin masu yin magudi da kuma sanya takunkumin tafiye-tafiye na cikin gida da gwaji da keɓewa, amma tare da ƙuntatawa, kamar yadda aka yi a Iceland da Koriya ta Kudu.
Wani bincike ya nuna cewa ƙasashen da suka yi gwaje-gwaje da yawa, idan aka kwatanta da yawan mutuwar, suna da ƙananan mutuwar, wataƙila saboda waɗannan ƙasashe sun fi iya gano waɗanda ke da ƙananan alamun ko kuma ba su da alamun.
WHO ta ba da shawarar ƙasashe da ba su da ikon yin gwaji ko kuma waɗanda ke da ƙananan dakunan gwaje-gwaje na gida da ke da ƙarancin ƙwarewa game da COVID-19 su aika da gwaje-gwaje biyar na farko masu kyau da gwaje-gwaje goma na farko marasa kyau na COVID-19 zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 da WHO ta amince da su don tabbatar da gwajin.
Daga cikin dakunan gwaje-gwaje 16 da aka amince da su, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin wannan hoton, shafi na "Gaskiya a cikin kashi na gwaji" ya shafi manufar ƙasa wajen yin gwaji.
Kasar da ke gwada mutane da aka kwantar a asibiti za ta sami kashi kashi biyu cikin dari na masu kamuwa da cutar fiye da ƙasar da ke gwada dukan jama'arta, ko suna da alamun cutar ko babu, idan aka yi la'akari da sauran abubuwan.
Wanke hannu, wanda aka fi sani da tsabtace hannu, shine aikin wanke hannu don cire datti, kitse, kwayoyin cuta ko wasu abubuwa da ba'a so.
Wanke hannuwanka da sabulu a kai a kai a "lokacin da ya kamata" a rana yana hana yaduwar cututtuka da yawa, kamar su zawo da kuma cutar kwalara, waɗanda ke wucewa ta hanyar hanci da bayan baki.
Mutane kuma suna iya kamuwa da cututtukan numfashi kamar mura ko sanyi, alal misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci ko bakinsu (kamar mucous membranes).
Waɗannan lokatai biyar na rana da ya kamata a wanke hannu da sabulu suna da muhimmanci: kafin da bayan yin fitsari, bayan wanke jariri ko canja masa wanki, kafin a ciyar da jariri, kafin a ci abinci, kafin a shirya abinci ko kuma kafin a shawo kan nama, kifi, ko kaji.
Idan babu ruwa da sabulu, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin, lokacin da ake dafa abinci, da kuma bayan.
Kafin da kuma bayan kula da wani mai ciwo.
Bayan an canja wa yaro wando ko bayan an wanke shi bayan ya je gidan wanka.
Bayan ka wanke hancinka, ko ka yi tari, ko kuma ka yi tari.
Bayan ta taɓa dabbobi, ko abincin su, ko kuma shararsu.
Tsabtace hannu na asibiti na nufin ayyukan tsabtace jiki da suka shafi hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kulawar likita zai iya hana ko rage yaduwar cuta.
Babban manufar wanke hannu a likita shi ne tsabtace hannu daga abubuwan da ke haddasa cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da ke iya haddasa cuta) da kuma sunadarai da ke iya haddasa lahani ko cuta.
Wannan yana da muhimmanci musamman ga mutanen da suke aiki da abinci ko kuma waɗanda suke aiki a fannin kiwon lafiya, amma kuma yana da muhimmanci ga mutane.
Wanke hannu yana da fa'idodi da yawa ga lafiyar mutum, ciki har da rage yaduwar mura, kwayar cutar corona, da sauran cututtuka, hana cututtukan da ke haifar da zawo, da rage kamuwa da cututtukan numfashi.
Kuma rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Wani bincike da aka yi a shekarar 2013 ya nuna cewa ingantaccen wanke hannu na iya haifar da ɗan ci gaba a cikin tsayin yara 'yan kasa da shekara biyar.
A ƙasashe masu tasowa, ana iya rage mutuwar yara da ke da nasaba da cututtukan numfashi da kuma zawo ta hanyar yin canje-canje a halayyarsu, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage mutuwar mutane daga waɗannan cututtuka da kusan kashi hamsin.
Matakan da ke inganta wanke hannu na iya rage yawan saurin amai da kusan kashi ɗaya bisa uku, daidai da samar da ruwa mai tsafta a yankunan da ke da karancin kuɗi.
Kashi 48% na raguwar cututtukan zawo na iya danganta ga wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da mafi arha don hana zawo da cututtukan numfashi (AER) lokacin da aka aiwatar da halayyar kai tsaye a gidaje, makarantu da al'ummomi a duniya.
Ciwon huhu, wanda shi ne babban ciwon numfashi, shi ne sanadin mutuwa mafi girma a tsakanin yara 'yan ƙasa da shekara biyar, yana kashe kusan yara miliyan 1.8 a kowace shekara.
Diarrhea da ciwon huhu suna kashe yara kusan miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan amfani da bayan gida zai iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma aikin likita, rage mutuwar da ke faruwa saboda zawo da kusan rabi, da kuma mutuwar da ke faruwa saboda cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu da wasu matakan tsabtace jiki a matsayin wani ɓangare na shirye-shiryen ruwa, tsabtace jiki da kuma tsabtace jiki.
Wanke hannu yana kuma kāre mutum daga cutar ƙuda da ke yaɗuwa ta wurin taɓawa ta jiki.
Wanke hannu yana da wata illa mai sauƙi, wanke hannu sau da yawa zai iya lalata fata saboda bushewa.
Wani bincike na Denmark a shekarar 2012 ya nuna cewa yawan wanke hannu na iya haifar da yanayin fata na fure da itching da aka sani da eczema na hannu ko kuma cututtukan fata, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Ana kuma yawan ganin wanke hannu a matsayin wata alama ta OCD.
Akwai lokatai biyar na rana da wanke hannu da sabulu yake da muhimmanci wajen rage yaduwar cututtuka ta hanyar hanci: bayan wanka (shiga ciki, zubar da jini), bayan wanke bayan jariri (canja wanki), kafin ciyar da jariri, kafin cin abinci, kafin/bayan shirya abinci ko kuma bayan cin nama, kifi ko kaji.
Ya kamata a yi wanka a wasu lokatai domin a hana yaduwar cuta, kamar kafin ko bayan maganin wani yanki ko rauni, bayan yin tari ko tari ko bayan wanke hanci, bayan taɓawa ko sarrafa ɓarnar dabbobi, da bayan taɓawa shara.
A ƙasashe da yawa, ana rage yawan wanke hannu da sabulu.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa, a kan matsakaita, kashi 38.7% na iyalai suna wanke hannayensu da sabulu. Wani bincike da aka gudanar a shekarar 2014 ya nuna cewa Saudi Arabia ce ke da kashi 97 cikin dari na yawan wanke hannu, Amurka ta kai kashi 77 cikin dari, kuma China ce ke da kashi 23 cikin dari. Yanzu akwai hanyoyi da yawa na sauya halayya don kara amfana daga wanke hannu da sabulu a lokuta masu muhimmanci. Wanke hannu a kai a kai ga yara a makarantu a wasu lokutan rana yana daga cikin zaɓuɓɓukan da ake da su a ƙasashe masu tasowa don kafa al'adar wanke hannu a cikin halayen yara.
Shirin Kula da Lafiya na Farko da Ma'aikatar Ilimi ta Philippines ta yi misali ne na yin aiki mai yawa don inganta lafiyar yara da iliminsu.
Maganin tsutsotsi sau biyu a shekara, tare da wanke hannuwanka da sabulu kullum da kuma tsabtace haƙoranka da fluoride kullum, suna cikin muhimmancin wannan shirin na kasa.
An yi nasara a Indonesia.
Sa sabulu ko kayan wanki a cikin ruwa yana sa a kawar da ƙwayoyin cuta daga fata.
Babban tasirin sabulu da kayan tsabtace jiki shi ne rage shingen narkewa, da kuma ƙara narkewa.
Ruwa kaɗai ba shi da amfani wajen tsabtace fata domin kitse da kuma sunadarai, waɗanda abubuwa ne da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Duk da haka, iskar ruwa mai yawa tana taimakawa wajen tsarkakewa.
Sabulu mai ƙarfi, saboda yadda ake sake amfani da shi, yana iya ɗauke da ƙwayoyin cuta da aka samu daga amfani da su a dā.
Wasu 'yan nazarin da suka lura da yaduwar kwayoyin daga sabulu mai tsananin gurbatawa sun ce ba zai yiwu ba domin ana wanke kwayoyin da kumfa.
Cibiyar Kula da Cututtuka ta ci gaba da cewa "ya fi kyau a yi amfani da sabulu mai ruwa fiye da na'urorin da ba sa taɓawa".
An yi amfani da sabulu mai guba da kwayoyin cuta sosai ga masu amfani da lafiyarsu.
Har zuwa yanzu, babu wata shaida da ta nuna cewa ana amfani da maganin kashe ƙwayoyin cuta da aka ba da shawarar don kawar da kwayoyin da suka saba wa maganin a yanayi.
Duk da haka, sabulu mai hana ƙwayoyin cuta yana ɗauke da abubuwa masu guba kamar triclosan, wanda ba ya shafar ƙwayoyin cuta da yawa.
Saboda haka, idan sabulu mai hana ƙwayoyin cuta bai shafi ƙwayoyin cuta masu tsayayya da ƙwayoyin cuta ba, ba zai yi tasiri ba kamar yadda ake tallatawa.
Baya ga mai rage tashin hankali da kuma mai kare fata, abubuwan da aka tsara na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita acid, benzoic acid mai aiki mai guba da sauran kayan shafawa na fata (caviar, bitamin, menthol, tsire-tsire na shuka). Cikakken bincike da Jami'ar Oregon ta yi na Kwalejin Kiwon Lafiyar Jama'a ya nuna cewa sabulu na yau da kullun yana da tasiri kamar sabulu mai hana ƙwayoyin cuta na masu amfani da shi wanda ke ƙunshe da trichlorine wanda ke kawar da cututtuka da kuma kawar da ƙwayoyin cuta daga hannaye.
Ruwan zafi da ya dace don wanke hannu ba ya isa ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37°C).
Duk da haka, ruwan dumi da sabulu sun fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke riƙe ƙasa da ƙwayoyin cuta.
Akasin abin da mutane suke tunani, bincike ya nuna cewa ruwan dumi ba ya rage yawan ƙwayoyin cuta a hannu.
Mai tsabtace hannu abu ne da ba ya da ruwa da za a wanke hannaye da shi.
A ƙarshen shekarun 1990 da farkon karni na 21, masu tsabtace hannu na giya, waɗanda ba su da ruwa da kuma maganin shafawa ta hanyar shafawa (wanda kuma aka sani da mai tsabtace hannu mai maye gurbin giya, mai tsabtace hannu ko kuma mai tsabtace hannu) sun fara samun shahara.
Yawancin su suna dogara ne akan isopropyl alcohol ko ethanol wanda aka hada shi da wani mai kara kuzari kamar carbomer (polymer acrylic acid) a cikin gel, ko mai danshi kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da rage tasirin bushewar giya.
Ƙara hydrogen peroxide mai ragewa yana ƙara aikin rigakafin ƙwayoyin cuta. Wutar hannu da ke da kashi 60 zuwa 95 cikin ɗari na barasa tana kashe ƙwayoyin cuta sosai.
Maganin kashe ƙwayoyin cuta yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu yawa da ba sa shan magani (gold cluster bacteria da methicillin cluster bacteria da kuma fungicillin cluster bacteria), tarin fuka, wasu ƙwayoyin cuta (har da cutar HIV, herpes, respiratory myelovirus, nasal viruses, scurvy, flu, hepatitis), da fungi.
Tsabtace shan giya mai dauke da kashi 70% na barasa ta hanyar shafawa yana kashe kashi 99.97% (ragewar logarithm na 3.5, kamar ragewar decibel na 35) na kwayoyin cuta a hannu bayan dakika 30 da sanyawa da kuma kashi 99.99% zuwa 99.999% (ragewar logarithm na 4 zuwa 5) na kwayoyin cuta a hannu bayan minti 1 da sanyawa. Tsabtace hannu ya fi tasiri akan kwayoyin cuta kuma ya fi tasiri akan wasu ƙwayoyin cuta.
Maganin kashe hannu na barasa kusan ba shi da tasiri sosai a kan ƙwayoyin cuta na Norovirus (ko Norwalk), wanda shi ne sanadin yawan kamuwa da cututtukan ciki. Ya kamata a yi amfani da isasshen maganin kashe hannu ko kuma shafawa da giya don a yi wanka ko kuma a rufe hannu biyu.
Ka shafa gaba da baya na hannayenka da tsakanin dukkan yatsunsu da gefuna na kimanin dakika 30 har sai ruwan ya bushe, ko kumfa, ko gel.
Ƙungiyar da ke kula da cututtuka da kuma rigakafin cutar ta Amurka ta ba da shawarar a wanke hannu da maganin kashe ƙwayoyin cuta, musamman idan hannayen sun yi datti sosai.
Amfani da waɗannan masu tsabtace hannu yana ƙaruwa ne saboda sauƙin amfani da saurin aikinsu na kawar da ƙwayoyin cuta; duk da haka, bai kamata su zama madadin wanke hannu daidai ba sai dai idan ruwa da sabulu ba su da wadatar.
Yin amfani da maganin kashe wuka sau da yawa zai iya sa fata ta bushe sai dai idan an ƙara ruwan sama ko ruwan shafawa ko duka biyun.
Za a iya rage ko kawar da tasirin giya a kan bushewar fata ta ƙara glycerin ko wasu ruwan sama ko duka biyu a cikin abun.
Gwaje-gwaje sun nuna cewa maganin kashe ciwon hannu da ke ɗauke da ruwan sama yana sa fata ta yi sanyi da kuma bushewa fiye da sabulu ko kuma kayan tsabtace jiki.
Rare ne za a iya samun cututtukan fata masu saurin roƙo, da kuma rashin lafiyar hanta ko kuma rashin jin daɗi ga barasa ko kuma abubuwan da ake sakawa a cikin kayan wanke hannu.
Rage yiwuwar kamuwa da cututtukan fata masu saurin kai ya zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake masu tsabtace hannu da ba su da ruwa suna da kyau, ba sa kawar da abubuwa masu guba daga hannuwansu, amma suna kashe su ne kawai.
Saboda haka, maganin kashe cututtukan hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtuka, saboda masu cutar suna kan hannu.
Ingancin maganin hannu mai hana shan giya ya dogara ne da abubuwan da aka yi da kuma yadda aka yi shi, kuma a tarihi, ba ya da tasiri sosai fiye da wanda ke da barasa da ke amfani da barasa.
Kwanan nan, an nuna cewa abubuwan da ake amfani da su na amfani da benzalkonium chloride suna da tasiri mai yawa da kuma ci gaba da zama mai guba bayan amfani, ba kamar giya ba wanda aka nuna cewa yana da tasiri bayan amfani da yawa, mai yiwuwa saboda jinkirin halayen fata.
Mutane da yawa a ƙasashe masu ƙarancin kuɗi ba su iya sayan sabulu ba, kuma suna amfani da toka ko ƙasa maimakon.
Tashin toka ko turbaya na iya zama mai amfani fiye da ruwa kaɗai, amma ba zai iya zama mai amfani ba kamar sabulu.
Wani abin damuwa shi ne, idan gurɓataccen abu ya shiga cikin ƙasa ko toka, zai iya ƙara yaɗuwar cuta maimakon rage ta.
Ash kuma, kamar sabulu, yana da maganin kashe ƙwayoyin cuta domin yana samar da maganin alkaline idan ya haɗu da ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da toka ko yashi maimakon sabulu idan babu shi.
Tsarin wanke hannu daidai wanda Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cutar ya haɗa da waɗannan matakai:
Ka wanke hannunka da ruwan dumi ko ruwan sanyi.
Ana ba da shawarar yin amfani da ruwan da ke gudana domin ana iya gurɓata ɗakunan wanka da suke wanzuwa, kuma a lokaci guda, zafin ruwan ba ya nuna bambanci.
Ka yi kumfa a hannunka, ka shafa sabulu mai yawa, ka saka hannunka a baya, tsakanin yatsunka, da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai sa'ad da suke amfani da sabulu maimakon ruwa kawai.
Ka shafe akalla sakan 20.
Yana sa a yi ta gogewa, wanda ke kawar da ƙwayoyin cuta daga fata, kuma yana sa a yi ta gogewa na dogon lokaci don kawar da ƙwayoyin cuta.
Ka wanke sosai a ƙarƙashin ruwan da ke gudana.
Wanke hannu a cikin wanka zai iya sake gurɓata su.
Ka bushe da tawul mai tsabta ko kuma ka bar shi ya bushe a iska.
Hannun da suka yi sanyi kuma suka yi ruwa suna iya sake samun gurɓataccen abu. Sassan da aka fi mantawa da su su ne babban yatsan, wuyan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusa.
Na'urar ƙusa da kuma zanen ƙusa na iya ƙunsar ƙananan ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da ruwan shafawa don hana hannu bushewa, domin bushewar fata na iya lalata shi wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya samar da zaɓuɓɓuka masu tsada daban-daban don sauƙaƙe wanke hannu a ƙasashe masu tasowa, inda babu ruwan famfo, sabulu, ko duka biyun, kamar zubar da ruwa daga kwanon rufi mai rataye ko tare da ramuka masu dacewa da / ko amfani da toka idan ya cancanta. A wuraren da ke da iyakantaccen wadatar ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin daidaita amfani da ruwa, kamar "Tabi faucet" da sauran zaɓuɓɓuka masu arha.
Tappi na yin amfani da ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin
Yin bushe hannu da kyau wani muhimmin sashe ne na tsaftace hannu, amma akwai takaddama game da yadda za a yi bushewa a cikin gidajen wanka.
Bincike da yawa na nuna cewa tawul na takarda sun fi na lantarki da ke wanke hannu da ke cikin gidajen wanka da yawa lafiya.
A shekara ta 2008, Jami'ar Westminster a Landan ta gudanar da bincike, wanda aka gudanar a ƙarƙashin kulawar taron taron masana'antun takarda na Turai, don kwatanta matakan tsabta da takarda ke bayarwa, da masu bushe hannu masu dumi, da kuma na'urorin bushe hannu masu iska.
Bayan wanke hannu da bushewa da na'urar bushewa, an gano cewa adadin kwayoyin cuta sun ƙaru a kan yatsunsu da kashi 194 cikin ɗari kuma a kan wuyan hannu da kashi 254 cikin ɗari.
Drying da na'urar busar iska ya sa yawan kwayoyin cuta a yatsun hannu ya ƙaru da kashi 42 cikin ɗari, kuma a hannu ya ƙaru da kashi 15 cikin ɗari.
Bayan wanke hannu da bushewa da tawul, adadin kwayoyin cuta a kan yatsun hannu ya ragu da kashi 76 cikin dari da kuma a kan tafin hannu da kashi 77 cikin dari. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko akwai yiwuwar yaduwar kamuwa da cuta ga sauran masu amfani da bayan gida da kuma yanayin bayan gida sakamakon kowane irin bushewa.
Mai bushewar iska mai iska, wanda ke fitar da iska daga cikin na'urar a saurin da ya kai 180 m/s (650 km/h; 400 mph), yana iya hura kwayoyin cuta daga hannu da na'urar, kuma yana iya yada cutar zuwa ga sauran masu amfani da bayan gida da kuma yanayin bayan gida har zuwa mita 2.
Yin amfani da na'urar bushewa mai zafi yana sa abubuwa masu ƙwayoyin cuta su yi nisa da na'urar bushewa na mita 0.25.
Takardar wanki ba ta nuna yawan ƙwayoyin cuta ba. A shekara ta 2005, wani bincike da TÜV Produkt und Umwelt ya yi ya kimanta hanyoyi daban-daban na bushe hannu.
An lura da waɗannan canje-canje a yawan ƙwayoyin cuta bayan an bushe hannu:
Akwai masana'antun bushe hannu da yawa, kuma ana amfani da bushe-bushe da takarda.
Wanke hannu da kayan kashe numfashi na hannu na iya zama madadin lokacin tafiya saboda rashin sabulu da ruwa.
Dole ne mai tsabtace hannu ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu ya zama tilas na likita na dogon lokaci bayan da likitan Hungary Agnates Simmelweis ya gano ingancinsa (a 1846) wajen hana cututtuka a cikin asibiti.
Akwai na'urorin lantarki da ke ba da sanarwa da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa shan su yana rage yawan kamuwa da cuta.
Wanke hannu na likita na aƙalla dakika 15, ta yin amfani da sabulu mai yawa da ruwa ko kuma gel don yin kumfa, kuma a shafa kowane ɓangare na hannu.
Dole ne a shafa hannayenka tare da yatsunsu a haɗe.
Idan akwai ƙazanta a ƙarƙashin ƙusa, za a iya amfani da goga mai gashi don cire shi.
Tun da yake ƙwayoyin cuta suna iya zama a cikin ruwan hannu, yana da muhimmanci a yi musu wanka sosai kuma a bushe su da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwa (kuma a buɗe kofa idan ya cancanta).
Wannan zai hana hannayenku daga sake gurɓata daga waɗannan rufin.
Manufar wanke hannu a wurin kiwon lafiya shi ne cire ƙwayoyin cuta masu haddasa cuta ("kwayoyin cuta") da kuma guje wa watsa su.
New England Journal of Medicine ta ruwaito cewa rashin wanke hannu har yanzu ba shi da kyau a yawancin wuraren kiwon lafiya, inda likitoci da yawa suka manta da wanke hannu a kai a kai kafin su taɓa marasa lafiya, wanda hakan ke kawo kwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi na iya rage kamuwa da cututtukan jini da ke tattare da catheter da kashi 66 cikin dari, kuma Hukumar Lafiya ta Duniya ta wallafa wata takarda da ta nuna yadda ake wanke hannu da kuma gogewa a fannin kiwon lafiya.
Ana kuma iya samun takardar jagorar tsabtace hannu da aka gabatar daga ƙungiyar a shafinta don jama'a su yi sharhi.
Whitby da wasu sun yi bincike.
Idan ana bukatar a tabbatar da bin ƙa'idodi, ana iya auna tsabtace hannu da kuma duba kayan aikin kasuwanci.
WHO tana da "Moments biyar" don wanke hannu:
Bayan an yi amfani da jini/ruwa na jiki
Kafin aikin kashewa,
Bayan kula da marasa lafiya, ƙara sinadarai masu tsabtace ga sabulu ("magani" ko "anti-microbial") yana ƙara wani abu mai kashewa a kan mai wanke hannu.
Ana iya son wannan kayan kashewa kafin a yi tiyata ko kuma a wuraren da kwayoyin da ke da juriya ga maganin rigakafi suka yadu. Idan mutum ya "sanya" hannunsa don yin tiyata, ana bukatar samar da bututun da za a iya kunnawa da kashewa ba tare da taɓa hannu ba, da wasu kayan wanke chlorhexidine ko iodine, da tawul ɗin da aka bushe don bushe hannaye bayan wanka, da goga mai tsabta don shafawa, da kuma wani kayan tsabta don tsabtace ƙusa.
Dole ne mu cire dukan kayan ado.
Wannan aikin yana bukatar wanke hannu da kuma hannu har zuwa gwiwoyi, yawanci na tsawon minti 2 zuwa 6.
Ba a bukatar tsawon lokaci na gogewa (minti 10)
Sa'ad da ake wankewa, ya kamata a hana ruwa daga komawa daga hannu zuwa hannu.
Bayan an gama wanke hannu, sai a bushe hannu da takardar da aka yi da ita kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko a yi amfani da maganin kashe cuta kafin a kula da wanda yake da cutar da kuma bayan haka.
Don sarrafa kamuwa da cuta a asibitoci, an gano cewa mafi yawan amfanin tsabtace hannu ya zo ne daga kashi 20 na farko na wankewa, kuma ya sami ƙaramin ƙarin amfanin lokacin da aka ƙara yawan wanke hannu zuwa sama da kashi 35 cikin ɗari.
Wanke hannu da sabulu na yau da kullun yana haifar da fiye da sau uku na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Amma ruwan da sabulu sun fi wanke hannu da giya tasiri wajen rage kwayar cutar H1N1 da kuma saurin kamuwa da hanci. Matakan inganta tsabtace hannu a wuraren kiwon lafiya na iya hada da ilimantar da ma'aikata game da wanke hannu, kara wadatar wanke hannu da giya, da kuma rubutaccen saƙon tunatarwa ga ma'aikata.
Ana bukatar ƙarin bincike don a san ko waɗanne ne daga cikin waɗannan matakan suka fi tasiri a wurare dabam dabam na kula da lafiya.
A ƙasashe masu tasowa, an yarda cewa wanke hannu da sabulu hanya ce mai araha da za a samu lafiya mai kyau, da kuma abinci mai gina jiki.
Duk da haka, rashin isassun ruwa, sabulu, ko wuraren wanke hannu a gidaje, makarantu, da wuraren aiki na sa ya zama da wuya a samu halayen wanke hannu na kowa.
Alal misali, a yawancin yankunan karkara na Afirka, ba a yawan samun famfo na wanke hannu kusa da kowane gidan wanka na jama'a ko na sirri, duk da cewa akwai zaɓuɓɓuka masu arha don gina tashoshin wanke hannu.
Duk da haka, ƙananan yawan wanke hannu na iya zama sakamakon al'ada maimakon rashin sabulu ko ruwa.
Tallafawa da wanke hannu da sabulu na iya tasiri da kuma ba da shawara ga yanke shawara na siyasa, da kuma wayar da kan jama'a game da amfanin wanke hannu, da kuma kawo canji a halayyar jama'a a cikin dogon lokaci.
Don wannan ya yi aiki da kyau, ana bukatar sa ido da kuma kimantawa.
Binciken da aka yi na nazarin 70 ya gano cewa hanyoyin zamantakewa suna da tasiri wajen kara wanke hannu a ƙasashe masu matsakaicin matsakaicin kuɗi, yayin da kamfen ɗin tallace-tallace na zamantakewa ba shi da tasiri. Wani misali na inganta wanke hannu a makarantu shine "Hanyar Taurari Uku" da aka tsara ta UNICEF don ƙarfafa makarantu su ɗauki matakai masu sauƙi da tsada don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran buƙatun kiwon lafiya.
Idan aka cika mafi ƙarancin ƙa'idodi, makarantu za su iya zuwa daga tauraro ɗaya zuwa uku a ƙarshe.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na inganta wanke hannu da ake yi don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke kokarin kawo sauyi a halayyar mutane. Saboda annobar cutar korona 2019-20, UNICEF ta karfafa yin amfani da alamar wanke hannu.
Bincike kaɗan ne suka bincika yadda yawan kuɗin wanke hannu a ƙasashe masu tasowa yake da alaƙa da shekarun rai bisa ga naƙasa.
Duk da haka, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin wanke ruwa da kuma tsabtace muhalli tasiri.
An fara gane muhimmancin wanke hannu ga lafiyar ɗan adam - musamman ga mutanen da ke cikin mawuyacin yanayi kamar uwaye da suka haifa ko sojoji da suka ji rauni a asibitoci - a tsakiyar karni na 19 daga manyan masu gabatar da tsabtace hannu: likitan Hungary Agnath Simmelweis wanda ya yi aiki a Vienna, Austria, da kuma Ingilishi Florence Nightingale "wanda ya kafa aikin jinya na zamani".
A lokacin, mutane da yawa sun gaskata cewa ana samun cutar ne daga ƙamshi mai ƙanshi da ake kira miasma.
A shekarun 1980, barkewar cututtukan da ke yada abinci da kuma cututtukan da ke da nasaba da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka su inganta tsabtace hannu sosai a matsayin hanya mai mahimmanci na hana yaduwar kamuwa da cuta.
Barkewar mura ta aladu a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa a ƙasashe da yawa a san muhimmancin wanke hannu da sabulu don kare kai daga wannan cuta mai yaduwa.
Alal misali, an saka alluna da ke nuna "hanyar wanke hannu" kusa da wuraren wanke hannu a wuraren wanka na jama'a da kuma wuraren wanka na gine-ginen ofisoshin da filayen jiragen sama a Jamus.
"Wanke hannuwanka daga" wani abu yana nufin cewa ba ka son ka ɗauki alhakin abin ko kuma ka yi tarayya da shi.
Ya samo asali ne daga nassi a cikin Littafi Mai-Tsarki a cikin Matta inda Bilatus na Pontiff ya wanke hannunsa daga hukuncin gicciye Yesu Kristi, amma ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Ingilishi.
A wasan Shakespeare na Macbeth, Mrs. Macbeth ta fara wanke hannayenta da yawa don ta tsabtace wani tabo na tunanin da ke wakiltar jin laifinta saboda laifin da ta aikata da kuma laifin da ya sa mijinta ya aikata.
An kuma gano cewa mutane, bayan sun ambata ko kuma sun yi tunanin wani abu da ba shi da ɗabi'a, sun fi wanke hannu fiye da sauran mutane, kuma sun fi daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ƙyale su su wanke hannayensu bayan wannan binciken ba su da saukin shiga wasu ayyukan "tsabtacewa" na ma'auni, kamar aikin sa kai.
Addinai suna bayyana wanke hannu don dalilai na kiwon lafiya da alama. Wanke hannu na alama, ta amfani da ruwa ba tare da sabulu ba don wanke hannu, wani ɓangare ne na al'adar wanke hannu wanda ya bayyana a addinai da yawa, ciki har da Baha'i, Hindu, Tiwila, wanke hannu a Yahudanci, wanke hannu a Kiristanci da kuma haske a Musulunci. Addinai kuma suna ba da umarnin wanke hannu, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bukaci a wanke hannu bayan an je bayan gida.
Addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun bukaci a wanke hannu kafin da kuma bayan kowane abinci.
Ka'idojin kula da haɗarin COVID-19 a wurin aiki
Kula da haɗarin COVID-19 a wurin aiki yana nufin aiwatar da hanyoyin lafiya da kiwon lafiya na aiki na kula da haɗarin rigakafin cutar korona 2019 (COVID-19).
Kulawa mai kyau na aiki ya dogara da wurin aiki da aikin, bisa la'akari da tushen haɗarin, haɗarin cutar a cikin al'umma, da kuma abubuwan da ke iya yin barazana ga ma'aikatan da ke da yiwuwar kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya a Aiki ta Amurka (OHSHA), ayyuka masu ƙarancin haɗari sun ƙunshi ƙarancin hulɗa da jama'a da sauran abokan aiki, inda ake ba da shawarar yin ayyuka na farko na rigakafin kamuwa da cuta, ciki har da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya, kiyaye ɗabi'a na tari da tari, da kuma kiyaye tsabtace aiki da kuma tsabtace yanayin aiki.
Ayyuka masu haɗarin matsakaici sun haɗa da waɗanda suke bukatar yin hulɗa na kusa ko na kullum da mutanen da ba a san ko ake zargin suna da cutar COVID-19 ba, amma waɗanda za su iya kamuwa da cutar ta hanyar watsa cutar a cikin al'umma ko kuma tafiya zuwa ƙasashen waje.
Wannan ya haɗa da ma'aikata da suka yi hulɗa da jama'a kamar a makarantu, wuraren aiki masu yawan aiki, da kuma wasu manyan wuraren sayar da kaya.
Dokokin kula da hadari na wannan rukuni, ban da matakan rigakafin kamuwa da cuta, sun hada da yin amfani da iska ta amfani da matattarar iska mai inganci, da shinge na hana tari, da kuma amfani da kayan kariya na mutum wanda ake samu idan aka yi hulɗa da wanda ke dauke da cutar COVID-19.
Hukumar Kula da Lafiya da Lafiya ta Duniya ta ɗauki ma'aikatan kiwon lafiya da masu kula da gawa da suka yi hulɗa da wanda aka sani ko ake zargin yana da cutar COVID-19 a matsayin waɗanda ke da haɗarin haɗari, wanda hakan ya ƙara haɗarin haɗari sosai idan ma'aikata suna yin aikin samar da iska, ko kuma yin hulɗa da samfurin mutum da aka sani ko ake zargin yana da cutar COVID-19.
Kula da haɗari da ya dace ga waɗannan ma'aikata ya ƙunshi kulawar injiniya kamar su ɗakunan iska mai matsin lamba, da kuma kayan kariya na mutum da ya dace da aikin da ake yi.
Cutar COVID-19 na iya haifar da sakamako da yawa a wurin aiki.
Ma'aikata suna iya yin rashin aiki domin rashin lafiya, ko kuma suna bukatar su kula da wasu, ko kuma suna tsoron cewa za a iya yi musu laifi.
Yanayin kasuwanci zai iya canjawa, ta yadda ake sayen kayayyaki da kuma hanyoyin da ake samunsu (kamar sayen kayayyaki a lokacin da ba a yawan jama'a, ko kuma ta hanyar isar da kayayyaki ko kuma sayen kayayyaki a cikin mota).
A ƙarshe, ana iya dakatar da jigilar kayayyaki daga yankunan da cutar ta COVID-19 ta fi shafa. Za a iya amfani da shirin shiri da amsa cututtuka don jagorantar matakan kariya.
Shirye-shiryen suna tattauna matakan haɗari da ke tattare da wurare dabam dabam na aiki da ayyuka, har da tushen haɗari, abubuwan haɗari da ke fitowa daga gida da kuma wuraren da ake zama, da kuma abubuwan haɗari ga ma'aikata na musamman kamar tsufa ko kuma ciwon da ba ya daɗewa.
Ya kuma bayyana matakan da ake bukata don magance waɗannan haɗarin, da kuma shirin gaggawa na yanayi da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen cututtuka masu yaduwa da kuma shirye-shiryen amsawa na iya zama ƙarƙashin shawarwari na ƙasa da na ƙasa.
Manufofin amsawa ga barkewar cutar sun haɗa da rage yaduwar kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke cikin haɗarin haɗarin haɗarin rashin lafiyar lafiya, kiyaye ayyukan kasuwanci, da rage tasirin tasirin tasirin wasu abubuwan da ke cikin sarkar samar da su.
Matsayin rashin lafiya a cikin al'umma inda kasuwancin yake yana shafar yadda ake amsawa.
Tsarin tsarin kula da haɗari tsari ne da ake amfani da shi sosai a cikin aikin lafiya da lafiya don rarraba kula da haɗari ta hanyar tasiri.
Tun da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun matakan sarrafawa sune na injiniya, sannan na gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba, kuma zai iya zama mafita mafi tsada don aiwatarwa.
Kulawa ta gwamnati canji ne na manufofin aiki ko kuma ayyuka da ke bukatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya na mutum (PBE) ba su da tasiri sosai fiye da na injiniya da na gwamnati, amma suna iya taimakawa wajen hana wasu wuraren da za a iya samun cutar.
Ya kamata a zaɓi kowane irin kayan kariya na mutum bisa ga haɗarin da ma'aikaci yake fuskanta, dacewa daidai inda ya dace (kamar masu numfashi), saka su a kai a kai da kuma yadda ya kamata, bincika, kiyaye, sauya a kai a kai, idan ya cancanta, cire, tsabtace, adana, ko kuma zubar da su yadda ya kamata don kauce wa gurɓata.
A cewar Hukumar Kula da Lafiya da Lafiya a Aiki ta Amirka (OHSHA), ayyuka da ba su da haɗari suna da iyakancewar sadarwa da jama'a da kuma sauran abokan aiki.
Ka'idojin rigakafin kamuwa da cuta da aka ba da shawarar ga dukan wuraren aiki sun haɗa da wanke hannu akai-akai da kuma cikakke, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kiyaye ɗabi'a na tari da tari ciki har da rufe baki da hanci lokacin tari da tari, samar da tawul da kwantena na shara, shirye-shiryen yin aiki daga nesa ko shirya sauye-sauye idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da kuma kiyaye tsabtace aiki da tsabtace yanayin aiki.
Gano mutane da za su iya kamuwa da cutar da wuri-wuri da kuma ware su mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi, da sauransu a wurin aiki.
Cibiyar Kula da Cututtuka da Rigakafinta (CDC) ta ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi mai tsanani su zauna a gida har zazzabi, alamun zazzabi, da wasu alamun su tafi na aƙalla sa'o'i 24 ba tare da shan maganin zazzabi ko wasu magungunan da ke inganta alamun ba, cewa manufofin hutu na rashin lafiya su kasance masu sassauci, kuma ma'aikata su zauna a gida don kula da wani cikin iyalin da ke da ciwo, kuma ma'aikata su san waɗannan manufofin.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki, ayyuka masu haɗarin matsakaici sun haɗa da waɗanda suke bukatar yin magana a kai a kai ko kuma a kusa da mutane masu nisan kafa shida (1.8 m) da ba a san ko ana zargin cewa suna da cutar COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda ci gaba da yaduwar kamuwa da cuta a cikin al'umma da ke kewaye da wurin aiki, ko kuma saboda mutumin ya yi tafiya zuwa ƙasashen waje kwanan nan zuwa wurin da cutar ta COVID-19 ta yaɗu.
Waɗannan sun haɗa da ma'aikata waɗanda ke hulɗa da jama'a kamar yadda ake yi a makarantu, yanayin aiki mai ƙarfi, da wasu manyan wuraren sayar da kayayyaki. Gudanarwar injiniya don wannan da ƙungiyoyi masu haɗari sun haɗa da shigar da masu tace iska masu inganci, haɓaka ƙimar iska, shigar da shinge na zahiri kamar su ƙyallen ƙyallen filastik, da shigar da ƙuƙwalwa don ba da sabis ga abokan cinikin da ke cin kasuwa ba tare da barin motar ba. Gudanarwar gudanarwa don wannan da ƙungiyoyi masu haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurruka tare da sadarwa na wucin gadi, samar da lokutan aiki na yau da kullun, dakatar da ayyukan da ba dole ba, haɓaka abubuwan da suka shafi rashin biyan haraji, ƙuntatawa game da amfani da kayan aiki, ƙuntatawa game da amfani da kayan aiki, ko kuma inganta ingantaccen tsarin samar da kayayyaki, da kuma inganta hanyoyin samar da kayayyaki da ke haifar da cutar COVID-19.
A wasu lokatai, ma'aikatan da suke cikin wannan rukunin haɗarin ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, matakan kariya na dacewa don kare ma'aikata da sauran fasinjoji sun haɗa da ajiye mai haƙuri mai haƙuri a nesa da ƙafa shida, sanya memba ɗaya na ma'aikatan jirgin sama ya kula da mai haƙuri, samar wa mai haƙuri da abin rufe fuska, ko kuma buƙatar mai haƙuri ya rufe bakinsa da hanci da takarda idan ya tari ko yayi tari.
Ma'aikatan jirgin ya kamata su sanya safofin hannu na likita da za a iya zubar da su idan suka yi hulɗa da matafiyi mai rashin lafiya ko kuma idan suka taɓa ruwan jiki ko wuraren da suka gurɓata, kuma wataƙila su yi amfani da ƙarin kayan kariya na sirri idan matafiyin mai rashin lafiya yana da zazzabi ko kuma yana ciwon tari ko kuma yana da wahalar numfashi.
Ya kamata a zubar da safofin hannu da sauran kayan da za a iya zubar da su a cikin jakar rigakafin haɗarin kwayoyin halitta, kuma a tsabtace wuraren da ke da gurɓataccen abu kuma a kashe su. Don jigilar kayayyaki na kasuwanci, ciki har da jiragen ruwa da sauran jiragen fasinja, dokokin sarrafa haɗari sun haɗa da jinkirta tafiya idan mutum ya kamu da rashin lafiya, da keɓe kansa da kuma sanar da cibiyar kiwon lafiya da ke cikin jirgin nan da nan idan mutum ya kamu da zazzabi ko wasu alamun yayin da yake cikin jirgin.
A yanayi mai kyau, ya kamata a ci gaba da kulawar a ɗakin da aka ware. A makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko kuma tsabtace idan mutumin da ke da cutar yana cikin ginin makaranta ko da kuwa ya yaɗu a cikin al'umma.
Lokacin da akwai iyakance zuwa matsakaiciyar iyaka ga yaduwar kamuwa da cuta a cikin al'umma, ana iya aiwatar da dabarun nisantar jama'a kamar soke tafiye-tafiye, tarurruka, da sauran manyan tarurruka kamar darussan ilimin motsa jiki ko darussan ƙungiyar mawaƙa ko cin abinci a kantin, ƙara nesa tsakanin ofisoshi, tsara lokutan zuwa da fita a jere, rage baƙi marasa mahimmanci, da amfani da keɓaɓɓiyar ofishin kiwon lafiya ga yara da ke da alamun cutar mura.
Idan akwai yaduwar kamuwa da cuta a cikin al'umma, ban da dabarun nisantar jama'a, ana iya yin la'akari da tsawaita lokacin tafiyar makaranta.
An shawarci jami'an tilasta bin doka da suke bukatar su tuntubi mutanen da aka tabbatar ko ake zargin suna da cutar COVID-19 su bi irin wannan jagorar da ma'aikatan gaggawa na asibiti suke bi, ciki har da kayan kariya na mutum.
Idan aka yi tuntuɓe kai tsaye a lokacin kamawa, ma'aikata su tsabtace da kuma tsabtace bel da kayan aiki kafin a sake amfani da su ta hanyar fesawa ko kuma shafawa, kuma su bi ƙa'idodin aiki na magance gurɓataccen abu da kuma zubar da kayan kariya na mutum da aka yi amfani da su, da kuma tattara tufafi da wanke su.
Hukumar Kula da Lafiya da Lafiya ta Kwarewa ta ce wasu ma'aikatan kiwon lafiya da na gawa suna cikin rukunin da ke da haɗari sosai ko kuma sosai.
Ayyuka masu haɗari sun haɗa da ma'aikatan kiwon lafiya, tallafi, dakunan gwaje-gwaje, da sufuri na likita waɗanda ke fuskantar sanannun marasa lafiya ko waɗanda ake zargi da COVID-19.
Wannan zai zama babban haɗari idan ma'aikata suka yi aikin samar da iska, da kuma tattara samfurori daga waɗanda aka tabbatar ko ake zargi da cutar COVID-19.
Ana yin amfani da iska a cikin ƙoshin ƙoshi, ana yin amfani da ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin.
Ayyukan babban hadarin na ɗakunan gawa sun haɗa da ma'aikatan da ke cikin shirya gawawwakin mutanen da aka tabbatar ko ake zargin suna da cutar COVID-19 a lokacin mutuwarsu; waɗannan suna da babban haɗari idan suka yi autopsy. Ƙarin sarrafawar injiniya na waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don waɗanda aka sani ko ake zargin suna da cutar COVID-19, ciki har da aiwatar da hanyoyin samar da iska.
Ana iya amfani da iska mai matsi mai ƙarfi a wasu wuraren kula da lafiya da kuma ajiye gawawwaki.
Dole ne a bi da samfurori bisa matakin tsaro na matakin 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar ware marasa lafiya da suka iso a yankunan jira daban-daban dangane da ko ana zargin cewa suna da COVID-19. Baya ga sauran kayan kariya na mutum, Hukumar Kula da Lafiya da Lafiya ta Kwarewa ta ba da shawarar yin amfani da na'urorin numfashi ga waɗanda ke aiki a nesa da ƙafa 6 daga waɗanda aka sani ko ake zargin suna da SARS-CoV-2, da waɗanda ke yin ayyukan samar da iska.
A Amurka, dole ne a yi amfani da na'urorin numfashi masu rufe fuska da aka ba da su da nau'in N95, wanda aka amince da shi daga Cibiyar Tsaro da Lafiya ta Kasa, ko kuma mafi kyau, a cikin shirin kare numfashi na rubuce-rubuce, wanda ya haɗa da gwaji da dacewa, horo, da kuma gwajin likita.
Wasu nau'o'in na'urorin numfashi na iya ba da kariya da kuma inganta kwanciyar hankali ga ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar yin amfani da na'urorin numfashi ba, domin COVID-19 cuta ce ta numfashi maimakon ta hanyar ruwan jiki.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa ma'aikatan bincike su yi amfani da abin rufe fuska na tiyata a wurin shiga kawai.
Ga waɗanda suke tattara samfurin numfashi daga marasa lafiya na COVID-19, ko kula da su, ko kuma kai su ba tare da yin amfani da hanyoyin samar da iska ba, WHO ta ba da shawarar yin amfani da abin rufe fuska, tabarau, ko abin rufe fuska, sirinji da tabarau.
Idan an yi aikin samar da iska, ana maye gurbin abin rufe fuska da abin rufe fuska na numfashi na N95 ko FFP2.
Ganin cewa samar da kayan kariya na mutum a duniya bai isa ba, WHO ta bada shawarar rage bukatar kayan kariya ta mutum ta hanyar jinya ta nesa, da shinge na zahiri kamar su tagogi, wanda ke ba wa waɗanda ke cikin kulawa ta kai tsaye damar shiga dakin da mai cutar ta COVID-19 yake, ta amfani da kayan kariya na mutum da ake buƙata kawai don takamaiman aikin, ci gaba da amfani da abin rufe fuska na numfashi ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali iri ɗaya da kuma sa ido da daidaita sarkar samar da kayan kariya ta mutum, da kuma hana amfani da abin rufe fuska ga mutanen da ba su nuna alamun cutar ba.
Daga: Catherine Maher, Shugabar Kamfanin Wikimedia
Ga: Dukkan ma'aikatan Wikimedia
Jigon: [COVID-19] Sauƙaƙa Nauyin Kuma Ka Shirya Domin Nan Gaba
Ranar da aka aika: 14 ga watan Maris na shekarar 2020, 00:24 GMT
Ba a kiyaye duk haƙƙoƙi ba
Mun sami kanmu cikin yanayi na musamman a wannan watan.
Cutar COVID-19 ta zama abin da ke nuna alaƙar ɗan adam da kuma hakkinmu ga wasu.
Tarihinmu bai taɓa ganin irin wannan ƙalubalen ba, amma mun san cewa amsa mafi kyau ta dogara ne da irin juyayi na duniya, haɗin kai da kuma gina al'umma, waɗanda sune abubuwan da suka fi dacewa a zuciyar wannan ma'aikata.
Ƙawa da kuma kulawar da muka samu tsakanin dukan abokan aikinmu ta hanyar imel da kira da kuma taɗi, tabbaci ne mai ban mamaki na yadda muke yin aiki.
Ina godiya da kuma alfahari da cewa ku abokan aiki ne na gaske.
A makon da ya gabata, wani ya aika mini da wasiƙa yana nuna godiyarsa ga aikinmu.
Sun tunatar da ni cewa yana da muhimmanci a yi amfani da shi a duniya a yanzu, kuma yana da muhimmanci a yi amfani da shi a kan intanet.
Ƙoƙarinku ne ya sa hakan ya yiwu, ko ta hanyar ci gaba da shafukan yanar gizo, ko ta hanyar biyan abokan aikinmu albashi, ko kuma ta hanyar kiyaye al'ummominmu lafiya.
Duniya tana bukatar bayanai da ke cikin Wikipedia fiye da kowane lokaci.
Lokaci ne da za mu iya yin tasiri a duniya ba kawai ta ƙoƙarinmu ba, amma kuma ta yadda muke yinsa.
Saboda muhimmancin wannan aiki da kuma matsayinku a cikinsa, za mu yi wasu gyare-gyare masu muhimmanci a yadda muke aiki tare, daga mako mai zuwa.
Canje-canje a tsarin aiki da kuma tsarin aiki
Kamar yadda Rubin ya ambata, ƙungiyar C ta taru a jiya don tattauna yadda za mu yi aiki da kuma tsarinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muka ga zai iya zama amsar da ta dace ga abin da muke fuskanta, da kuma hanya mafi kyau ta ci gaba da gudanar da ayyukanmu a wannan lokacin.
Muna son mu kawar da damuwa da damuwa, kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kuna son rage nauyi da ayyuka, to hakan yayi daidai.
Ga ma'aikata, 'yan kwangila da ma'aikatan kwangila:
Aikin yau da kullum na tsawon sa'o'i 4 a rana, ko kuma sa'o'i 20 a mako har sai an ba da sanarwar gaba.
Ba a sanar da ranar hutu ba, idan za ka iya yin aiki fiye da yadda ka saba, za ka iya ƙara ƙoƙari.
Duk da haka, duniya ta zama abin da ba za a iya tsammani ba, ko kana son ka kula da ƙaunatattunka ko ka je kantin sayar da abinci ko kuma ka je wurin likita, lafiyarka ita ce fifiko na farko.
Ba mu bin sa'a naka ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata a fahimci wannan a matsayin ƙyale ba tare da furta ba, amma muna ambata shi.
Ba a bukatar hutu na rashin lafiya ko hutu da ake biya, sai dai ka sanar da shugabanninka kuma ka taimaki ƙungiyarka ta duba kalandarku da jadawalinku don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan likitanka ya gano cewa kana da cutar COVID-19, ka gaya wa Brian a Sashen Koyarwa da Takaddun shaida domin Sashen Koyarwa da Takaddun shaida ya taimake ka kuma ya tabbata cewa kana samun kulawar da ta dace daga Sashen.)
Ana biyan ma'aikatan da suke aiki na awa ɗaya albashi na cikakken lokaci.
Mun riga mun ambata, kuma mun sake maimaita wannan alkawarin game da wajibai ga 'yan kwangilarmu da kuma abokan aikinmu na sa'a.
Kowane ma'aikaci zai sami albashinsa bisa ga lokutan aiki na al'ada a cikin yanayi na al'ada.
Wannan ya haɗa da ko ma'aikaci yana rashin lafiya ko kuma ba zai iya aiki ba.
Idan kana son aiki, za mu goyi bayan ka.
Mutane da yawa suna amfani da aiki don su sha kan matsi da ke ko'ina a duniya.
Abin da za mu iya yi zai kasance mai amfani sosai, musamman ma a lokacin da muke fuskantar irin wannan yanayi mai wuya.
A nan ma, yana da muhimmanci mutum ya kula da kansa.
Muna roƙon ka kawai ka tuntuɓi mai kula da kai domin ya san abin da za a yi tsammani kuma ya daidaita tsarin yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
Ƙungiyoyin gine-gine na amincin shafin, ayyukan HR, amincewa, gaskiya, tara kuɗi (da sauransu) suna yin aiki mai muhimmanci, wanda zai bukaci ƙarin tallafi.
Za mu fara aiki tare da dukan sassan gwamnati don mu bincika makasudin da muke da shi yanzu kuma mu mai da hankali ga tallafa wa abubuwan da suke da muhimmanci don cim ma aikinmu.
Akwai aiki mai yawa da ya kamata mu yi, kuma za mu mai da hankali ne kawai a kan ayyukan da suka fi muhimmanci.
Idan muka yi jinkiri yanzu, ba zai cutar da mu ba.
Ba mu da shirin "sake aiki don magance abin da ya gabata" bayan annobar ta ƙare.
Ba a sa ran cewa za mu yi aiki na sa'o'i da yawa don cika wa'adin da ba zai yiwu ba.
Mun yarda cewa yanayi ya canja, kuma za mu kafa sababbin manufofi da kuma jadawalin lokacin da ya dace.
Menene ke faruwa a shirin APP?
Don daidaitawa da sabon yanayi da kuma sa'o'in aiki na yau da kullum, muna shirin gyara jadawalin isarwa na shirinmu na shekara-shekara na 2020-2021.
Muna son mu ba da shawarar a tsawaita shirinmu na 2019-2020 domin a ba da ƙarin lokaci a tsara kasafin kuɗi don a ba ma'aikata damar fifita aiki mai muhimmanci, kula da kansu da kuma kula da waɗanda suke ƙauna yayin da kuma daidaita yanayin waɗanda suke bukatar ko kuma suke son su yi aiki a cikin sa'o'i kaɗan na makonni masu zuwa.
Wannan ƙarin lokaci yana rage yawan aiki da ake yi a yau da kuma matsi a dukan ƙungiyar.
Za mu gabatar da shawararmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilai da kuma ƙungiyoyi game da matakai na gaba da zarar mun sami tabbaci.
Muna godiya ga ƙungiyar tsara shekara-shekara don rawar da suka taka wajen wannan.
Yanayin ofishi, nunawa da kuma tsabtace shi
A makon da ya gabata mun samu labarin cewa wani abokin aikinmu a San Francisco yana iya kamuwa da cutar COVID-19.
Amma, saboda mu mai da hankali sosai, mun yi amfani da masu tsabtace gidajenmu da ke San Francisco don tsabtace dukkan rufin.
Ƙungiyar ta yi amfani da maganin rigakafin ƙwayoyin cuta da ake amfani da shi a asibitoci don tsabtace dukkan rufin, har da ɗakin kwana da kuma ɗakunan hawa da ke kaiwa ga bene.
Ginin ya bi tsarin kula da shi ta hanyar amfani da kayayyakin da ke tallafa wa lafiyar masu haya.
Muna jin daɗin ofishin da yake a shirye har sai lokacin da muka yanke shawarar komawa aiki.
Ofishinmu da ke Washington, D.C. yana cikin ginin kamfanin WayWork, wanda ya ba mu damar yin amfani da tsarin COVID-19 da kuma dukan ma'aikatanmu da ke hedkwatarmu da ke Washington, D.C.
A makon da ya gabata, ofishinmu da ke Washington, D.C., ya koma wani wuri mai nisa sosai, a ƙarƙashin umurnin da muka samu daga ofishinmu da ke San Francisco.
Kamar yadda wasu abokanmu a hedkwatarmu a birnin New York suka sani, mun tattauna batun yin hayar wani wuri a Brooklyn.
Har yanzu ana ci gaba da wannan tattaunawar, amma za a iya jinkirta ta na wani lokaci.
Wasu abokan aikinmu suna aiki ne daga nesa a karon farko.
Abokanmu da suka daɗe suna aiki daga nesa sun san cewa zai iya zama gyara, kuma suna son su ba ku wasu shawarwari:
Ya kamata a ƙayyade lokacin tarurruka na awa ɗaya ko kuma a hankali a ƙara zuwa awa biyu.
Idan ana bukatar a yi taro na tsawon lokaci, ya kamata a yi la'akari da yadda za a raba shi cikin kwanaki da yawa.
Ya kamata a bayyana tarurrukan, a shirya tsarin ayyuka, kuma a aika da littattafan karatu a gaba.
Ya kamata a sanya bidiyo a matsayin mafita, kuma a yi amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da sadarwa kai tsaye.
Ya kamata a ɗauki matakin sauƙaƙa kowane taro, kuma a sa wani ya lura da tattaunawar don ya san tambayoyi da kuma jerin masu magana, kuma wani ya taimaka wajen rubuta bayanin kula (ko kuma aiwatar da tsarin rubuta bayanin kula na haɗin kai).
Ya kamata ka aika saƙon imel zuwa tallafi na fasaha idan kana bukatar belun kunne masu dadi.
Za a iya amfani da shirin lafiya da tsaro don samun kuɗin abincin dare.
Za ka iya shiga tashar #remoties a kan Slack don tattaunawa da abokan aiki game da aikin da aka rarraba.
Ƙungiyar HR tana neman jagora don abubuwan da za su amfane masu amfani bisa ga tarurrukan kan layi, don tallafa wa karuwar aikin da aka rarraba a dukan ma'aikata.
A makon da ya gabata, mun nemi duk masu samun tallafin al'umma su soke duk wani taron jama'a da Wikimedia ke tallafawa, kamar su taron masu gyara na yanar gizo na Editathon har sai WHO ta sanar da ƙarshen annobar.
Mun gaya musu cewa mun fahimci cewa neman sokewa da wasu takunkumi zai iya sa ba zai yiwu a kammala ayyukan tallafin da aka amince da su ba, kuma ba za a ci tara ga kowa ba saboda jinkirta ko gyara waɗannan manufofin.
A mako mai zuwa za mu fitar da ƙarin jagora don biyewa game da Wikimedia da sauran taron al'umma na yanki da kuma takamaiman batutuwa.
Ra'ayoyin jama'a a duniya sun rikice tsakanin baƙin ciki da rashin kwanciyar hankali, gamsuwa da bayyanawa da kuma iyawar mayar da hankali ga al'ummominsu, Wikimedia, da sauransu.
A cikin hangen nesa da ci gaban waɗannan matakan, ƙungiyar amsa rikice-rikice tana tsara shafi a MetaWiki don samar da sarari ga al'umma don lura da tasirin da kuma ci gaba da duk sadarwa tare da shi.
Ka kasance a farke game da batutuwan da suka shafi COVID-19
Za mu aika muku da gayyatar ranar Alhamis mai zuwa, karfe 2:00 na yamma, karfe 7:00 na yamma, lokacin yankin Pacific, don taron musamman na rukunin ma'aikata.
Za mu yi amfani da wannan lokacin mu raba ƙarin labarai, amsa tambayoyi, da kuma tattauna da juna.
Muna cikin wannan gwaji tare kuma a shirye muke mu taimaka a duk lokacin da za mu iya.
A wannan lokacin, za mu iya ci gaba da samun bayanai daga wannan imel ɗin, da kuma duk wasu bayanai masu muhimmanci game da COVID-19 da ke cikin Ofishin Wiki.
Ƙungiyarmu ta gaggawa za ta ci gaba da sabunta waɗannan shafuka kuma ta sa dukan bayanai su kasance a wuri ɗaya.
Muna kuma ci gaba da sadarwa a kai a kai da ma'aikatan da ke zaune a ƙasashen da abin ya shafa sosai.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, manyan fannoni na aiki, ƙalubalen da ke tattare da ɗaukar hoto, ko wani abu da kake bukatar taimako a kai, ka tuntuɓe mu kuma ka yi aiki tare da ƙungiyarmu ta amsa matsalolin.
A ko yaushe muna shirye mu ba da taimako da kuma sadarwa idan ya cancanta.
Idan kana da wani sirri ko kuma tambaya mai muhimmanci, ka aika imel zuwa Brian Gooden, darektan ayyukan duniya na ma'aikatan ma'aikata.
Duk wani canji a cikin waɗannan canje-canjen ba zai zama ya bar aikinmu ko kuma wajibai da ke kanmu ba.
Maimakon haka, fahimta ce a wannan lokacin, cewa aikinmu da wajibai suna bukatar daidaitawa a hanyar da ba mu taɓa yi ba.
Mun yi imanin cewa waɗannan matakai suna da muhimmanci don tallafa wa juna, don mu ci gaba da aiki da kuma ba ma'aikatanmu goyon bayan da suke bukata, da kuma ba wa duniya sabis da suke dogara da shi.
Ayyukan da muka shirya za su jira mu idan lokaci ya yi.
Yanzu, lokaci ya yi da kowa zai ba da hannu ya taimaki juna da kuma samar da sarari don aiki mai muhimmanci da zai zo cikin makonni da watanni masu zuwa.
Muna bukatar ku duka ku yi wannan, don haka muna bukatar ku duka ku kula da kanku da iyalanku domin ku kasance cikin mafi kyawun yanayi lokacin da ake buƙatar ƙoƙarinku.
Yanzu muna roƙonku ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, darektan tawagar amsa matsalar (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jimmy V, Joel L, Lynette L, Ryan M, Tony S), da sauran mambobin tawagar jagorancin (Grant I, Heather W, Jimmy V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
Enzyme mai canzawa na angiotensin 2 (ACE2) yana ɗaure da farfajiyar waje (tashin sel) na ƙwayoyin cikin huhu, jijiyoyi, zuciya, koda, da kuma hanji.
Enzyme mai canza angiotensin 2 yana hana aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin 2 da haɓaka angiotensin (1-7), yana mai da shi magani mai ban sha'awa a cikin maganin cututtukan zuciya. Hakanan yana da ƙofar wasu nau'ikan ƙwayoyin cuta zuwa ƙwayoyin cuta.
An kira kwayar halitta ta mutum hACE2.
An san enzyme mai canzawa zuwa angiotensin 2 a matsayin enzyme na ƙarfe wanda ke ɗauke da sinadarin zinc kuma yana kan farfajiyar ƙwayoyin linzamin kwamfuta da sauran ƙwayoyin.
Kwayar enzyme mai canza angiotensin 2 tana da kewayon peptidase M2 wanda yake da amino end, kuma jerin colectrains a matsayin carboxyl end wanda shine mai ɗaukar amino acid na koda.
Angiotensin-converting enzyme 2 shine nau'in 1 mai wucewa guda ɗaya, wanda ke da masu karɓar enzymes masu aiki waɗanda ke kan ƙwayoyin huhu da sauran ƙwayoyin cuta.
An cire ɓangaren waje na ƙwayoyin halitta na enzyme mai canza angiotensin 2 daga cikin ƙwayoyin cuta ta hanyar enzyme da ake kira Shidas, wanda ke haifar da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta.
Ana samun enzyme mai canzawa zuwa angiotensin 2 a yawancin sassan jiki: yana da alaƙa da membrane na nau'in 2 na ƙwayoyin cuta a cikin huhu, a cikin ƙwayoyin hanji na ƙananan hanji, da ƙwayoyin linzamin na jijiyoyi da jijiyoyi, da kuma a cikin ƙwayoyin tsoka masu laushi na jijiyoyin jini a yawancin sassan.
Ana samun RNA mai aikawa na enzyme mai canza Angiotensin 2 a cikin kwakwalwar kwakwalwa, cikin kwakwalwa, a cikin yankin da ke ƙarƙashin matashin kai, da kuma cikin kwakwalwa.
Aikin farko na enzyme mai canza angiotensin 2 shi ne yin aiki a matsayin mai daidaita enzyme mai canza angiotensin.
Enzyme mai canza angiotensin yana motsawa ya canza hormone angiotensin 1 zuwa angiotensin 2 wanda ke riƙe jijiyoyin jini.
A madadin haka, enzyme mai canza angiotensin 2 mai dauke da amino acid carboxyl mai dauke da amino acid phenylelanine ya rabu da angiotensin 2 (aspartate-arginine-valine-tyrosine-isoleucine-histidine-proline-phenylelanine) kuma ya canza shi zuwa angiotensin (1-7), (histidine-aspartate-arginine-valine-tyrosine-isoleucine-histidine-proline-phenylelanine).
Enzyme mai canza Angiotensin 2 ya rabu zuwa wasu peptides da suka hada da [dis-arginine9] -bradricenin, apelin, neurotensin, dinorphine A, da gerlin.
Hakanan enzyme mai canza angiotensin 2 yana daidaita wucewar membrane na mai watsa amino acid mai tsaka tsaki SLC6A19, kuma yana da rawa a cutar Hartnup.
Anzime mai canza Angiotensin 2, a matsayin furotin trans-membrane, shine babban hanyar shiga cikin ƙwayoyin cuta na wasu coronaviruses, waɗanda suka haɗa da kwayar cutar ta NL63, SARS-CoV (kwayar cutar da ke haifar da SARS), da SARS-CoV-2 (kwayar cutar da ke haifar da cutar COVID-19).
Musamman, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV-2 tare da zangon enzymatic na enzyme mai canza angiotensin 2 a farfajiyar ƙwayoyin cuta yana haifar da haɗuwa da ƙwayoyin cuta da kuma yaduwar ƙwayoyin cuta da enzyme zuwa cikin kwayoyin da ke cikin ƙwayoyin.
Wannan aikin shigarwa yana buƙatar yin amfani da furotin S ta hanyar enzyme mai amfani da protease, mai masaukin baki, Serin2, wanda har yanzu ana hana shi a matsayin magani mai yiwuwa. Wannan ya sa wasu sun yi tunanin cewa rage matakan enzyme mai canza Angiotensin 2 a cikin ƙwayoyin zai iya taimakawa wajen tsayayya da kamuwa da cuta.
Ko yaya dai, ƙungiyoyi da yawa da kuma ƙungiyoyi masu sarrafa kansu suna ba da shawarar ci gaba da yin amfani da maganin da ake kira angiotensin converting enzyme inhibitors da kuma masu hana masu karɓa na angiotensin.
Wani bincike da kuma nazarin da aka yi a kan maganin da ake kira angiotensin converting enzyme inhibitors da aka wallafa a ranar 11 ga Yuli, 2012, ya nuna cewa "a yi amfani da maganin da ake kira angiotensin converting enzyme inhibitors, an rage haɗarin kamuwa da ciwon huhu da kashi 34% idan aka kwatanta da na mutanen da aka yi amfani da su wajen yin maganin".
Bugu da ƙari, "yankan ciwon huhu ya ragu a tsakanin waɗanda aka yi wa maganin maganin na'urar hana yaduwar jini na angiotensin, waɗanda suka fi fuskantar ciwon huhu, musamman waɗanda suka yi bugun jini ko kuma rashin ƙarfi na zuciya.
Yin amfani da maganin hana enzyme mai canzawa zuwa angiotensin ya rage yawan mutuwar ciwon huhu, ko da yake sakamakon bai yi ƙarfi ba idan aka kwatanta da haɗarin ciwon huhu gaba ɗaya".
An yi imanin cewa enzyme mai canzawa na ɗan adam na angiotensin 2 (rhACE2) zai zama sabon magani don raunin huhu mai tsanani. An gano cewa yana inganta rarraba jini na huhu, da kuma isashshen oxygen a cikin aladu da ke fama da cututtukan numfashi mai tsanani da ke haifar da mai mai yawa.
Anjiotensin 2 yana da rabin rai na kimanin sa'o'i 10, yana aiki bayan minti 30, kuma yana aiki har tsawon sa'o'i 24.
Akwai alamun da yawa da ke nuna cewa enzyme mai canza angiotensin 2 mai yiwuwa ya zama magani mai ban sha'awa ga waɗanda ke da rashin haƙuri ga masu hana tsarin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin jijiyoyin
Aikace-aikacen COVID-19 aikace-aikacen software ne na na'urar hannu da aka tsara musamman don taimakawa wajen bin diddigin mutanen da suka kamu da cutar a cikin amsar cutar coronavirus ta 2019-20, wanda ke nufin gano mutanen da suka kamu da cutar ("masu kamuwa da cutar").
An tsara aikace-aikace da yawa ko kuma an gabatar da su tare da goyon bayan gwamnati a wasu yankuna da kuma yankuna.
An kafa tsarin aiki da yawa don tsara aikace-aikacen bin diddigin masu ɓarna.
Mutane da yawa sun nuna damuwa game da sirrin su, musamman game da tsarin da ke dogara da bin diddigin wurin da masu amfani da manhajoji suke.
Zaɓuɓɓuka da ba su da matsala wajen ɓoye sirri sun haɗa da yin amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani daga wasu wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa sun haɗa aikin da ke tallafawa waɗannan aikace-aikacen da ke amfani da Bluetooth, kai tsaye a cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin tare da haɗin gwiwar Alipay ta fitar da wani manhaja da ke ba wa 'yan ƙasa damar duba ko sun yi hulɗa da mutanen da ke da cutar COVID-19.
A yanzu haka, mutane suna amfani da shi a birane fiye da 200 a China, kuma a Singapore, mutane suna amfani da wani app da ake kira TraceTogether.
Kungiyar IT ta gida ce ta tsara wannan app, kuma ta fitar da shi a matsayin aikace-aikacen bude tushen da za a ba wa gwamnati. Macedonia ta Arewa ta ƙaddamar da "StopKorona", aikace-aikacen da ke amfani da Bluetooth don bin diddigin haɗarin haɗuwa da waɗanda ke da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha tare da Ma'aikatar Lafiya ne suka tsara wannan app.
A ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewar Google Play da App Store daga Apple.
A ranar 12 ga Afrilu, gwamnati ta ce ana ci gaba da inganta manhajar bin diddigin masu cutar, kuma za a iya rarraba ta cikin makonni. Ireland da Faransa suna shirin ƙaddamar da irin wannan manhajar, ("StopCovid").
Australia da New Zealand suna tunanin tsara aikace-aikace bisa TraceTogether da Singapore ta kaddamar, da kuma BlueTrees.Rasha na shirin gabatar da aikace-aikacen da ke amfani da yanayin yanayin ƙasa ga marasa lafiya da likitoci suka gano COVID-19 daga mazauna Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, Farfesa a fannin aikin tsaro a Jami'ar Cambridge, ya ambata wasu matsaloli na aiki da ke tattare da tsarin da ke kan aikace-aikace, ciki har da rashin inganci da rashin inganci idan amfani da aikace-aikacen ya iyakance ga ƙaramin ɓangaren jama'a.
Don magance damuwar yaduwar aikace-aikacen cutar coronavirus masu ɓatarwa ko cutarwa, Apple ya sanya takunkumi kan nau'ikan ƙungiyoyi waɗanda za su iya ƙara aikace-aikacen da ke da alaƙa da cutar ta Corona zuwa shagon aikace-aikacen su; yana iyakance shi ga "hukuma" ko wasu ƙungiyoyi masu suna.
Google da Amazon sun kafa irin wannan takunkumi.
Masu kare sirrin sun nuna damuwa game da tasirin sa ido na jama'a da ake samu daga amfani da aikace-aikacen cutar korona, musamman idan tsarin sa ido da aka tsara don magance annobar korona zai tafi da zarar barazanar ta wuce.
Kungiyar Amnesty International da fiye da wasu kungiyoyi 100 sun fitar da wata sanarwa da ke kira ga takaita irin wannan sa ido.
Ƙungiyoyin sun kuma bayyana sharudda takwas ga ayyukan gwamnati:
Ya kamata a yi sa ido "daidai, dole, kuma daidai".
Ya kamata a haɗa da ƙarin lokaci na sa ido da kuma sa ido a kan lokacin da za a dakatar da su;
Ya kamata a ƙuntata amfani da bayanai don dalilai da suka shafi COVID-19.
Tsaron bayanai da sirrin su ya kamata a kiyaye kuma a tabbatar da hakan bisa hujjoji;
Ya kamata sa ido na dijital ya guji ƙara nuna bambanci da kuma warewa;
Ya kamata a ƙayyade ko wane irin rabawa ne na bayanai da wasu a cikin doka;
Ya kamata a samar da abubuwan karewa daga cin zarafi da kuma kare hakkin 'yan kasa wajen magance cin zarafi;
Ana buƙatar "haɗin kai" daga duk "masu ruwa da tsaki" da suka shafi, ciki har da masana kiwon lafiyar jama'a da ƙungiyoyin da ke kan iyaka. Chaos Computer Club (CCC) na Jamus da kuma Reporters Without Borders (RSF) sun fitar da jerin bita.
Shirin Google/Apple da aka gabatar yana nufin magance matsalar sa ido ta hanyar cire tsarin bin diddigin na'urori daga tsarin aiki da zarar an daina bukatarsu.
Wasu ƙasashe sun yi amfani da hanyar sa ido ta hanyar hanyar sadarwa maimakon amfani da manhajoji, wanda hakan ya kawar da bukatar saukar da manhajoji kuma ya ba da damar kaucewa sa ido.
A Isra'ila, jami'ai sun amince da bin hanyar sadarwa.
Amma hanyoyin sadarwa da ke da damar shiga bayanan farko na wurin da ake zama suna da matsala mai girma game da tsare sirri.
Duk da haka, ba dukan tsarin da ke da maɓallin keɓaɓɓun suna bukatar samun damar yin amfani da bayanan wurin da mutum yake ba; an kafa wasu tsarin tsare sirri da ke amfani da maɓallin keɓaɓɓun don sadarwa kawai (duba sashe na gaba a ƙasa).
A Koriya ta Kudu, jami'ai sun yi amfani da tsarin da ba na aikace-aikace ba don bin diddigin masu yin ɓarna.
Maimakon amfani da wata manhaja, tsarin yana tattara bayanan sa ido daga tushe daban-daban, ciki har da bayanan sa ido na na'urorin hannu da bayanan ma'amalar katin, kuma yana haɗa wannan bayanan don aika sanarwar saƙon rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu ɓoye ɓoye, gwamnati ta kuma ba da damar samun bayanan wurin a fili, saboda canje-canje masu yawa a cikin dokokin tsare sirri bayan barkewar cutar coronavirus a wannan ƙasar.
Ana samun wannan bayanin a fili ta hanyar aikace-aikace da kuma shafukan intanet. Ƙasashe, har da Jamus, sun yi la'akari da yin amfani da tsarin da aka kafa da kuma tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a fitar da cikakken bayani game da wannan ba.
Masu amfani da keɓaɓɓun bayanan sirri suna bin ingantaccen tsari mai nasara wanda ke da goyon bayan ingantaccen wallafe-wallafen bincike wanda ya fara aƙalla 2013. A ranar 7 ga Afrilu, 2020, fiye da gungun masana da dama sun yi aiki don samar da hanyoyin da suka dace da sirri, kamar Bluetooth mai ƙarancin ƙarfi (BLE) don yin rikodin kusanci da mai amfani daga wasu wayoyin hannu.
Duk da haka, BEP-BT ya kasance ƙoƙari ne na daidaitawa wanda ya ƙunshi duka hanyoyin da aka mayar da hankali da kuma rarraba, ba yarjejeniya ba. Hanyoyin da aka rarraba sun haɗa da tsarin kulawa da keɓaɓɓen tsarin (DP-PBT/DP-3T), lambobin tuntuɓar wucin gadi (TCN, wanda aka sani da lambar taron lamba, CEN), ladabi mai mahimmanci, da kuma bin diddigin masu amfani da na'urorin hannu (PECT) da sauransu.
A cikin waɗannan ƙa'idodin, bayanan sirri ba sa barin na'urar, kuma duk abubuwan da suka dace suna faruwa a na'urar.
Ƙungiyar tsare sirri a MIT Media Lab tana aiki kan ci gaba da SafePaths, wani dandamali don amfani da fasahohin tsare sirri lokacin tattara bayanai na wuri ko kuma hanyar haɗuwa da amfani da su don bin hanyar yaduwar COVID-19.
Ya dogara ne da bincike da aka samu daga rahoton "Maganar Aikace-aikacen: Kula da Sirrin Sirri a cikin Cutar", wanda aka fitar a watan Maris na 2020. Tsarin SafeTrace na Enigma MPC, wani kamfanin haɓaka fasahar tsare sirri wanda kuma ya samo asali a MIT Media Lab, wani irin wannan ƙoƙari ne.
SafeTrace tana amfani da fasahohin tsaro na na'ura don ba masu amfani damar raba bayanai na wuri da kuma lafiyar mai amfani da sauran masu gudanarwa ba tare da lalata sirrin bayanai ba.
A ranar 5 ga Afrilu, 2020, an kafa Ƙungiyar Kula da Lambar Sadarwa ta Duniya ta ƙungiyoyi waɗanda ke da sha'awar abin da ya kasance kusan irin wannan tsarin aiki da kuma hanyoyin sadarwa masu rikitarwa, da nufin rage rikicewa da kuma ba da damar musayar duniya tsakanin aikace-aikacen sa ido da faɗakarwa, babban fasalin samun yaduwar amfani.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta sanya yarjejeniyar BlueTress, wacce aikace-aikacen gwamnati ke amfani da ita, ta zama mai buɗewa.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa tsarin aiki na wayoyin hannu na Android da iOS, sun sanar da wani shiri na bin diddigin masu shiga tsakani; suna mai cewa za su kiyaye sirrin ta hanyar dogaro da haɗin Bluetooth mai ƙarancin ƙarfi da ɓoye sirrin sirri.
Sun kuma wallafa takamaiman fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, manufar ita ce a sa tsarin ya kasance cikin matakai uku, wato:
Kawo kayan aiki da za su baiwa gwamnatoci damar samar da aikace-aikacen sirri na hukuma don bin diddigin cutar korona.
Shigar da wannan aikin kai tsaye a cikin Android da iOS kamar yadda Google da Apple ke shirin magance matsalolin amfani da sa ido na yau da kullun ta hanyar rarraba tsarin da farko ta hanyar sabunta tsarin aiki sannan kuma ta hanyar cire su ta hanyar da zarar barazanar ta ƙare.
Sake sanya magani (wanda kuma ake kira sake amfani, sake tsarawa, canza manufa ko sauyawar magani) shine sake amfani da magani da aka amince dashi don magance wata cuta ko yanayin likita daban da abin da aka tsara don magance shi da farko.
Wannan wata hanya ce ta bincike da masu bincike suke bi don samar da magani mai lafiya da tasiri ga COVID-19.
Sauran hanyoyin bincike sun haɗa da samar da allurar rigakafin COVID-19 da kuma watsa plasma mai tsabta. SARS-CoV-2 yana da kusan sunadarai 66 da za a iya magance su da magani, kowannensu yana da wurare da yawa da ke da alaƙa da ƙwayoyin cuta.
Binciken waɗannan rukunin yanar gizon yana ba da kyakkyawan shiri game da samar da maganin rigakafin cutar da ke kashe sunadarai na COVID-19.
Wasu daga cikin mahimman sunadarai da ke niyya ga SARS-CoV-2 sune protease mai kama da papine, ribose-based DNA polymerase, helixase, S-protein, da adenosine biphosphate lipophosphatase.
Hussein AA, da sauransu sun yi nazarin wasu magungunan da aka zaɓa waɗanda aka inganta su kuma suka bincika su don su yi kama da magungunan da aka amince da su da suka fi kama da juna, da nufin hanzarta haɓaka ingantaccen maganin SARS-CoV-2 a cikin binciken farko na asibiti don ba da shawarar a cikin ƙirar gwajin asibiti.
Chloroquine magani ne na zazzabin cizon sauro wanda likitoci suke amfani da shi wajen magance wasu cututtukan rigakafi.
A ranar 18 ga Maris, WHO ta sanar da cewa chlorokine da hydroxychloroquine na iya kasancewa cikin magunguna huɗu da ake nazari a matsayin wani ɓangare na gwajin haɗin kai na asibiti.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chloroquine da hydroxychloroquine na iya farawa a ranar 24 ga Maris. A ranar 28 ga Maris, Hukumar Abinci da Magunguna ta FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin amfani na gaggawa (EUA).
Ba a amince da maganin ta hanyar gwajin asibiti na FDA ba kuma an ba da izinin amfani da shi a ƙarƙashin lasisin gaggawa ne kawai a matsayin gwajin gaggawa don kula da marasa lafiya da aka kwantar a asibiti amma ba za su iya samun magani a gwajin asibiti ba.
CDC ta sanar cewa har yanzu ba a tantance "amfani da hydroxychloroquine don rigakafin cutar SARS-CoV-2 ba, ko maganin sa, ko sashi ko kuma lokacinsa".
Likitoci sun ce suna amfani da miyagun ƙwayoyi ne idan "ba su da wani zaɓi".
Wata ƙungiyar bincike ta Turkiya a Istanbul tana yin ƙaramin bincike a kan amfani da chlorine tare da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da bincike mai zurfi a jami'ar Duke da kuma Oxford.
Makarantar Lajun ta Jami'ar New York tana gudanar da gwaji kan lafiyar da kuma ingancin maganin hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa Favipravir ya kasance "mai tasiri sosai".
A cikin marasa lafiya 35 a Shenzhen, sakamakon gwajin ya kasance mara kyau a matsakaicin kwanaki 4, yayin da tsawon rashin lafiya ya kai kwanaki 11 a cikin marasa lafiya 45 da ba su samu ba.
A wani bincike da aka yi a birnin Wuhan, an yi wa marasa lafiya 240 da ke fama da ciwon huhu, rabi sun sha maganin favifira, rabi kuma sun sha maganin ominfenvir.
Hukumar Magunguna ta Italiya ta gargadi mutane cewa hujjojin da ke goyon bayan maganin ba su da cikakke kuma ba su da tushe.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ƙara shi cikin ajiyarta, kuma za ta yi amfani da sojoji don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning, Shinzo Abe ya yi tattaunawa ta farko da gwamnatin Trump game da sayan maganin. Maganin na iya zama mai tasiri a magance mawuyacin hali inda cutar ta riga ta ninka.
Ba zai zama lafiya ba ga mata masu juna biyu ko waɗanda suke son su yi juna biyu.
Wani bincike da ya yi amfani da Lupinavir/Ritonavir (Caletra), wani maganin rigakafi da ya hada Lupinavir da Ritonavir, ya ce sakamakon "ba shi da amfani".
An tsara miyagun ƙwayoyi don hana HIV ya yi kwafi ta hanyar haɗa shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magungunan don samun mahaɗan da ke da alaƙa da SARS-CoV-2 kuma ƙungiyar kimiyya tana fuskantar ƙin yarda game da tura albarkatu don sake tsara abubuwan da ake amfani da su don maganin cutar HIV/AIDS.
Hukumar Lafiya ta Duniya ta ƙara Lupinavir/Ritonavir a gwajin hadin kai na duniya.
Gilead Sciences ta haɓaka Remdesivir a matsayin magani don cutar Ebola da kamuwa da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir yana da aikin antiviral a cikin dakin gwaje-gwaje akan yawancin ƙwayoyin cuta, mucosal, da coronaviruses.
Wata matsala da ke tattare da maganin rigakafin ƙwayoyin cuta ita ce, yana iya haifar da ƙin kamuwa da ƙwayoyin cuta ta hanyar maye gurbi da zai iya kai ga kamuwa da cututtuka masu tsanani.
Wasu nazarin farko na asibiti sun nuna cewa Remdesivir yana da babban shinge na jini ga juriya. Akwai gwaje-gwaje da yawa a halin yanzu, ciki har da biyu da aka gudanar a asibitocin Jami'ar Cleveland; ɗaya a kan marasa lafiya masu matsakaici, ɗayan kuma ga marasa lafiya masu tsanani.
Akwai gwaje-gwaje uku na asibiti game da bitamin C na rigakafin cutar a kan marasa lafiya da aka kwantar da su a asibiti da ke fama da mummunar cuta saboda COVID-19, da kuma gwaje-gwaje biyu da aka sarrafa ta amfani da maganin karya (China, Kanada) da kuma gwajin da ba a sarrafa shi ba (Italiya).
Jihar New York ta fara gwaji kan tasirin maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Lafiya da Magunguna ta Japan (NCGM) na shirin gudanar da gwajin asibiti kan amfani da alvesco (cyclosonide) wanda Teijin ke samarwa, corticosteroid da ake sha don maganin asma, don magance marasa lafiya da ke dauke da sabon kwayar cutar korona kafin bayyanar cututtuka.
Ana gudanar da gwaji na kashi na biyu na amfani da nau'in enzyme mai canzawa na angiotensin 2 a kan marasa lafiya 200 da ake bukata su shiga gwajin daga asibitoci masu tsanani a Denmark, Jamus, da Austria domin sanin ingancin magani.
Masu bincike daga Cibiyar Kula da Zuciya ta Montreal a Kanada suna nazarin matsayin colchicine wajen rage kumburi da kuma rikitarwa na huhu a cikin marasa lafiya da ke da alamun cutar COVID-19.
Binciken, wanda ake kira Kolcorona, ya kunshi manya 6,000 masu shekaru 40 zuwa sama waɗanda likitoci suka gano suna da cutar COVID-19 kuma suka sami ƙananan alamun cutar ba tare da bukatar asibiti ba.
Mata masu juna biyu, masu shayarwa ko kuma waɗanda ba su da hanyar hana haihuwa ba ba su cancanci wannan ba.
Ana kuma gwada wasu magungunan hana kumburi a Italiya.
A yanzu haka ana amfani da maganin da ke da nauyin kwayoyin halittar low molecular weight (LMOH) a yawancin marasa lafiya, kuma Hukumar Kula da Magunguna ta Italiya ta bukaci a wallafa jagororin amfani da shi.
An sanar da gudanar da bincike mai yawa a Italiya kan marasa lafiya 300 don bincika amfani da sodium inoxaparin a cikin rigakafin cututtuka da magungunan magani a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai kan sake amfani da maganin rigakafin cutar da aka amince da shi wanda aka tsara don magance barkewar cutar kamar Mars, SARS, da West Nile.
Ripavirin: Masana sun bada shawarar yin amfani da ripavirin don maganin COVID-19 bisa ga fitowar 7 na jagororin kasar Sin.
Omifenovir: Masana sun bada shawarar yin amfani da Omifenovir don maganin COVID-19 bisa ga fitowar 7 na jagororin kasar Sin.
Wasu maganin rigakafi da masana suka gano cewa za a iya sake amfani da su a matsayin maganin COVID-19 sun haɗa da:
Tuselizumab (mai karɓar maganin Interleukin 6): An amince da shi daga China.
An kuma yi gwaji a Italiya da China.
Rigakafin COVID-19 rigakafin rigakafin cutar korona 2019 ne.
Ko da yake babu allurar rigakafin da aka kammala gwajin asibiti, ana ƙoƙarin yin gwaji da yawa don samar da wannan maganin.
A ƙarshen Fabrairu 2020, WHO ta ce ba ta tsammanin za a sami allurar rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
Akwai alluran rigakafi biyar da aka ƙaddamar a matakin farko na gwajin lafiya a watan Afrilu.
An gano COVID-19 a watan Disamba na shekarar 2019.
Wata babbar annobar ta bazu a duniya a shekarar 2020, wanda ya haifar da zuba jari da bincike mai yawa don samar da rigakafi.
Ƙungiyoyi da yawa suna amfani da wannan kwayar halittar don samar da allurar rigakafin SARS-CoV-2.
Bukatun Coalition for Epidemic Preparedness Innovations don haɓaka allurar rigakafi, wanda aka sanar a watan Afrilu, shine saurin, ƙarfin masana'antu, yaduwa da kuma isa ga duniya.
A watan Afrilu, masana kimiyya na Coalition for Epidemic Preparedness Innovations sun ba da rahoton cewa ana gudanar da bincike da ci gaban dandamali daban-daban guda 10 a farkon 2020 don ƙirƙirar rigakafin COVID-19 mai tasiri.
Babban manufofin dandalin da suka ci gaba zuwa matakin farko na binciken aminci sun haɗa da:
DNA (oxygen-deficient ribosomal DNA da ribosomal DNA) (mai haɓaka mataki na farko da kuma takardar rigakafin Moderna, da mRNA-1273)
Mai ɗaukar kwayar cutar (mai tsara matakin farko da kuma mai neman rigakafin: Moderna, mai ɗaukar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cuta)
A cewar masana kimiyya na Coalition for Epidemic Preparedness Innovations a watan Afrilu, akwai takardun rigakafi 115 a farkon matakan ci gaba, tare da tabbatar da ayyukan aiki 78, (79, a cewar Cibiyar Milken), kuma an sanar da wasu ayyuka 37, amma tare da samun karancin bayanai na gama gari (wanda ake zaton ana shirinsa ko kuma ana tsara shi).
Gwajin na farko da na biyu na gudanar da gwajin farko na aminci da rigakafi, yawanci bazuwar, da kuma sarrafawa a wurare da yawa, tare da tantance mafi daidaito da inganci.
Gwajin mataki na uku yawanci ya ƙunshi mutane da yawa, ciki har da rukunin da aka yi amfani da su, da kuma gwada yadda allurar rigakafin take hana cutar, tare da lura da munanan sakamako na maganin da ya dace.
Daga cikin alluran rigakafi 79 da ake shirin samarwa (wanda aka tabbatar da shi a farkon watan Afrilu na 2020), 74 ba su riga sun kai ga kimantawa a cikin mutane ba (har yanzu ana gudanar da bincike "kafin asibiti").
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar cewa tana binciken yiwuwar yin allurar rigakafin kwayar cuta da za ta iya gyara kwayoyin kwayar cutar don ta haifar da amsawar rigakafi.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar rigakafin rigakafin duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin rigakafin, da nufin fara gwajin mutum a 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafi ta kasar Sin a ranar 26 ga Janairu, 2020, kuma a Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, kamfanonin magunguna na Janssen, karkashin jagorancin Haneke Schwitmiker, sun sanar da cewa sun fara aiki kan samar da rigakafi.
Janssen tana haɗin gwiwa wajen samar da allurar rigakafin baki tare da abokin aikinta na fasahar kere-kere, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, OncoGen Laboratory a Romania ta wallafa wani bincike game da ƙirar allurar rigakafi da ke da irin wannan fasaha da ake amfani da ita wajen maganin cutar kansa da sabon rigakafin antigen.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun gama samar da allurar kuma sun fara gwajin.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani reshen Generex, ya sanar da cewa ya fara aikin rigakafin don ƙirƙirar maganin Ii-Key peptide na COVID-19.
Suna son su samar da maganin rigakafi da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirin samar da rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Binciken Likitocin Amurka da Kayan Aikin Soja a Fort Derek da Cibiyar Bincike ta Soja ta Walter Reed a Silver Spring, duka biyun a Yammacin Maryland, sun sanar da cewa suna kan aikin allurar rigakafi.
A kusan 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta kafa wata kungiya tare da Novavax Inc.
A cikin samar da rigakafi.
Abokan hulɗa sun kuma sanar da tsare-tsaren gwajin rigakafin asibiti da gwajin asibiti na mataki na 1 zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar cewa tana aiki tare da wasu mutane 11 da aka ware, kuma ko da tare da hanzarta aikin zai ɗauki aƙalla shekara ɗaya da rabi zuwa kusan shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasaha na zamani a Quebec City, Quebec, ya ba da rahoton cewa ya haɓaka kwayar cutar coronavirus tare da wani ɓangare na kudade daga Cibiyoyin Nazarin Lafiya na Kanada.
Ana gudanar da gwajin rigakafin a cikin dakin gwaje-gwaje, tare da shirin gwadawa a cikin mutane a watan Yuli ko Agusta 2020.
A farkon wannan makon, jaridar Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac "babban kuɗi" don samun damar yin rigakafin COVID-19, wanda gwamnatin Jamus ta bukaci.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka rigakafin da ya dogara da RNA mai aikawa.
Rigakafin mai amfani da RNA mai aikawa mai suna BNT162 a halin yanzu yana cikin gwajin rigakafin ne da ake sa ran fara gwajin a watan Afrilu na shekarar 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar kere-kere na Italiya, ya sanar da cewa zai sami sakamakon gwajin rigakafin a watan Afrilu na 2020 kuma za a iya fara gwajin rigakafin a cikin mutane a lokacin kaka.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPA) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike kan allurar COVID-19 wanda ya haɗa da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kai jimillar saka hannun jari na Coalition for Epidemic Preparedness Innovations a cikin haɓaka allurar COVID-19 zuwa dala miliyan 29.
Abokan haɗin gwiwar sabbin abubuwan kirkirar shirye-shiryen annoba don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi don takardun rigakafi daban-daban guda shida.
Masu bincike a kwalejin Imperial a Landan sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da rigakafin rigakafin cutar COVID-19 mai saurin kara karfin kansa.
An samar da maganin a cikin kwanaki 14 bayan an samu jerin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da kudade na dala miliyan 275 na Kanada don ayyukan bincike 96 kan matakan kiwon lafiya na COVID-19, gami da alluran rigakafi da yawa da aka ƙaddamar a kamfanoni da jami'o'in Kanada, kamar Medicago Initiative da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da dala miliyan 192 na musamman don samar da allurar rigakafin COVID-19, tare da tsare-tsaren kafa "Bankin rigakafin" na ƙasa na sabbin alluran rigakafi da za a iya amfani da su idan cutar ta sake barkewa.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwaji don PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, inda suka ba da rahoton cewa "allurar rigakafin SARS-CoV-2 na S1 subunit da aka ba da su ta hanyar microsurgery sun haifar da amsa mai ƙarfi ga takamaiman antibody na rigakafi [a cikin beraye] wanda ya bayyana tun daga makonni 2 bayan allurar".
A Kanada a ranar 16 ga Afrilu, 2020, Kwalejin Magunguna a Jami'ar Waterloo ta sanar da ƙirar rigakafin mai zaɓin rigakafi bisa ribosome DNA mai ƙarancin oxygen a matsayin mai yuwuwar fesa hanci.
Ta amfani da maganin rigakafi, ribosome DNA zai tsara iskar oxygen don sake haifuwa a cikin kwayoyin halittar mutum don samar da kwayoyin cutar da ba su da lahani, wanda hakan zai iya motsa tsarin garkuwar jiki don samar da kwayoyin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun hada albarkatu don samun damar manyan kwamfutoci daga IBM, tare da albarkatun girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako dabam, wanda ake kira sakamako marar ma'ana.
Wannan yana nufin cewa za su iya samun amfanin da ya wuce cutar da suke fama da ita.
Wani gwaji na Australiya yana neman a yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Ba za a iya samun lafiya ko kuma tasiri ba a alluran rigakafin da ake ci gaba da samarwa.
Bincike na farko don kimanta ingancin allurar rigakafi ta amfani da takamaiman samfuran dabbobi don COVID-19, kamar su berayen da aka canza su ta hanyar kwayar halitta ta Angiotensin 2, da sauran dabbobin gwaji, da kuma shugabannin da ba mutane ba, ya nuna buƙatar matakan kiyaye lafiyar kwayar halitta na matakin 3 don magance ƙwayoyin cuta masu rai, da daidaitawa na duniya don tabbatar da matakan aminci na daidaito.
An gwada allurar rigakafin SARS da na ciwon numfashi na Gabas ta Tsakiya a kan dabbobi da ba mutane ba.
Tun daga shekarar 2020, babu magani ko rigakafin SARS da aka tabbatar da cewa yana da lafiya da tasiri a cikin mutane.
Dangane da takardun bincike da aka buga a cikin 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don maganin SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duniya. Babu kuma wani allurar rigakafin da aka amince da ita game da cutar ta Gabas ta Tsakiya.
Lokacin da Maris ya bazu, an yi imanin cewa binciken SARS zai iya samar da samfurin da zai taimaka wajen samar da allurar rigakafi da kuma maganin cutar Mars-CoV.
Ya zuwa Maris 2020, akwai rigakafin cutar ta gabashin gabashin (RAD) guda daya da ya kammala gwaji na farko a cikin mutane, kuma akwai wasu rigakafi guda uku da ake ci gaba, duk sun kasance rigakafin da ke kan cutar, rigakafin da ke kan cutar ta gonar (ChAdOx1-MERS, da BVRS-GamVac), da kuma rigakafin da ke kan cutar MVA (MVA-MERS-S).
Shafukan sada zumunta sun tayar da ka'idar makirci da ke nuna cewa an san cutar COVID-19 kuma an riga an samu rigakafin.
Takardun mallakar da aka ambata a shafukan sada zumunta da dama sun yi nuni ne ga takardun mallakar da aka samu na jerin kwayoyin halitta da kuma allurar rigakafin wasu nau'in kwayar cutar korona kamar SARS-CoV-2.
Cutar kwayar cutar korona ta 2019 (COVID-19) cuta ce da ake haifar da ita ta kwayar cutar korona ta 2 wadda ke da nasaba da cutar SARS-CoV-2.
Alamun da suka fi kowa sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Wasu alamun na iya haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da kuma ciwon ciki.
Lokaci tsakanin kamuwa da cutar da bayyanar cututtuka yawanci kwanaki biyar ne, amma yana iya wucewa daga kwana biyu zuwa kwana goma sha huɗu.
Ko da yake yawancin cututtuka suna da ƙananan alamu, wasu suna ƙaruwa zuwa kumburi na huhu da kuma rashin aiki da yawa.
A ranar 17 ga Afrilu, 2020, an ba da rahoton kamuwa da mutane sama da miliyan 2.24 a cikin ƙasashe 210 da yankuna, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yaduwa ne a tsakanin mutane yayin da suke hulɗa, galibi ta hanyar fesawa yayin tari, tari, ko magana.
Sa'ad da aka watsa ruwa a lokacin da ake yin bututun, yawanci yakan fāɗi a ƙasa ko kuma a kan saman ƙasa maimakon ya yi nisa sosai.
Mutane ma za su iya kamuwa da cutar idan suka taɓa wani gurɓataccen abu, sai suka taɓa idanunsu, hanci, ko kuma bakinsu.
Kwayar cuta za ta iya rayuwa a kan rufi har tsawon sa'o'i 72.
Yana da saurin kamuwa a cikin kwanaki uku na farko da bayyanar cututtuka, ko da yake yana iya yaduwa kafin bayyanar cututtuka da kuma a ƙarshen cutar. Hanyar ganewar asali ita ce ta hanyar yin amfani da maganin nan take na RT-PCR (RTC-PCR) ta hanyar maganin hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da kamuwa da cutar da kuma masu kula da su.
Shawarwarin amfani da abin rufe fuska ga jama'a sun bambanta, wasu hukumomi sun bada shawarar kada a yi amfani da shi, wasu sun ce ba haka ba, wasu kuma sun hana yin amfani da shi.
A yanzu, babu maganin rigakafi ko magani na musamman na cutar COVID-19.
An ba da rahoton yaduwar cutar a cikin gida a yawancin ƙasashe a duk yankuna shida na WHO.
Waɗanda suke da cutar ba sa nuna alamun cutar ko kuma suna nuna alamun cutar kamar mura, kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Ana ba da shawara a nemi taimakon likita nan da nan idan akwai alamun gaggawa kamar wahalar numfashi, ciwo ko matsi a cikin ƙirjin, rikicewa, wahalar farkawa, fuska ko lebe suna da shuɗi.
A wasu lokatai, za a iya samun wasu alamun da ke nuna cewa mutum yana numfashi, kamar su tari, hanci, ko kuma ciwon makogwaro.
An lura da wasu alamun da ke shafar tsarin narkewar abinci kamar su, rashin jin daɗi, da kuma zawo a wurare dabam dabam.
Da farko, wasu mutane a China suna shan wahala ne kawai daga ƙuntatawa da kuma bugun zuciya.
A wasu, cutar tana iya kaiwa ga ciwon huhu, rashin aiki da gabobin jiki da yawa, da mutuwa.
Ana kiran wannan lokacin kula da yara.
Lokaci na ciki na COVID-19 yawanci kwanaki biyar zuwa shida ne amma yana iya zama tsakanin kwana biyu zuwa 14.
Kashi 97.5 na waɗanda ke nuna alamun cutar za su yi hakan cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duka mutane ba ne ke nuna alamun cutar.
Har yanzu ba a fahimci matsayin masu dauke da cutar ba tare da bayyanar cututtuka ba wajen watsa cutar; duk da haka, hujjoji na farko sun nuna cewa suna iya taimakawa wajen yada cutar.
Ba a san yawan mutanen da suka kamu ba tare da bayyanar cututtuka ba kuma ana ci gaba da bincike. Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Koriya (KCDC) sun ruwaito cewa kashi 20 cikin dari na dukkan wadanda aka tabbatar da su ba su nuna alamun cutar ba yayin da suke asibiti.
Hukumar Lafiya ta kasa ta kasar Sin ta fara lissafin wadanda ba su da alamun cutar a cikin adadin yau da kullum a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu a wannan rana, 130 (78%) daga cikin wadannan mutane ba su da alamun cutar a gwajin.
Wasanni da wasannin da ake yi na iya ɗauke da ƙwayoyin cuta da yawa.
Magana da ƙarfi tana sa mutane su yi magana fiye da yadda muke yi.
Wani bincike a Singapore ya nuna cewa tari ba tare da rufe baki ba zai iya haifar da feshi mai nisa har zuwa mita 4.5 (15 feet).
Ko da yake ba a yawan watsa cutar ta iska, National Academy of Sciences ta nuna cewa ana iya yada ta ta hanyar iska mai iska. Binciken samfurori daga wuraren da ake ajiye iska a cikin ɗakunan mutane ya nuna cewa kwayar cutar ta riga ta kamu da cutar.
Wasu hanyoyin magani kamar su tubal nephritis da kuma CPR na iya sa abubuwa da ke cikin numfashi su fito kamar feshi, kuma cutar ta yaɗu ta iska.
Ko da yake akwai damuwa cewa za a iya yada shi ta hanyar fitsari, ana ganin cewa wannan hadarin yana da iyaka. Kwayar cutar tana da saurin kamuwa yayin da mutane ke da alamun cutar; yayin da za ta iya yaduwa kafin bayyanar cututtuka, haɗarin ya fi ƙanƙanta.
Cibiyar Kare da Cututtuka ta Turai (ECDC) ta ce duk da cewa akwai wasu rashin tabbas game da yadda sauƙin cutar take yaɗuwa, mutum ɗaya na iya yaɗa cutar daga mutane biyu zuwa uku. Kwayar cutar tana iya zama a kan rufi na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cewa cutar tana wanzuwa har kwana daya a kan takarda mai wuya, har kwana uku a kan filastik (polypropylene) da bakin karfe mai tsayayye da tsatsa (AISY 304), har tsawon awa hudu a kan jan karfe kashi 99 cikin dari.
Amma, wannan ya bambanta bisa ga zafi da kuma zafin jiki.
Sabulu da kayan kashe cuta suna da tasiri idan aka yi amfani da su yadda ya kamata; sabulu yana narkar da kuma dakatar da ƙwayar mai da ke kare cutar, da kuma kawar da fata da sauran wurare daga cutar.
Wasu hanyoyin, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe jini), ba su da tasiri sosai. A wani bincike a Hong Kong, an ɗauki samfurin sallama bayan kwana biyu da shigar da mutum asibiti.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna cewa suna da kwayar cutar sosai, kuma a rana ta biyu na gwajin, mai haƙuri na shida ya nuna cewa yana da kwayar cutar sosai.
SARS-CoV-2 wani sabon kwayar cutar korona mai nasaba da cutar numfashi mai tsanani, wanda aka fara ganowa daga mutane uku da ke fama da ciwon huhu a cikin rukunin cutar numfashi mai tsanani a birnin Wuhan.
Sabuwar cutar SARS-CoV-2 tana da halaye iri ɗaya da na coronaviruses masu kama da ita da ke wanzuwa a yanayi.
A waje da jiki, sabulu na gida yana kashe kwayar cutar, yana lalata garkuwar kariya. SARS-CoV-2 tana da dangantaka da SARS-CoV na asali.
Cutar COVID-19 tana shafar huhu sosai domin kwayar cutar tana shiga cikin ƙwayoyin da ke cikin ƙwayoyin cuta ta hanyar enzyme mai sauya nau'in angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin cuta na nau'in 2 da ke cikin huhu.
Kwayar cutar tana amfani da wani furotin na musamman na sukari da ake kira spike don ya haɗa da ACE2 kuma ya shiga cikin kwayar mai masaukin.
Kashi 12 na waɗanda suka kamu da cutar da aka kwantar a asibiti a birnin Wuhan na ƙasar Sin sun kamu da ciwon zuciya mai tsanani, kuma ya fi faruwa a cikin mawuyacin yanayi.
Rashin lafiyar zuciya da jijiyoyin jini suna da yawa, saboda rashin lafiyar jiki da kuma rashin lafiyar jiki yayin da cutar ke ci gaba, amma kuma ciwon zuciya mai tsanani yana iya kasancewa da nasaba da masu karɓa na ECA2 a cikin zuciya.
Masu karɓar ECA2 suna da muhimmiyar rawa a cikin zuciya kuma suna da hannu wajen yin aikinta.
An samu ƙaruwar ƙwayoyin cuta (31%) da kuma ƙwayoyin jini (25%) a cikin marasa lafiya da ke sashen kula da lafiya na COVID-19, wanda hakan na iya danganta da rashin iya hango abin da zai faru. An gano cewa a lokacin da aka yi bincike kan jikin mutanen da suka mutu saboda COVID-19, akwai lalacewar jini (DAD) da kuma ƙwayoyin cuta masu kumburi da ke dauke da ƙwayoyin cuta a cikin huhu.
Ko da yake SARS-CoV-2 yana kaiwa ga ƙwayoyin ECA2 a cikin numfashi, marasa lafiya masu cutar COVID-19 suna fama da alamun cutar hyperhidrosis.
Musamman, an nuna cewa kwayoyin T-cell na GM-CSF masu haifar da cuta suna da alaƙa da kawo kwayoyin guda ɗaya na interleukin 6 wanda ke haifar da kumburi da cututtukan huhu a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton cewa akwai wani kumburi na jini a lokacin autopsy.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Ana yin gwajin ta hanyar yin amfani da maganin da ake kira RT-PCR.
Ana yin gwajin ne ta hanyar yin amfani da samfurin numfashi da aka ɗauka daga wani abin shafa na hanci; duk da haka, ana iya yin amfani da abin shafa na hanci ko samfurin abin shafa.
Sakamakon yana samuwa cikin sa'o'i kadan zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a ɗauki jini biyu a kowane mako biyu, kuma sakamakon ba shi da muhimmanci.
Masana kimiyya na kasar Sin sun iya ware wani nau'in kwayar cutar korona da kuma rarraba jerin kwayoyinta domin dakunan gwaje-gwaje a duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da kwayar cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya ko a'a), amma ba a yi amfani da shi sosai ba tukuna.
Gwajin da Sin ta yi ya nuna cewa gwajin ya kai kashi 60 zuwa 70 cikin dari.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin farko na asibiti a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagororin bincike da aka bayar daga asibitin Chongnan na Jami'ar Wuhan sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halayen asibiti da haɗarin annoba.
Ruwan gilashi mai rufi biyu da ke da yawa da ke da bambanci da kuma baya suna da alamun da suka fi kowa a farkon kamuwa da cuta.
Za a iya samun ɓarna a ƙarƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin
Akwai bayanai kaɗan game da ƙwayoyin cuta da kuma ilimin cututtukan COVID-19.
Babban sakamakon binciken gawawwakin:
Binciken: Ciwon gaba, ciwon kumburi, kumburi da kuma ciwon huhu
Za a iya lura da nau'i huɗu na cutar huhu ta ƙwayar cuta:
Ƙananan ciwon huhu: kumburi, ƙwayoyin huhu da yawa, ƙwayoyin cuta da yawa, ƙwayoyin cuta da yawa, ƙwayoyin cuta da ke sa jijiyoyin jini su yi yawa, kuma ƙwayoyin cuta masu girma da yawa suna girma
Ciwon huhu mai tsanani: lalacewar hanci da kuma jini da ke da yawan ɓarkewa.
Rashin lafiyar ƙwayar cuta na iya sa mutum ya yi ciwon kumburi mai tsanani da kuma rashin iskar oxygen.
Kula da ciwon huhu: daidaita abubuwan da ke fitowa daga hanjin mutum da kuma ƙwayoyin cuta na huhu
Jini: Ƙwaƙwalwa da ke cikin jijiyoyin jini (DIC)
Matakan kariya na rage yiwuwar kamuwa da cutar sun haɗa da zama a gida, guje wa wuraren da mutane suke da yawa, wanke hannu da sabulu da ruwa sosai na akalla sakan 20, yin tsabtace numfashi, da kuma guje wa taɓa ido, hanci, ko baki da hannuwa da ba a wanke ba.
CDC ta ba da shawarar a rufe baki da hanci da tawul idan ka yi tari ko kuma tari, kuma a yi amfani da ciki na sutura idan babu tawul.
Ana ba da shawarar a wanke hannu sosai bayan wani tari ko tari.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, wani ɓangare don rage yaduwar kamuwa da cuta daga waɗanda ba su da alamun cutar. Dabarun nisantar jama'a suna nufin rage haɗuwa da manyan mutane ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiye-tafiye da soke manyan tarurrukan jama'a.
Ƙa'idodin nesa sun kuma haɗa da mutane su kasance aƙalla ƙafa 6 (1.8 m) daga juna.
Babu wani magani da aka sani da zai iya hana COVID-19. Kuma saboda ba a sa ran samar da allurar rigakafi har zuwa 2021 ba da wuri, babban ɓangaren sarrafa COVID-19 shine ƙoƙarin rage girman cutar, wanda aka sani da "yarfafa ƙwanƙwasa".
CDC ta kuma ba da shawarar mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla sakan 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun yi datti sosai, kafin cin abinci, da kuma bayan sun goge hanci, sun yi tari ko kuma sun yi tari.
Ya kuma bada shawarar yin amfani da maganin kashe cutar hannu wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa, idan sabulu da ruwa kawai ba su da yawa. Ga yankunan da ba a samun isasshen kayan tsabtace hannu na kasuwanci, WHO ta ba da shawarar hada abubuwa biyu da aka samar a gida.
Abubuwan da ke hana ƙwayoyin cuta a waɗannan abubuwa biyu sun fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin giya; "ba mai tsabtace hannu ba ne".
Ana ƙara glycerol a matsayin mai ɗanɗano.
Mutane suna samun taimako, wanda zai iya haɗa da maganin ruwa, taimakon iskar oxygen, da taimakon sauran gabobin da suka kamu.
CDC ta ba da shawarar cewa duk wanda ake zargi da kamuwa da cutar ya sa takunkumin fuska.
Ana amfani da maganin ECMO don magance matsalar rashin numfashi, amma har yanzu ana nazarin amfaninsa.
Ana ba da shawarar tsabtace jiki da kuma salon rayuwa mai kyau da abinci don inganta garkuwar jiki.
Magani mai taimako zai iya taimaka wa waɗanda ke da ƙananan alamun cutar a farkon lokacin kamuwa da cutar. Hukumar Lafiya ta Duniya da Kwamitin Lafiya na China sun wallafa shawarwari don kula da waɗanda aka kwantar a asibiti saboda COVID-19.
Masana kula da gaggawa da masu ilimin cututtukan huhu a Amirka sun tattara shawarwarin magani daga ƙungiyoyi dabam dabam a cikin wani littafin kula da gaggawa da ake samu a kan layi.
Tun daga watan Afrilu na shekarar 2020, babu wani takamaiman magani na COVID-19.
Don bayyanar cututtuka, wasu likitoci na musamman suna ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen a matsayin magani na farko.
Dole ne a ɗauki matakan kariya don rage haɗarin kamuwa da cutar, musamman a wuraren kiwon lafiya, lokacin da ake yin ayyuka da za su iya haifar da fesawa, kamar su yin bututun ruwa ko numfashi da hannu.
Ga masu kula da lafiyar da ke kula da waɗanda ke da cutar COVID-19, CDC ta ba da shawarar a sanya mutum a cikin dakin keɓewa daga kamuwa da cuta ta iska (AIR) da kuma yin amfani da matakan tsaro, da kuma na rigakafi. CDC ta bayyana jagororin amfani da kayan kariya na mutum (PPE) a lokacin annobar.
Abin da aka ba da shawara: kayan kariya na mutum, na'urar numfashi ko abin rufe fuska, kwaroron roba, da kuma tabarau. Idan kana da na'urar numfashi (maimakon abin rufe fuska) zai fi kyau ka yi amfani da shi.
An amince da na'urar numfashi ta N95 don masana'antu, amma Hukumar Abinci da Magunguna ta amince da amfani da abin rufe fuska a ƙarƙashin izinin amfani na gaggawa (EUA).
An tsara su ne don su kāre su daga abubuwa masu saurin tashi kamar ƙura, amma ba a san ko suna da tasiri a kan wani abu ba idan aka yi amfani da su a wasu hanyoyi.
Idan ba a samu abin rufe fuska ba, CDC ta ba da shawarar yin amfani da abin rufe fuska, ko abin rufe fuska da aka yi a gida a matsayin mafita ta ƙarshe.
Yawancin mutane da ke da cutar COVID-19 ba su da ciwo sosai da zai sa a yi amfani da maganin numfashi na roba ko kuma wasu hanyoyin, amma wasu suna bukatar yin hakan.
Ana ci gaba da nazarin irin taimakon numfashi da ake bayarwa ga waɗanda ke fama da rashin numfashi da ke da nasaba da COVID-19 a asibitoci, tare da wasu shaidu da ke nuna cewa ana iya guje wa yin amfani da bututun hanci mai gudana sosai ko kuma matsin lamba mai kyau na biyu na iska.
Ba a san ko zabin zai amfane waɗanda suke da ciwo mai tsanani ba.
Wasu likitoci sun fi son ci gaba da yin amfani da na'urar numfashi ta hanyar gas a duk lokacin da aka samu domin wannan fasaha tana rage yaduwar ƙwayoyin iska fiye da na'urar numfashi mai gudana sosai.
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti da za su iya kula da yawan jama'arsu, kuma hakan yana hana tsarin kiwon lafiya kula da karuwar masu cutar COVID-19 da ke bukatar a kwantar da su a asibiti.
Wani bincike a China ya gano cewa kashi 5 cikin 100 na waɗanda suka kamu da cutar sun shiga sashen kula mai tsanani, kashi 2.3 cikin 100 sun bukaci taimakon numfashi, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30 cikin 100 na waɗanda aka kwantar da su asibiti saboda COVID-19 suna zuwa sashen kulawa mai tsanani.
Yin numfashi na ƙara zama da wuya yayin da cutar ta ARDS ke tasowa a cikin waɗanda ke da COVID-19, kuma isar da iskar oxygen na ƙara ƙalubale.
Ana bukatar na'urar numfashi da ke da matsin lamba da kuma matsin lamba mai kyau don ƙara yawan iskar oxygen da kuma rage haɗarin raunin huhu da ke tattare da na'urar numfashi da kuma rage sanyin zuciya.
Ƙarfin jini mai ƙarfi na iya zama babu shi a cikin na'urar numfashi na dā.
Bincike kan hanyoyin warkarwa ya fara a watan Janairu na shekarar 2020, kuma magungunan rigakafin ƙwayoyin cuta da dama suna cikin gwajin asibiti.
Remdesivir ya fi kowa kyau.
Ko da yake zai ɗauki har zuwa 2021 kafin a samu sababbin magunguna, magunguna da yawa da ake gwadawa sun riga sun sami izini don wasu amfani ko kuma suna cikin wani mataki na ci gaba na gwaji.
Ana iya gwada maganin rigakafin cutar a kan waɗanda suke da ciwo mai tsanani.
Hukumar Lafiya ta Duniya ta ba da shawarar masu sa kai su shiga gwajin inganci da amincin hanyoyin magani. Hukumar Abinci da Magunguna ta ba da izinin ɗan lokaci don amfani da plasma mai gyara a matsayin magani na gwaji a cikin yanayin da rayuwar mutum ke cikin haɗari ko kuma kai tsaye.
Ba a yi gwajin asibiti da ya nuna cewa yana da lafiya kuma yana da tasiri a kan cutar ba.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da manhajar wayar salula domin magance barkewar cutar.
Ana bukatar masu amfani su shigar da suna da lambar shaidar.
Aikace-aikacen na iya gano 'masu shiga' ta amfani da bayanan sa ido kuma saboda haka haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba yanayin wasu masu amfani uku.
Idan an gano wata barazana, app ɗin ba wai kawai yana ba da shawarar keɓe kai ba ne, amma kuma yana faɗakar da jami'an kiwon lafiya na gida. Yana amfani da manyan bayanan bayanai na wayar salula, fasahar gane fuska, bin diddigin wayar salula, da kuma hankali na wucin gadi don bin diddigin waɗanda ke da cutar da waɗanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta bai wa jami'an tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zaton suna da cutar korona.
An dauki matakan hana mutane shiga gidajensu da kuma kare duk wanda zai iya shiga cikin mutanen da suka kamu da cutar.
Har ila yau a watan Maris na 2020, Deutsche Telekom ta raba bayanan wuraren da aka tara na wayoyin salula tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don dalilai na bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano masu karya dokar keɓewa.
Kwamishinan kiwon lafiya na yankin Italiya, Mr. Giulio Galleria ya ce kamfanonin wayar salula sun gaya masa cewa "kashi 40 na mutane har yanzu suna tafiya a ko'ina".
Gwamnatin Jamus ta gudanar da wani taron hackathon na tsawon sa'o'i 48 a karshen mako inda mutane sama da 42,000 suka halarta.
Shugaban Estonia, Uwargida Kirsty Kalliolaid, ta kuma gabatar da gayyatar duniya don gabatar da sabbin hanyoyin hana yaduwar cutar korona.
Mutane na iya jin damuwa saboda keɓewa, ƙuntatawa na tafiya, illa na magani, ko kuma tsoron kamuwa da cutar kanta.
BBC ta wallafa wani zance da Rory O'Connor ya rubuta: "Ƙara warewa daga jama'a, kaɗaici, damuwa game da lafiyar jiki, matsi, da kuma koma bayan tattalin arziki suna kawo bala'i da ke shafan lafiyar mutane da kuma lafiyarsu".
Cutar za ta iya zama mai sauƙi da ba ta da wata alama ko kuma ta zama marar alama, kamar yadda take da wasu cututtuka na sama kamar su mura.
Sau da yawa, marasa tsanani suna warkewa cikin makonni biyu, amma masu tsanani suna bukatar makonni uku zuwa shida.
Mata masu juna biyu na iya zama cikin haɗarin kamuwa da cutar COVID-19 bisa ga bayanai na wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma har yanzu akwai ƙarancin bayanai game da COVID-19. COVID-19 na iya shafar huhu a wasu mutane, yana haifar da kumburi.
A cikin waɗanda cutar ta fi shafa, COVID-19 na iya saurin zama matsanancin ciwon numfashi (ARDS) wanda ke haifar da rashin numfashi, ciwon shanyewar jiki ko kuma rashin aiki da gabobin jiki.
Abubuwan da ke tattare da COVID-19 sun haɗa da kamuwa da cuta, ƙwayoyin jini da ba su da kyau, da kuma cutar zuciya, koda da hanta.
An gano kashi 6 cikin dari na waɗanda ke da cutar COVID-19 da aka kwantar da su asibiti suna da cutar cuta ta jini, musamman, an ƙara lokaci na prothrombin, yayin da aka gano rashin aikin koda a kashi 4 cikin dari.
Kusan kashi 20-30% na waɗanda ke da COVID-19 suna da ƙaruwar ƙwayoyin cuta na hanta (amine transporters).
A cewar wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, daga cikinsu kwanaki biyar a asibiti.
Duk da haka, matsakaicin lokacin da waɗanda aka kai su sashen kula mai tsanani suka mutu tsakanin lokacin da aka kwantar da su asibiti kwanaki bakwai ne.
A cikin binciken farko, matsakaicin lokacin daga bayyanar cututtuka zuwa mutuwa kwanaki 14 ne, kuma jimillar adadin cututtuka daga kwanaki shida zuwa kwanaki 41.
A wani bincike da Hukumar Lafiya ta kasa ta Sin ta yi, yawan mace-macen maza ya kai kashi 2.8 cikin dari, yayin da mace-mace ta kai kashi 1.7 cikin dari.
Binciken jikin mutum na jikin mutum bayan mutuwa ya nuna cewa akwai lalacewar hakori da ke faruwa a cikin ƙwayoyin fibromycin a cikin ƙwayoyin cuta biyu.
An ga canji a cikin ƙwayoyin cuta na ƙwayoyin cuta.
Hoton yana nuna ciwon numfashi mai tsanani (ARDS).
An ga lalacewar zuciya ta hanyar yawan yawan troponin ko kuma bugun zuciya a kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta kasa ta kasar Sin ta ruwaito.
A cewar bayanai daga Amurka a watan Maris, kashi 89% na waɗanda aka kwantar a asibiti suna da cututtukan da suka riga sun faru. Samun wadatar magunguna da yanayin tattalin arziki na yankin na iya shafar mutuwar.
Ƙididdigar mutuwar da ke faruwa saboda wannan yanayin ya bambanta saboda bambancin da ke tsakanin yankuna, amma kuma saboda ƙalubale na tsarin.
Rashin ƙididdigar ƙananan cututtuka na iya sa a yi tunanin yawan mutuwar fiye da yadda yake.
Duk da haka, gaskiyar cewa cutar ta riga ta sa mutane mutuwa zai iya nuna cewa yawan mutuwar yanzu ya fi na gaskiya.
Masu shan sigari sun fi fuskantar kamuwa da cutar COVID-19 sau 1.4 fiye da marasa shan sigari, suna bukatar kulawa mai zurfi sau 2.4 fiye da marasa shan sigari, kuma suna iya mutuwa. An kuma yi fargaba game da rikitarwa na tsawon lokaci.
Hukumar asibiti ta Hong Kong ta gano cewa wasu masu warkewa sun rage karfin huhu da kashi 20 zuwa 30 cikin dari, kuma gwajin huhu ya nuna cewa suna da lalacewa.
Wannan kuma zai iya haifar da ciwon bayan kulawa mai tsanani bayan warkewa.
Tun daga Maris 2020, ba a san ko waɗanda suka warke daga kamuwa da cutar ba suna samun gagarumar rigakafi na dogon lokaci.
Ana ganin samun rigakafi zai yiwu, bisa ga halayyar wasu coronaviruses, amma an sanar da cewa akwai waɗanda suka warke daga COVID-19 kuma suka sake kamuwa da shi daga baya.
An yi imanin cewa waɗannan yanayin za su ƙaru idan kamuwa da cuta ta ci gaba fiye da yadda take a lokacin da ta sake faruwa.
An yi imanin cewa cutar ta zama ta halitta kuma ta samo asali ne daga dabbobi, saboda yadda cutar ta yadu.
Ba a san ainihin asalin ba, amma a watan Disambar 2019, yaduwar cutar ta samo asali ne daga yaduwar mutum zuwa mutum.
Wani bincike da ya yi nazari kan mutane 41 da aka tabbatar da cutar ta COVID-19, wanda aka buga a cikin Janairu 2020 a cikin jaridar The Lancet, ya nuna cewa ranar 1 ga Disamba, 2019 ita ce ranar da za a fara nuna alamun cutar.
A cikin sanarwar da Hukumar Lafiya ta Duniya ta fitar, an ce ranar 8 ga watan Disamba na 2019 ce farkon lokacin da za a fara nuna alamun cutar.
Ana yin ayyuka da yawa don sanin adadin mutuwar.
Waɗannan adadi sun bambanta bisa ga yanki da kuma lokaci, kuma sun dangana ne bisa yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma halaye na yawan jama'a kamar su shekaru, jinsi, da kuma lafiyar jama'a.
A ƙarshen 2019, Hukumar Lafiya ta Duniya ta ba da lambar gaggawa U 07.1 ga waɗanda suka sami tabbacin SARS-CoV-2 da kuma lambar U 07.2 ga waɗanda suka kamu da COVID-19 da aka gano tare da asibiti ko annobar SARS-CoV-2 ba tare da tabbatar da cutar ba. An nuna yawan mutuwar daga kamuwa da cuta ta hanyar mutuwar da aka raba da adadin waɗanda aka gano a cikin wani lokaci.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar kamuwa da cuta a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Ƙididdigar sun bambanta da yankin. Sauran ma'auni sun haɗa da yawan mutuwar mutane (CFR), wanda yake nuna yawan waɗanda aka gano kuma suka mutu daga cutar, da yawan mutuwar cututtuka (IFR), wanda yake nuna yawan waɗanda suka kamu (wanda aka gano da wanda ba a gano ba) da kuma waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da lokaci, suna bin takamaiman mutane daga lokacin da aka kamu da cutar zuwa lokacin da aka san abin da ke faruwa da ita.
Ko da yake ba dukan mutane ba ne suke samar da rigakafin cutar, amma idan akwai, za su iya ba da bayani game da yawan waɗanda suke da cutar.
A tsakiyar annobar a Italiya, Castilloni d'Ada, ƙaramar ƙauye mai mutane 4,600, mutane 80 (1.7%) sun riga sun mutu.
A Ganglet, cutar ta yadu ne saboda bukukuwan bikin, kuma ta kai ga matasa, wanda ya haifar da karancin mutuwar, kuma watakila ba duk mutuwar COVID-19 aka tsara su a matsayin sakamakon ba.
Bugu da ƙari, ba a kashe tsarin kiwon lafiya na Jamus ba.
A Netherlands, kusan kashi uku cikin dari na masu ba da jini suna da rigakafi, bisa ga kimantawa da aka yi.
An tabbatar da mutuwar mutane 69 (0.004% na yawan jama'a) saboda COVID-19.
Tasirin annobar da kuma yawan mutuwar da ta haifar sun bambanta tsakanin maza da mata.
A cikin binciken da aka yi a ƙasar Sin da kuma Italiya, maza ne suka fi mutuwa.
Maza suna da haɗari sosai a shekara 50, kuma bambancin tsakanin maza da mata ya ragu ne kawai a shekara 90.
A ƙasar Sin, kashi 2.8 cikin 100 na maza da kuma kashi 1.7 cikin 100 na mata ne suke mutuwa.
Ba a san ainihin dalilin da ya sa mata da maza suke da bambanci ba, amma za a iya ganin cewa wasu abubuwa da suka shafi hali da kuma kwayoyin halitta ne suke da alaƙa da wannan.
Bambancin jikin mutum bisa jinsi, rashin shan sigari a tsakanin mata, da kuma ciwon da ke saurin faruwa a tsakanin maza kamar hawan jini a lokacin da suke ƙanana da mata, wataƙila sun sa maza su mutu sosai.
A Turai, kashi 57 cikin 100 na waɗanda suka kamu da cutar maza ne kuma kashi 72 cikin 100 na waɗanda suka mutu sanadiyyar COVID-19 maza ne.
Tun daga watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta bin diddigin bayanan da aka rarraba ta jinsi don kamuwa da COVID-19.
Bincike ya nuna cewa cututtuka kamar su Ebola, HIV, mura, da kuma SARS suna shafan maza da mata dabam dabam.
Ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, sun fi mata yawa, kuma suna da hadarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar a hukumance shi ne "COVID-19".
Darakta Janar na WHO, Tedros Adhanom Ghebreyesus, ya bayyana cewa KO shine gajerar kalmar corona, kuma WID shine gajerar cutar COVID-19 kuma yana nufin shekarar da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa nuna takamaiman wuri (kamar Sin), ko nau'in dabba ko rukunin mutane, daidai da shawarwarin ƙasashen duniya don lakabi da nufin hana lakabi. Ana kiran kwayar cutar da ke haifar da COVID-19 SARS-CoV-2.
Bugu da ƙari, Hukumar Lafiya ta Duniya ta yi amfani da kalmomin nan "COVID-19" da "virus da ke haddasa COVID-19" a cikin bayanan jama'a.
Ana kiran wannan cuta da kwayar cutar "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira wannan cuta da cutar "coronavirus" da kuma "Wuhan coronavirus".
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da sunayen Novel Coronavirus-2019 da kuma cutar numfashi mai tsanani da ke da alaƙa da Novel Coronavirus-2019 a matsayin sunayen wucin gadi na cutar da cutar bisa ga jagororin 2015 da ke hana amfani da shafukan yanar gizo a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a sarkar samar da kayayyaki, masana'antun dijital suna fitar da kayayyakin kiwon lafiya kamar su na'urar yin hanci da na'urar numfashi.
Alal misali, sa'ad da asibiti a Italiya yake bukatar bawul na na'urar numfashi, kuma mai ba da kayayyaki bai iya kawowa a kan lokaci ba, wani kamfani da ke wurin ya juya tsarinsa ya samar da bawul 100 da ake bukata cikin dare ɗaya.
Bayan barkewar cutar COVID-19, ka'idojin maƙarƙashiya, bayanai na ƙarya da kuma ruɗu game da asalin cutar, girmanta, rigakafinta, magani da sauran fannoni sun bayyana kuma sun bazu cikin sauri a Intanet.
Da alama mutane na iya canja wannan cuta zuwa wasu dabbobi.
Binciken bai sami tabbaci na cutar ta haifa a aladu, da duck, da kaza ba.
Babu magani ko rigakafi da aka amince da shi don magance cutar.
Hukumomin gwamnati, kungiyoyin ilimi, da masu bincike a masana'antu suna gudanar da bincike na duniya game da alluran rigakafi da magungunan COVID-19.
A watan Maris, WHO ta kaddamar da "Gwaji na Haɗin Kai" don kimanta tasirin maganin ƙwayoyin cuta huɗu na riga-kafi da ke da kyakkyawan aiki.
Babu riga-kafi, amma hukumomi daban-daban suna aiki tukuru wajen samar da riga-kafi da za a iya gwadawa.
Ana amfani da binciken SARS-CoV-2 na baya saboda yana kama da SARS-CoV-2 wajen amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ana nazarin dabarun yin amfani da kwayoyin halitta guda uku.
Na farko, masu bincike suna son su samar da cikakken maganin rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko ta mutu ko ta mutu, an yi niyyar haifar da amsawar rigakafin gaggawa a jikin mutum kan sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafin ƙwayoyin cuta, tana nufin samar da allurar da za ta sa tsarin garkuwar jiki ya zama mai saukin kamuwa da ƙwayoyin cuta.
A cikin SARS-CoV-2, wannan bincike ya mai da hankali ne a kan sunadarin Spike S wanda ke taimakawa kwayar cutar ta shiga cikin masu karɓar kwayar cutar ta ACE2.
Dabara ta uku ita ce allurar rigakafin DNA (tallafin RNA, sabuwar fasaha ce ta samar da rigakafi).
Ya kamata a gwada allurar rigakafin gwaji da aka samar ta kowane ɗayan waɗannan dabarun don tabbatar da amincinsu da ingancinsu. A ranar 16 ga Maris, 2020, an fara gwajin rigakafin farko a kan masu sa kai huɗu a Seattle.
Rigakafin yana dauke da lambar kwayar cutar da ba ta da lahani daga kwayar cutar da ke haifar da cutar. An nuna haɓaka da ke dogara da kwayar cutar a matsayin wata ƙalubale ga ƙirar SARS-CoV-2, amma wannan ya sabawa.
Akwai gwaje-gwaje na asibiti sama da 300 da ake yi tun daga watan Afrilu na shekarar 2020.
An riga an gwada magani guda bakwai da aka amince da su don zafin zazzabin cizon sauro, har da huɗu da suka shafi hydroxychloroquine ko chlorokine.
Magungunan rigakafin ƙwayoyin cuta da ake son sake amfani da su wajen magance sabuwar cutar sun kasance mafi yawan bincike na kasar Sin, tare da gwajin kashi na uku tara na Remdesivir a ƙasashe da dama da kuma shirin bayar da rahoton sakamakon su a ƙarshen watan Afrilu.
An gudanar da nazarin ci gaban asibiti na yiwuwar allurar rigakafin COVID-19 da magungunan rigakafi daga watan Afrilu 2020. Ana kuma kimanta magungunan rigakafin cutar da ke akwai don maganin COVID-19, ciki har da Remdesivir, Chlorokin, Hydroxychloroquine, Lupinavir/Ritonavir, da Lupinavir/Tonavir a hade tare da Interferon beta.
Akwai tabbaci na farko na ingancin Remdesivir, daga Maris 2020.
An ga ci gaba a asibiti a cikin marasa lafiya da aka yi wa magani da Remdesivir don amfani da shi a cikin mahaifa.
Ana gudanar da gwajin asibiti na mataki na uku a Amurka, China da Italiya. An yi amfani da chlorokine, wanda a baya ake amfani da shi wajen maganin zazzabin cizon sauro, a China a watan Fabrairu na 2020, kuma yana da sakamako na farko.
Duk da haka, akwai kira ga bita na takwarorinsu don bincike.
Hukumomin kiwon lafiya na Koriya da na Sin sun ba da shawarar yin amfani da chlorokine.
Koyaya, Cibiyar Binciken Kwayoyin cuta ta Wuhan ta nuna cewa duk da shawarar da aka bayar na gram ɗaya, kasa da wannan matakin na da haɗari sosai kuma na iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, Hukumar Abinci da Magunguna ta FDA ta ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine bisa ga shawarar likitocin da ke kula da waɗanda ke fama da COVID-19. Na 7 na jagororin na Sin ya haɗa da interferon, ribavirin ko ominefinovir don amfani da su don maganin COVID-19.
Bayanai na farko sun nuna cewa ana bukatar miyagun ƙwayoyi masu yawa na ribavirin don hana SARS-CoV-2 a cikin dakin gwaje-gwaje.
An ba da shawarar yin ƙarin bincike kan tasirin nitasoxaneid akan halittu bayan an tabbatar da hana shi zuwa ƙananan maida hankali na SARS-CoV-2. Nazarin ya nuna cewa farkon saitin furotin na Spike ta hanyar sirrin mai wucewa ta membrane 2 (TMPRSS2) ya zama dole don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACEA2.
Nazarin chlorokin da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da manyan gazawar da suka hana likitocin karɓar waɗannan jiyya ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a cikin dakin gwaje-gwaje kuma ba shi da sanannen rawar da yake takawa wajen maganin COVID-19.
Wataƙila wannan hadari na cytokine yana ɗaya daga cikin abubuwan da ke faruwa a ƙarshen COVID-19.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-citokin storm. Hukumar Lafiya ta Kasa ta China ta kara tosilezumab a cikin ka'idojin magani bayan kammala karamin binciken.
Ana gudanar da gwajin ba-da-tsari na mataki na 2 a ƙasar Italiya bayan da ya nuna cewa yana da kyau a cikin waɗanda suke da ciwo mai tsanani.
Ban da amfani da shi wajen gwada furotin a cikin jini don gano guguwar cytokine, yana nufin ya magance irin waɗannan ci gaba, wanda ake tsammanin ya sa wasu suka mutu.
Hukumar Abinci da Magunguna ta FDA ta amince da maganin mai karɓar kwayar cutar ta interleukin-6, maganin T-cell mai karɓar kwayar cutar ta chimeric, bisa ga nazarin yanayin koma baya don maganin cututtukan cytokine na marasa amsawa ga steroid wanda ke da dalili daban a cikin 2017.
Har zuwa yanzu, babu tabbaci mai ƙarfi cewa tosilezumab magani ne mai tasiri ga cututtukan cytokine.
Ana nazarin hanyar isar da rigakafin da aka tsabtace da kuma mai da hankali da tsarin rigakafin waɗanda suka warke daga COVID-19 ke samarwa ga waɗanda suke bukatarsu a matsayin hanyar da ba rigakafi ba na yin rigakafin.
An gwada wannan dabarar a kan SARS kuma sakamakon ba shi da kyau.
Rashin amfani da kwayar cutar na wakiltar hanyar aiki da ake tsammani ta hanyar maganin ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta na iya zama matsakaici na kariya ga SARS-CoV-2.
Amma, wataƙila za a iya yin amfani da wasu hanyoyin kamar su maganin ƙwayoyin cuta da ke dogara da ƙwayoyin cuta ko kuma ƙwayoyin cuta da ke dogara da ƙwayoyin cuta ko kuma su bi da bi.
Akwai wasu nau'o'in maganin ƙwayoyin cuta masu guba, kamar su yin amfani da ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta, da ake ci gaba da aiwatarwa.
Za a iya ƙara samar da maganin rigakafi, wanda ya ƙunshi ruwan jini na marasa lafiya da suka warke kuma yana ɗauke da ƙwayoyin cuta na musamman da ke hana cutar, don a iya yaɗuwa da sauri.
Cutar kwayar cuta ta Corona, tarin cututtuka masu alaƙa
Li Wen Liang, likita a asibitin Wuhan na tsakiya, ya kamu da cutar COVID-19 kuma ya mutu bayan ya jawo hankali kan yaduwar cutar.
